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ABSTRACT 
 
 
Amino Acids, Polyamines, and Nitric Oxide Synthesis 
in the Ovine Conceptus. (May 2004) 
Hyuk Jung Kwon, B.S., Konkuk University 
Co-Chairs of Advisory Committee: Dr. Thomas E. Spencer 
                                           Dr. Guoyao Wu 
 
The objective of this study was to determine concentrations of amino 
acids and polyamines as well as nitric oxide (NO) and polyamine synthesis in 
the ovine conceptus (embryo/fetal and associated placental membrane).  Ewes 
were hysterectomized on Days 30, 40, 60, 80, 100, 120, or 140 of gestation to 
obtain allantoic and amniotic fluids, intercotyledonary placenta, placentomes and 
uterine endometrium for the analyses.  Alanine, citrulline plus glutamine 
accounted for about 80% of total α-amino acids in allantoic fluid during early 
gestation.  Serine (16.5 mM) contributed about 60% of total α-amino acids in 
allantoic fluid on Day 140 of gestation.  Maximal ornithine decarboxylase (ODC) 
and arginase activities and highest rates of polyamine and NO synthesis 
occured in all tissues on Day 40 of gestation.  In ovine allantoic and amniotic 
fluids, polyamines were most abundant during early (Days 40-60) and late (Days 
100-140) gestation, respectively.  Activity of guanosine 5’-triphosphate-
cyclohydrolase I (GTP-CH), and concentrations of NOS cofactors, 
tetrahydrobiopterin (BH4) and NADPH (nicotinamide adenine dinucleotide), 
peaked on Day 40 of gestation in placental and endometrial tissues.  In these 
tissues, NO synthesis was positively correlated with total NOS activity, GTP-CH 
activity, and concentrations of BH4 and NADPH.  The physiological significance 
of these changes was manifested by undernutrition-induced intrauterine growth 
retardation (IUGR).  Maternal undernutrition (50% of National Research Council 
nutrient requirements) reduced concentrations of total α-amino acids in fetal 
 iv
plasma and fluids, and retarded fetal growth at both mid (Day 78) and late (Day 
135) gestation. Concentrations of polyamines in fetal fluids were lower in 
underfed ewes than in control-fed ewes.  Realimentation of underfed ewes 
between Days 78 and 135 of gestation increased concentrations of total α-
amino acids and polyamines in fetal plasma and fluids, when compared with 
non-realimented ewes.  Results of these studies demonstrate metabolic 
coordination among the several integrated pathways to enable high rates of 
polyamine and NO synthesis in the placenta and endometrium during early 
pregnancy.  Collectively, our findings may have important implications for both 
IUGR and fetal origins of adult disease. 
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CHAPTER I 
INTRODUCTION 
 
Amino acids are quantitatively important nutrients for fetal growth and 
development (Battaglia and Meschia, 1988), because they are building blocks 
for protein synthesis in the fetus.  Amino acids are an important source of energy 
for the growing fetus (Bell et al., 1989) and are essential to embryonic 
development and viability (Petters et al., 1990; Lane and Gardner, 1997).  They 
also act as interorgan shuttles for nitrogen or carbon (Christensen, 1990; 
Battaglia, 1992).  Amino acids are also substrates for the synthesis of a wide 
array of molecules with enormous versatility and importance.  For example, nitric 
oxide (NO) and polyamines (products of arginine catabolism) play a vital role in 
placental growth and development in rats and both are necessary for placental 
angiogenesis and development.   
The demand for amino acids during fetal life is met primarily by transport 
systems from maternal to fetal plasma as well as de novo synthesis by the 
placenta and/or the fetus (Cetin et al., 1991).  Conceptus (embryo/fetus and 
associated placental membranes and fluids) development during pregnancy can 
be affected by nutritional factors.  The quantity and quality of amino acids are 
more important to fetal growth and development (Hoet and Hanson, 1999). In 
general, the ovine fetus takes up more amino acids than are utilized for protein 
deposition (Battaglia, 2002).  However, little is known about metabolic fate or 
regulatory roles of amino acids in the ovine fetus and placenta.  Likewise, little is 
known about changes in amino acid concentrations in ovine fetal plasma and 
placental (amniotic and allantoic) fluids during gestation.  In the pig, an unsual 
abundance of arginine (4-6 mM) was observed in allantoic fluid during early (Day 
abun 
_______________ 
This thesis follows the style and format of Molecular Reproduction and 
Development. 
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40) gestation, compared with maternal plasma arginine concentrations (0.1-0.15 
mM) (Wu et al., 1995a, 1996b).  Such information provides an important 
foundation for studying protein nutrition and metabolism in the fetus.  The 
comparison between fetal and maternal amino acid concentrations provides 
useful information about dynamic changes in nitrogen exchange between the 
fetus and dam. 
The sheep is a widely used animal model for studying human concpetus 
development (Lemons et al., 1976; Marconi et al., 1989; Meier et al., 1981; Rice 
et al., 1987; Moores et al., 1994; Stewart et al., 2000; Battaglia and Regnault, 
2001; Osgerby et al., 2002).  The sheep has a synepitheliochorial type of 
placenta in which fetal-placental cotyledons fuse with uterine endometrial 
caruncles to form placentomes.  Ovine placental growth occurs largely in the first 
half of gestation before the majority of fetal growth that occurs during late 
gestation (Carter and Myatt, 1995).  The placentae of all mammalian species 
undergo rapid formation of new blood vessels (angiogenesis) and marked 
growth during gestation (Ford, 1995; Reynolds and Redmer, 2001).  Placental 
growth is the critical factor for controlling the survival, growth, and development 
of the fetus. 
 Polyamines (putrescine, spermidine, spermine) are key regulators of 
angiogenesis, early mammalian embryogenesis in the uterus, regulate the 
synthesis of DNA and protein, and are essential for cell proliferation and 
differentiation.  NO is a signaling molecule, a major endothelium-derived relaxing 
factor, a mediator of immune responses, a neurotransmitter, and an angiogenic 
factor (Reynolds and Redmer, 2001).  However, little is known about NO and 
polyamine synthesis in the placenta of the sheep or any other species. 
In the pig, nitric oxide synthase (NOS) activity and NO synthesis during 
early gestation decreased in response to maternal protein deficiency (Wu et al., 
1998b). However, little is known about placental NO and polyamine syntheses or 
hormonal regulation of these two pathways in sheep or any other species.  
Usually, amino acids are transported from the mother to the fetus by transport 
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systems.  The dysfunction of amino acid transport systems is associated with 
preeclampsia in the human (Evans et al., 2003).  Reduction in NO production by 
placenta may contribute to disorders of pregnancy, such as preeclampsia and 
intrauterine growth retardation (IUGR). 
Undernutrition in pregnant women may result from low dietary intake of 
nutrients owing to either a limited supply of foods or severe nausea and vomiting 
known as hyperemesis gravidarum (Snell et al., 1998).  Epidemiological studies 
in humans suggest that alterations in fetal nutrition and endocrine status may 
result in developmental adaptations that permanently change the structure, 
physiology and metabolism of the offspring, thereby predisposing individuals to 
cardiovascular, metabolic and endocrine diseases in adult life (Barker and Clark, 
1997).  Thus, studies of the mechanisms for IUGR brought about by maternal 
undernutrition have important implications for both human medicine and animal 
agriculture. 
Arginine is an essential precursor for the biosynthesis of a variety of 
substances with enormous importance.  Thus, the present work focuses on two 
metabolic pathways for arginine catabolism.  The first pathway is initiated by 
arginase, the enzyme which catalyzes the conversion of arginine to ornithine 
and urea; ornithine is utilized for the synthesis of polyamines by ornithine 
decarboxylase (ODC).  The second pathway is the conversion of arginine to 
citrulline and NO by NOS.  Importantly, arginase and NOS enzyme use arginine 
as a common substrate (Fig 1.1).  Thus, arginase may play an important role in 
regulating NO and polyamine synthesis in placenta. 
The objectives of this research are to determine changes in 
concentrations of amino acid and polyamines in ovine fetal fluids as well as 
placental and uterine tissues during normal and maternal undernutritional 
pregnancy.  The findings will provide an important foundation for future studies 
of the regulation of fetal and placental growth by amino acids under altered 
nutritional and physiological conditions.  New knowledge generated from this 
research will be beneficial for improving the efficiency of ovine reproduction in 
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ruminants.  This will estabilish the role of arginine as a major precursor for 
placental polyamine synthesis during gestation, and quantify placental NO 
synthesis.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1.1 Important roles for arginine in embryogenesis as well as placental and 
fetal growth.  Through increases in NO and polyamine synthesis, arginine 
stimulates angiogenesis and placental blood flow.  This auguments the transfer 
of nutrients and oxygen from the mother to the fetus, thereby promoting fetal 
growth and development. NO, nitric oxide; O2, oxygen. 
 
 
Arginine 
Embryogenesis 
Placental angiogenesis and growth 
Placental-fetal blood flow 
Nutrient and O2 supplies from the mother to the fetus 
Fetal growth and development  
NO Polyamines 
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CHAPTER II 
LITERATURE REVIEW 
 
Implantation and placentation in sheep 
 Implantation and placentation are required for fetal growth and 
development.  The first event is that the fertilized ovum reaches the uterus as a 
morula within 3-4 Days, and then the blastocyst develops and enlarges rapidly.  
After the initial expantion of the blastocyst at about Day 10, the inner layer forms 
the yolk sac wall with endoderm, and the elongated chorionic sac contains 
allantoic cavity that apposes the chorion to the end of the outer chorionic sac 
and apposes the amnion directly over its central portion (Fig 2.1).  Initiation and 
development of blastocyst cell motility is regulated by amino acid availability, 
especially leucine and arginine in mouse (Martin et al., 2003).  The blastocyst 
attaches with cytoplasmic protrusions to the endometrial surface, particularly 
caruncles of endometrium.  Caruncles are areas of non-glandular but well 
vascularized endometrium, and present within the uterus of ruminants.   The 
allantois originates from the posterior region of the primitive gut, and makes 
contact with chorion, thus refered to as the chorionallantoic membrane.  Patches 
of chorioallantoic membrane become cotyledons by developing villi, and 
cotyledons caruncular fuse with uterine epithelium, forming binucleate 
trophoblasts (Wooding, 1982; Cross et al., 1994).  In between the cotyledons is 
the intercotyledonary chorion, which is covered by simple trophoblast and 
modified only over the mouths of endometrial glands.  Multiple cotyledons are 
scattered across the placental surface.  Thus, placentation begins with 
implacntation of the blastocyst beneath the uterine epithelium and differentiation 
into embryonic and extraembryonic tissues (Cross, 1998)    
 
Placental growth and fetal development in sheep 
The placenta is a vital membrane, without which the fetus cannot develop 
during pregnancy.  The placenta is: (1) the interface for the exchange of nutrient 
                                                                                                                                 6 
 
Fig 2.1 Schematic of the ovine conceptus between about Days 20 and 40 of 
gestation. 
 
and waste products between the mother and the fetus (Rossant and Cross, 
2001); (2) the fetal respiratory organ for the exchange of gases of the fetus 
(Wimsatt,1950; Wooding, 1998; Mossman, 1987); (3) an active endocrine organ 
that synthesizes and secretes hormones, including progesterone, placental 
lactogen and growth hormone; and (4) the barrier for the fetus against 
pathogens and the maternal immune system (Regnault et al., 2002). 
The sheep has a synepitheliochorial type of placenta in which fetal-
placental cotyledons fuse with uterine endometrial caruncles to form 
placentomes.  Placental angiogenesis during early gestation is necessary to 
increase placental-fetal blood flow and, therefore, the supply of nutrients from 
Amniotic Cavity 
Embryo 
Allantois 
Yolk Sac 
Amnion 
Chorion 
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maternal to fetal blood (Ford, 1995).  Placental growth is also a critical factor for 
controlling the survival, growth and development of the fetus.  In sheep, the 
period of maximal placental weight is attained between Day 30 and 80 of 
gestation (Schneider, 1996).  A positive correlation exists between fetal birth 
size and placental weight (Heasman et al., 1999).  Three critical time points 
during ovine gestation include: (1) Day 58 (when placentomes are established); 
(2) placental growth is maximal prior to Days 60 to 70 of gestation; and (3) the 
maximal fetal growth occurs between Days 70 to 135 (a period of rapid fetal 
growth) (Osgerby et al., 2002).  The endometrium (a mucosal layer underlying 
the placenta) is also important for early embryonic development, implantation, 
placentation, as well as successful placenta and fetal development (Bazer, 
1992).  The developing fetus (Fig 2.1), surrounded by the amniotic fluid 
compartment and connected with the allantoic sac via the urachus and placental 
vasculature, receives nutrients mainly via the umbilical vein (Battaglia and 
Meschia, 1988).  The umbilical vein carries oxygen and nutrients obtained from 
the placenta to the fetus.  The amniotic fluid of the amnion provides a unique 
aqueous environment in which the fetus develops symmetrically (Fig 2.1).  
Amniotic fluid is composed of water and electrolytes from both the fetus 
(kidneys, lungs, epidermis, and fetal blood vessels in the placenta and umbilical 
cord) and the mother (decidual blood vessels via amniotic membranes) (Schmidt, 
1992).  When it is swallowed, amniotic fluid is a significant source of nutrients for 
the fetus (Schmidt, 1992).  The allantoic sac was traditionally considered to be a 
reservoir for fetal wastes (Alexander and Williams, 1968).  This fluid is derived 
from fetal and maternal secretions, but primarily from placental transport 
mechanisms (Bazer, 1989).  However, recent studies with pigs have shown that 
the allantoic sac plays an important role in the accumulation of nutrients and 
metabolism of both uteroferrin (a progesterone-induced iron-binding protein) and 
iron (Bazer, 1989), suggesting a hitherto unrecognized function of the allantoic 
sac in fetal nutrition.   
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Thus, the placenta and fetus interact in a variety of ways to ensure 
adequate nutrient supplies to the fetus to support developmental, metabolic, and 
signaling processes that are unique to fetal growth and development (Hay, 
1991).  The fetal demand for some factors, e.g. amino acids and glucose, is met 
in several ways, such as synthesis by the placenta and/or by the fetus and 
transport systems from maternal to fetal blood.  Amino acids, macronutrients, 
undoubtedly play a crucial role in supporting both placental and fetal growth. 
 
Roles of amino acids in conceptus development 
Amino acids are quantitatively important nutrients for many processes 
involved in fetal growth and development (Battaglia and Meschia, 1988).  Amino 
acids represent the main source of nitrogen for the growing fetus.  They are 
precursors for the synthesis of proteins and other biologically important 
substances, such as peptides, creatine, carnitine, porphyrins, polyamines, and 
nitric oxide (Reeds and Hutchens, 1994; Wu and Morris, 1998).  Amino acids 
also function as antioxidants (Fang et al., 2002), regulators of hormone secretion 
(Kuhara et al., 1991; Flynn et al., 2002), major fuels for fetal growth (Bell et al., 
1989), and signaling molecules (Wu and Morris, 1998; Flynn et al., 2002).  Some 
amino acids (e.g. arginine and ornithine) regulate the secretion of insulin, 
glucagon, growth hormone, prolactin, and placental lactogen.  Other amino acids 
(e.g. leucine and arginine) regulate gene expression and signal transduction.  In 
addition, amino acids are an important source of energy for the growing fetus 
(Bell et al., 1989). 
 
Glutamine 
Glutamine is the physiological precursor of both ornithine and arginine in 
mammals, including pigs (Wu et al., 1995b) (Fig 2.2).  In particular, glutamine 
serves as an essential precursor for the synthesis of purine and pyrimidine 
nucleotides for cell division, amino sugars and NAD+ (nicotinamide adenine 
dinucleotide) (Krebs, 1980) and serves as an important fuel for rapidly dividing 
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dinucleotide) (Krebs, 1980) and serves as an important fuel for rapidly dividing 
cells.  In sheep,  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 2.2. De novo synthesis of tetrahydrobiopterin in cells.  ASS, 
argininosuccinate synthase; ASL, argininosuccinate lyase; ASP, aspartic acid 
CP, carbamoyl phosphate; Glu, glutamic acid; α-KG, α-ketoglutarate; OAT, 
ornithine aminotransferase; OCT, ornithine carbamoyltransferase; P5C, 
pyrroline-5-carboxylate; NH3, ammonia.  
 
 
cells.  In sheep, the maternal to fetal flux of glutamine was the greatest among 
all amino acids (Bell et al., 1989).  Glutamine is essential to embryonic 
development (Petters et al., 1990) and viability (Lane and Gardner, 1997).  The 
abundance of glutamine in fetal fluids is consistent with its important role in fetal 
nitrogen and carbon metabolism (Vaughn et al., 1995), as well as in early 
mammalian embryogenesis (Petters et al., 1990).  Glutamate, a product of 
glutamine hydrolysis by glutaminase, binds with the N-methyl-D-aspartic acid 
receptor, resulting in an increase in the influx of calcium and its intracellular 
Glutamine 
Glutamate 
Pyrroline-5-carboxylate 
P5C synthase 
NH3Glutaminase 
Ornithine
Citrulline
Argininosuccinate
Arginine
ASL Fumarate
ASS 
ASP 
CP 
OCT
Glu 
OAT 
α-KG 
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concentration and consequently activation of neuroral NOS (nNOS) for NO 
synthesis (Atlante et al., 2001). 
 
Arginine 
Arginine is the precursor of ornithine and NO (Fig 2.3), a free radical with 
enormous physiological importance, including its possible role in regulating 
uterine and placental-fetal blood flow development.  Although arginine is found 
in liver via in the urea cycle, there is no net synthesis of arginine by this organ 
because an exceedingly high activity of arginase results in rapid hydrolysis of 
arginine (Flynn et al., 2002).  Arginine is one of the most abundant amino acids 
deposited in fetal tissue proteins (Meier et al., 1981; Sparks et al., 1985; Wu et 
al., 1999a), indicating the quantitative importance of arginine in fetal growth.   
In addition, arginine is the immediate physiological precursor of ornithine and 
NO.  NO has been recognized as an endothelium-derived relaxing factor, a 
neurotransmitter and a modulator of the immune response (Moncada and 
Higgs,1993).  Recent studies also implicate NO as a critical factor in increasing 
uterine 
 
 
 
                                    Cit 
 
 
 
 
 
 
Fig 2.3. Pathways for the production of NO and polyamines from arginine.  BH4, 
tetrahydrobiopterin; Cit, citrulline; DCAM, decarboxylated S-adenosylmethionine; 
MTA, methylthioladenosine; NOS, nitric oxide synthase; ODC, ornithine 
decarboxylase; SPDS, spermidine synthase; SPES, spermine synthase. 
Arginase
Arginine
NO 
NOS 
Ornithine
Spermine
Spermidine 
Putrescine 
ODC CO2
SPES
SPDS
DCAM 
DCAM 
MTA 
MTA 
BH4
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Uterine blood flow, and probably placental-fetal blood flow during gestation 
(Weiner et al., 1994; Suburo et al., 1995).  Therefore, the arginine-dependent 
NO synthesis plays an important role in regulating nutrient supply to the fetus.  
Moreover, NO has been shown to play a crucial role in maintaining uterine 
quiescence during pregnancy (Buhimschi et al., 1995). 
 
Ornithine 
Ornithine serves as the precursor for biosynthesis of polyamines (Fig 
2.3).  Ornithine also plays an important role in ammonia detoxification via the 
hepatic urea cycle (Smith, 1981; Meijer et al., 1990).  Half of the nitrogen must 
be supplied in the form of aspartate and another half in the form of carbamoyl 
phosphate in the synthesis of urea through the ornithine cycle (Fig 2.3).  As 
amino acid oxidation is a major source of energy for the fetus (Lemons et al., 
1976; Bell et al., 1989), the ammonia generated by this process must be 
efficiently removed as water-soluble urea, because of ammonia toxicity to animal 
cells (Meijer et al., 1990) and, particularly, the brain (Visek, 1968).  There is no 
known pathway for direct conversion of citrulline into ornithine in animals (Wu 
and Morris, 1998).  Thus, via the formation of arginine from citrulline in cells and 
tissues, citrulline can be a major source of ornithine, which has versatile roles in 
cellular nutrition and metabolism.  For example, ornithine is the precursor for the 
synthesis of polyamines, which are essential for placental and fetal development 
(Fozard et al., 1980). 
 
Citrulline 
Citrulline is an effective precursor for the synthesis of arginine.  NO is 
produced from L-arginine by NOS enzymes, forming the free radical NO and 
citrulline as a co-product.  The conversion of citrulline into arginine consumes 
ammonia in the form of aspartate (Wu and Morris, 1998).  All three NOS 
isoforms use NADPH as an electron donor and employ five enzyme cofactors to 
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catalyze a five-electron oxidation of arginine to NO with stoichiometric formation 
of citrulline (Bredt, 1999).  L-citrulline is utilized for NO production in virtually all 
cell types (Su and Austic, 1999).  As a neutral amino acid, citrulline does not 
compete with basic amino acids for transport by cells, because citrulline 
transporter is not energy-dependent and thus does not use the mitochondrial 
proton potential gradient (Indiveri et al., 1997).  Neutral amino acids share 
transport systems which are different form the ones responsible for cellular 
uptake of charged amino acids (Christensen, 1990).  Citrulline has recently been 
recognized as an efficient antioxidant protecting DNA, lipids and proteins from 
hydroxyl radical-induced oxidative damage (Akaschi et al., 2001).  This action of 
citrulline may contribute to a protective environment for fetal development.  In 
addition, citrulline is an effective precursor for arginine synthesis in virtually all 
animals because of the widespread presence of argininosuccinate synthase and 
argininosuccinate lyase in tissues, including placenta and kidneys (Wu and 
Morris, 1998) (Fig 2.2).   
 
Other amino acids 
Important nitrogenous products of amino acid metabolism in animals are 
summarized in Table 2.1.  The branched amino acids (leucine, isoleucine and 
valine) are used within the fetus and placenta for energy production and protein 
synthesis.  Proline plays an important role in making collagen in vertebrates, and 
generating of extracellular matrix.  Lysine shares the same transport system (y+) 
with arginine for entry into cells, and thus an increase in extracellular lysine 
concentration would be expected to decrease the intracellular availability of 
arginine for constitutive NO synthesis.  Taurine is a β-amino acid critical for 
neurological and cardiovascular development (Sturman, 1993). 
As previously indicated, amino acids play a vital role in development of 
the conceptus.  In general, the ovine fetus takes up more amino acids than 
utilized for protein deposition.  However, little is known about the metabolic fate 
or regulatory roles of amino acids in the ovine fetus.  Likewise, little is known ab- 
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TABLE 2.1 Important nitrogenous products of amino acid metabolism in animals 
Precursors Products     Functions 
Arg 
 
NO  
 
Vasodilator; signaling molecule; angiogenesis; cell metabolism; 
apoptosis 
 
Agmatine 
 
Signaling molecule; inhibitor of NOS and ODC; brain & renal 
function 
Cys 
 
Taurine 
 
Antioxidant; muscle contraction; bile acid conjugates; retinal 
function 
Glu 
 
GABA 
 
Neurotransmitter; inhibitor of glutamatergic, serotonin & NEPN 
activities 
Gln 
 
Glu & Asp  
 
Neurotransmitters; fuels for enterocytes; components of the malate 
shuttle 
 Citrulline Free radical scavenger; arginine synthesis 
 Glucosamine  Glycoprotein & ganglioside formation; inhibitor of NO synthesis 
 
Ammonia 
 
Renal regulation of acid-base balance; CP formation; cell 
metabolism 
Gly 
 
Serine 
 
One-carbon unit metabolism; ceramide & phosphatidylserine 
formation 
 
Heme 
 
Hemoproteins (e.g., hemoglobin, myoglobin, Cyt C, Cyt P450 & 
catalase) 
His 
 
Histamine 
 
Allergic reaction; vasodilator; control of gastric acid & central Ach 
secretion 
Met 
 
Homocysteine 
 
Oxidant; inhibitor of NO synthesis; risk factor for cardiovascular 
disease 
 
Betaine 
 
Methylation of homocysteine to methionine; one-carbon unit 
metabolism 
 Choline Synthesis of Ach (neurotransmitter & vasodilator), PTC & betaine 
Ser 
 
Glycine 
 
Antioxidant; bile acid conjugates; neurotransmitter; 
immunomodulatory 
Tryptophan Serotonin Neurotransmitter; smooth muscle contraction; hemostasis 
 NAS Inhibition of sepiapterin reductase (an enzyme for BH4 synthesis) 
 Melatonin Circadian & circannual rhythms; free radical scavenger; antioxidant
Arg & Met 
 
Polyamines 
 
Gene expression; DNA & protein synthesis; ion channel function; 
apoptosis; signal transduction; antioxidants; cell function, 
proliferation & differentiation 
Gln & Asp 
 
Nucleic acids 
 
Gene expression; cell cycle and function; protein and uric acid 
synthesis 
Trp & Gln 
 
NAD(P) 
 
Coenzymes for oxidoreductases; substrate of poly (ADP-ribose) 
polymerase  
Arg, Pro  
or Gln 
Ornithine 
 
Glutamate, glutamine & polyamine synthesis; mitochonfrial 
integrity 
 
Ach, acetylcholine; BH4, tetrahydrobiopterin; CP, carbamoylphosphate; Cyt, cytochrome; EPN, 
epinephrine; GABA, γ-aminobutyrate; NAS, N-acetylserotonin; NEPN, norepinephrine; NOS, 
nitric oxide synthase; ODC, ornithine decarboxylase; PTC, phosphatidylcholine; T3, 
triiodothyronine; T4, thyroxine. 
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out changes in amino acid concentrations in ovine fetal plasma and placental 
(amniotic and allantoic) fluids during gestation.  Comparisons between fetal and 
maternal amino acid concentrations provide useful information about dynamic 
changes in nitrogen exchange between the fetus and dam. 
 
Polyamine synthesis 
Arginine from the diet or from protein breakdown is hydrolyzed by 
arginase to form urea and ornithine.  Arginase is a key enzyme of the urea cycle 
that removes high toxic ammonium ions resulting from the protein degradation 
(Jenkinson et al., 1997; Wu and Morris, 1998).  Type I arginase is a cytosolic 
enzyme that is most abundant and highly expressed in the liver.  On the other 
hand, Type II arginase is a mitochondrial enzyme that is located primarily in the 
mitochondrial matrix and is widespread.  Type II arginase may be involved 
primarily in the production of ornithine as a precursor for the synthesis of proline, 
glutamate, or polyamines.  Arginase activity is inhibited by ornithine, lysine, and 
the branched amino acids (leucine, isoleucine, and valine) (Levillain et al., 1994).  
By modulating arginine availability, arginase can regulate NO synthesis (Li et al., 
2001). 
Ornithine serves as the precursor for biosynthesis of polyamines (Fig 2.3), 
with the first and rate-limiting step being catalyzed by ornithine decarboxylase 
(ODC) (Johnson, 1988).  Ornithine, as mentioned above, plays an important role 
in ammonia detoxification via the hepatic urea cycle (Smith, 1981).  The 
importance of ornithine and ODC in fetal development is suggested by the 
previous finding that polyamines are essential to early mammalian 
embryogenesis (Forzard et al., 1980).  Rapid cell proliferation is associated with 
enhanced ODC activity (Johnson, 1988), which necessitates an increased 
availability of ornithine.  The activity of ODC is dramatically increased in rapid 
tissue growth (Janne et al., 1978) and embryogenesis in rats (Russel and 
McVicker, 1972; Guha and Janne, 1976).  In rat placenta, the ODC activity 
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increased 40-fold from Day 10 to 17 of gestation and at the same time paralleled 
the period of rapid growth of the placenta (Hoshiai et al., 1981).   
The polyamines (putrescine, spermidine and spermine) are cationic 
molecules present in all living organisms.  Many natural products contain 
polyamine residues.  Polyamines are synthesized from ornithine (a product of 
arginine catabolism) and are essential to cell growth and diffentiation.  For 
example, uterine and placental growth is dependent on ODC activity (Willams 
and McAnulty, 1976).  Thus, ODC is widely expressed in all cell types, and 
expression of ODC is regulated by a variety of hormones and cytokines (Wu and 
Morris, 1998).  On the basis of recent findings of intestinal polyamine synthesis 
(Wu et al., 2000a, 2000b), ornithine produced in placental mitochondria can be 
available for polyamine synthesis by cytosolic ODC, spermidine synthase, and 
spermine synthase (Fig 2.3).  
Polyamines (putrescine, spermidine, and spermine) are key regulators of 
angiogenesis, early mammalian embryogenesis, placental trophoblast growth, 
and embryonic development in the uterus (Forzard et al., 1980; Henningsson et 
al., 1982).  Through binding intracellular RNA, DNA, nucleotide triphosphates, 
proteins, and other negatively charged molecules, polyamines (polycationic 
molecules) regulate gene expression, signal transduction, ion channel function, 
as well as DNA and protein synthesis (Igarashi and Kashiwagi, 2000).  
Polyamines, particularly spermine, are also endogenous scavengers of reactive 
oxygen species and hydroxyl radical (Ha et al., 1998), thereby protecting DNA 
(Khan et al., 1992; Basu and Marton, 1995), proteins, and lipids from oxidative 
damage (Chattopadhray et al., 2003), and potential transformation (Ha et al., 
1998).  Particularly, spermidine has an effect on the elongation of nascent RNA 
chains in cell nucleus (Hoshiai et al., 1981).  Thus, polyamines are essential for 
cell proliferation, differentiation, and function.  Consequently, the deficiency of 
ODC results in the depletion of polyamines and leads to massive apoptosis in 
the inner cellular membrane (Pendeville et al., 2001). 
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NO or not, does it matter during pregnancy? 
NO is derived from the amino acid L-arginine in an oxidative reaction that 
consumes molecular oxygen and NADPH (nicotinamide adenine dinucleotide 
phosphate hydrogen).  NOS is a monooxygenase that converts L-arginine and 
molecular oxygen to NO and L-citrulline.  NOS requires FAD (flavin adenine 
dinucleotide), heme, calcium, FMN (flavin mononucleotide), calmodulin and BH4 
(tetrahydrobiopterin) as cofactors, and the products of this reaction are NO, 
NADP+ and citrulline.  The regulated synthesis of NO in biological systems is 
essential, because NO cannot be stored and it is released as needed.  NO can 
diffuse and permeate across membranes, without the need for specific 
receptors.  Interaction of NO with oxygen results in the formation of the relatively 
inactive end products nitrate (NO3-) and nitrite (NO2-).  There are 3 isoforms of 
NOS identified: neuronal NOS (nNOS or type I); inducible NOS (iNOS or type II); 
and endothelial NOS (eNOS or type III).  Those three NOS isoforms can be 
divided into two functional classes based on the dependency of the enzymes on 
calcium for their activity.  Inducible forms, Type II NOS or iNOS, contain 
irreversibly bound calmodulin, and are hence largely independent of Ca+, 
although the constitutive forms, Type I NOS and III NOS (collectively referred to 
as cNOS), require Ca+ for their activity.   
Constitutive NOS is constitutively expressed in various cell types.  In 
contrast, inducible NOS is induced by inflammatory cytokines and certain 
hormones (Knowles and Moncada, 1994).  The NOS isoforms are present in the 
rat uterus during gestation (Buhimschi et al., 1996) and also in uterine tissues in 
sheep (Sladek et al., 1997).  NOS expression or activity exists in myometrium 
and endometrium of pregnant and non-pregnant sheep (Figueroa and 
Massmann, 1995; Massmann et al., 1999).  Uterus can have the capacity to 
produce NO, and NOS activity is high during pregnancy and decreases at the 
onset of parturition (Natuzzi et al., 1993).  Also uterine NO derives from neuronal 
NOS and endothelial NOS during the last third of gestation (Massmann et al., 
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1999).  On the other hand, the most abundant NOS mRNA in the rat uterus is 
the inducible NOS isoform (Ali et al., 1997).   
 
Nitric oxide production in different species 
Rates of NO production vary among tissues, depending on NOS activity 
and the availability of its substrates and cofactors.  In humans, NOS activity in 
placenta is greater than that in other tissues (Di Iulio et al., 1996; Ramsay et al., 
1996; Thomson et al., 1997).  In rats, inducible NOS and endothelial NOS were 
present in uterus during gestation (Buhimschi et al., 1996) and inducible NOS 
expression was not detected on Day 22 of pregnancy (Farina et al., 2001).  
Constitutive NOS activity was higher than inducible NOS activity in rat placenta 
during gestation, and thus NO production in placenta was higher during early 
gestation compared to mid- and late gestation (Thanda et al., 1996).  This result 
is consistent with the report that the activity of Ca2+-dependent NOS increased 
during early gestational age (Weiner and Thompson, 1997).   
Both constitutive NOS and inducible NOS are expressed in porcine 
placenta on Days 40 to 60 of gestation (Wu and Morris, 1998).  Placental NOS 
activity and NO synthesis were decreased during early gestation in response to 
maternal protein deficiency in pig (Wu et al. 1998b).  In sheep, there is very little 
inducible NOS activity in nonpregnant uterus of sheep (Figueroa and Massmann, 
1995; Massmann et al., 1999).  Inducible NOS activity may account for 
approximately 10% of total NOS activity in the endometrium (Massmann et al., 
1999).  However, constitutive NOS activity significantly increased in ovine 
myometrium, but not endometrium, in response to estrogen administration 
(Figueroa and Massmann, 1995).  In sheep, NO production by cotyledonary and 
intercotyledonary placenta tissues increased between Day 110 and 130 (Zheng 
et al., 2000).  However, little is known about placental and endometrium NO 
synthesis during early gestation. 
As previously indicated, NO, synthesized from L-arginine, has enormous 
metabolic versatility and physiological importance, including its potential roles in 
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regulating placental angiogenesis (Reynolds and Redmer, 2001) and uterine 
blood flow during gestation (Sladek et al., 1997).  NO may play a critical role in 
regulating uterine blood flow and thus nutrient supply to the fetus during 
gestation (Sladek et al., 1997).  However, as the endothelial vasodilator 
(Magness et al., 1996) and nitrovasodilator (Zhang et al., 2001), NO plays an 
important role in conceptus development.  Other physiological roles of NO 
during gestation are to regulate placental blood flow and limit platelet 
aggregation at the interface between the uterine and fetoplacental circulation 
(Norman and Cameron, 1996).  During pregnancy, arginase (Lowe, 2000), 
cyclooxygenase (Faletti et al., 1999), or sex hormones (Weiner et al., 1994) 
regulate placental NO synthesis.   
At present, little is known about NO synthesis or its regulation in the ovine 
placenta.  Available evidence supports the ideas that NO produced in placenta 
during pregnancy can: (1) regulate maintenance of uterine quiescence (Natuzzi 
et al., 1993; Massmann et al., 1999); (2) maintain or regulate vessel relaxation; 
(3) control vascular tone (King et al., 1995); (4) limit platelet aggregation in both 
maternal and fetal circulations (Radomski et al., 1990); and (5) suppress 
contractions of the underlying myometrium.  The reduction of NO production by 
placenta may contribute to disorders of pregnancy such as pre-eclampsia and 
intrauterine growth restriction (Sladek et al., 1997).  
 
Studies in intrauterine growth retarded (IUGR) pregnancies  
In normal pregnancy, concentrations of amino acids are significantly 
higher in the fetus than in the mother (McIntosh et al., 1984, Wu et al., 1998a).  
However, concentrations of amino acids were reduced in fetal rat plasma 
(Malandro et al., 1996) as well as plasma and fluids of fetal pigs (Wu et al., 
1998a) in response to maternal protein deficiency.  Under intrauterine growth 
retardation (IUGR), concentrations of amino acids, such as the branched amino 
acids (leucine, isoleucine, and valine) (Cetin et al., 1988, 1990) were 
significantly reduced in ovine fetus compared to normal pregnancy during 
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second and third trimesters (Cetin et al., 1992a).  Cetin and his coworkers 
suggested impairment in placental amino acid transport in women with IUGR, on 
the basis the finding that concentrations of the three branched amino acids, 
which share a common transport system, designated system “L”, in the human 
placenta, were lower in fetal plasma than in maternal plasma (Cetin et al., 1988, 
1990, 1992a).  Also concentrations of other amino acids, such as arginine, 
glutamine, and threonine, were consistently reduced in IUGR fetus, whereas, 
concentrations of some amino acids, particular glycine and proline were 
increased in amniotic fluid (Cetin et al., 1988; Economides et al., 1989).   
Each amino acid has its own unique metabolic pathway in a cell- and 
tissue-specific manner (Stipanuk and Watford, 2000), but the metabolic fate of 
amino acids may be different in IUGR.  For instance, glycine is usually rapidly 
taken up by the placenta from the maternal circulation via the “L” system, whose 
characteristics are Na+ independent.  The “L” system is responsible for the 
transport of several neutral amino acids (Jasson, 2001).  Interestingly, glycine is 
produced in the ovine placenta from serine (Cetin et al., 1991, 1992b; Moores et 
al., 1994), but metabolism of glycine and serine may be different in IUGR (Cetin 
et al., 1991, 1992b). 
Available evidence indicates that the birth weight and placental weight in 
sheep were reduced in IUGR (De Barro et al., 1992; Mellor and Murrary, 1981).  
Fetal growth depends on the supply of nutrients and oxygen from maternal to 
fetal blood via the placenta.  The limitation in the supply of these substances 
from maternal to fetal plasma may be related to placental dysfunction.  
Therefore, a decrease in the availability of amino acids in the fetus may 
contribute to IUGR.  Because IUGR is a major health problem in the U.S. and 
worldwide, elucidating the mechanisms responsible for IUGR is essential to 
improve pregnancy outcomes, and reduce the high costs of health care 
associated with small-for-gestation infants. 
In summary, available evidence indicates that both NO and polyamines 
(products of arginine catabolism) are key regulators of angiogenesis, 
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mammalian embryogenesis, as well as placental and fetal growth.  NO is an 
endothelium-derived relaxing factor, and plays an important role in regulating 
placental-fetal blood flow, and thus the transfer of nutrients and O2 from mother 
to fetus.  Recent studies have shown that NO is a key mediator of various 
female reproductive processes, including implantation, pregnancy maintenance, 
and delivery.  Likewise, polyamines regulate DNA & protein synthesis and, 
therefore, cell proliferation and differentiation, as well as placental and fetal 
growth.  Thus, amino acids play a crucial role in fetal growth and development.  
Maternal undernutrition results in IUGR in humans and domestic animals.  
However, the underlying mechanism(s) remain elusive.  The prevalence of 
maternal undernutrition in the United States and worldwide and the resulting 
poor pregnancy outcomes have provided an impetus for us to identify means to 
reverse the fetal growth retardation caused by this condition.  New knowledge 
about the mechanisms controlling fetal growth and development will be 
beneficial for designing new preventative and therapeutic interventions to 
optimize intrauterine growth.  Promoting an optimal intrauterine environment will 
not only ensure optimal fetal development but will also reduce the risk of chronic 
diseases in adult life.  This, in turn, will help ensure optimal pregnancy outcomes 
while saving billions of healthcare dollars annually both in the U.S. and around 
the world.  
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CHAPTER IlI 
                       DEVELOPMENTAL CHANGES OF AMINO ACIDS  
                                IN OVINE FETAL FLUIDS 
 
Introduction 
 Amino acids serve as essential precursors for the synthesis of proteins, 
peptides, neurotransmitters, aminosugars, purine and pyrimidine nucleotides, 
creatine, carnitine, porphyrins, melatonin, melanin, sphingolipids, polyamines, 
and nitric oxide (Wu and Morris, 1998; Stipanuk and Watford, 2000).  Amino 
acids also function as antioxidants (Fang et al., 2002), regulators of hormone 
secretion (Kuhara et al., 1991; Flynn et al., 2002), major fuels for fetal growth 
(Bell et al., 1989), and signaling molecules (Wu and Morris, 1998; Flynn et al., 
2002).  In particular, glutamine plays an important role in fetal nitrogen and 
carbon metabolism (Vaughn et al., 1995).  Polyamines, synthesized from 
ornithine (ultimately arginine) by ornithine decarboxylase, are essential to 
placental development and mammalian embryogenesis (Fozard et al., 1980).  
Importantly, nitric oxide, synthesized from L-arginine, has enormous metabolic 
versatility and physiological importance, including potential roles in regulating 
placental angiogenesis (Reynolds and Redmer, 2001) and uterine blood flow 
during gestation (Sladek et al., 1997).  Furthermore, serine and glycine are a 
major source of one-carbon units for cellular metabolism, including DNA 
synthesis and methylation (Snell and Fell, 1990).  Thus, amino acids play a vital 
role in development of the conceptus (embryo/fetus and associated placental 
membranes). The developing fetus, surrounded by the amniotic fluid 
compartment and connected with the allantoic sac via the urachus and placental  
 
_______________ 
*Reprinted with permission from “Developmental Changes of Amino Acids in Ovine 
Fetal Fluids” by Hyukjung Kwon, Thomas E. Spencer, Fuller W. Bazer, and Guoyao 
Wu. 2003. Biol Reprod 68(5): 1813-1820. Copyright by the Society for the Study of 
Reproduction. 
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vasculature, receives nutrients mainly via the umbilical vein (Battaglia and 
Meschia, 1988).  The amniotic fluid provides a unique aqueous environment in 
which the fetus develops symmetrically.  When it is swallowed, amniotic fluid is a 
significant source of nutrients for the fetus (Schmidt, 1992).  In contrast, the 
allantoic sac was traditionally considered to be a reservoir for fetal wastes 
(Alexander and Williams, 1968).  However, recent studies with pigs have shown 
that the allantoic sac plays an important role in the accumulation of nutrients and 
metabolism of both uteroferrin (a progesterone-induced, iron-binding protein) 
and iron (Bazer, 1989), suggesting a hitherto unrecognized function of the 
allantoic sac in fetal nutrition.   
 We recently reported an unusual abundance of arginine (4-6 mM) in 
porcine allantoic fluid during early (Day 40) gestation, compared with maternal 
plasma arginine concentrations (0.1-0.15 mM) (Wu et al., 1995a, 1996a, 1998a).  
However, it is not known whether such high concentrations of arginine are 
unique for porcine allantoic fluid or whether they represent an important 
physiological phenomenon for mammals.  Although there have been studies of 
amino acid uptake into umbilical vessels (Lemons et al., 1976), placental 
arginine transfer (Thureen et al., 2002), as well as placental and hepatic 
metabolism of glycine, serine, glutamate and glutamine (Geddie et al., 1996; 
Chung et al., 1998) in fetal sheep during late gestation (Days 118–146), little is 
known regarding changes in concentrations of amino acids in ovine fetal fluids 
associated with conceptus development.  Such information will provide a critical 
database for future studies to quantify amino acid metabolism in the ovine fetus, 
to define fetal amino acid requirements, and to elucidate mechanisms 
responsible for intrauterine growth retardation and fetal origin of adult diseases.   
 We hypothesized that arginine was the most abundant amino acid in 
ovine allantoic fluid during early gestation. This hypothesis was tested by 
quantifying concentrations of 24 amino acids in ovine amniotic and allantoic 
fluids, as well as fetal and maternal plasma, between Days 30 and 140 of 
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gestation.  The measurement of amino acids other than arginine is necessary to 
determine its relative abundance in ovine fetal fluids. 
 
Material and Methods 
Chemicals 
High-performance liquid chromatography (HPLC)-grade water and 
methanol were obtained from Fisher Scientific (Fair Lawn, NJ).  All other 
chemicals used for amino acid analysis were purchased from Sigma Chemicals 
(St. Louis, MO). 
 
Ewes 
Columbia cross-bred ewes were mated to Suffolk rams when detected as 
being in estrus (Day 0) and at 12 and 24 h later.  Ewes were then assigned 
randomly to be hysterectomized (n = 4 per day) on either Day 30, 40, 60, 80, 
100, 120, or 140 of gestation to allow collection of fetal fluids as well as maternal 
and fetal blood.  These gestational ages were selected to include early, mid- and 
late gestation in sheep (term, 147 days).  In preliminary studies, we determined 
that concentrations of amino acids in fetal plasma, allantoic fluid, or amniotic 
fluid were similar between twin fetal lambs from the same ewes.  Thus, samples 
were obtained from only one fetus per ewe for amino acid analysis when twin 
fetal lambs were present.  None of the ewes in the study had more than twin 
fetuses.  Throughout gestation, ewes had free access to water and were fed 
individually 1.4 kg/day of an alfalfa-based diet (consisting of 13.6% corn, 1.9% 
rice bran, 4.5% cottonseed meal, 3.0% cottonseed hull, 73.31% dehydrated 
alfalfa, 2.5% liquid binder, 0.4% soy oil, 0.5% ground limestone, 0.065% vitamin 
mixture, 0.15% salt mixture, and 0.075% mineral oil) that met the recommended 
NRC (National Research Council, 1985) requirements.  The diet contained the 
following nutrients: 90.9% dry matter, 58.7% total digestible nutrients, 15.8% 
crude protein, 3.7% fat, 27.0% acid detergent fiber, 35.0% neutral detergent 
fiber, 1.23% calcium, 0.441% chloride, 0.285% magnesium, 0.306% 
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phosphorus, 2.01% potassium, 0.135% sodium, 0.221% sulfur, 0.385 ppm of 
cobalt, 7.67 ppm of copper, 0.258 ppm of iodine, 335 ppm of iron, 38.4 ppm of 
manganese, 0.555 ppm of selenium, 23.7 ppm of zinc, 147554 IU/kg of vitamin 
A, 316 IU/kg of vitamin D, 100 IU/kg of vitamin E, and 6.45 mg/kg of vitamin K.  
Ewes consumed all of the feed provided daily.  This study was approved by the 
Texas A&M University Institutional Agricultural Animal Care and Use Committee. 
 
Hysterectomy and sample collection 
Hysterectomies were performed between 0800 and 0900 h at 24 h after 
the last feeding.  All ewes were administered isofluorane (5%) to induce 
anesthesia and anesthesia was maintained with isofluorane (1%-5%).  A mid-
ventral laparotomy was then performed to expose the reproductive tract.  
Maternal uterine arterial blood (3 ml) and fetal umbilical venous blood (1 ml) 
were collected into heparinized tubes.  Blood could not be obtained from fetal 
umbilical vein on Day 30 of gestation because of the small size of the vessels.  
Amniotic and allantoic fluids were obtained through the amniochorion and 
chorioallantoic membranes, respectively.  Blood was centrifuged at 3000 x g at 
4oC for 10 min to obtain plasma.  Plasma, amniotic and allantoic samples (0.5 
ml) were deproteinized with 0.5 ml of 1.5 M HClO4 and neutralized with 0.25 ml 
of 2 M K2CO3.  Recovery of free amino acids from blood and fetal fluids was 
determined by adding known amounts of amino acid standards as previously 
described (Wu et al., 1998a) and was found to be greater than 95% for all amino 
acids. 
 
Analysis of amino acids. 
Amino acids, except for proline, were determined by fluorometric HPLC 
methods involving precolumn derivatization with o-phthaldialdehyde as 
previously described (Wu et al., 1997).  The values for total cysteine in plasma 
and fluids represent free cysteine plus ½ cystine.  Proline was measured using a 
fluorometric HPLC method involving precolumn derivatization with 9-
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fluorenylmethyl chloroformate (Wu et al., 1997).  Amino acids in samples were 
quantified on the basis of authentic standards (Sigma) using Millenium-32 
Software (Waters, Milford, MA). 
 
Calculations and statistical analysis 
Amino acid concentrations in plasma, amniotic and allantoic fluids were 
calculated on the basis of the recovery rates of amino acids from ovine plasma, 
amniotic fluid, and allantoic fluid, respectively.  For each gestational age, total 
content of amino acids in amniotic and allantoic fluids was calculated by 
multiplying amino acid concentrations by amniotic and allantoic fluid volumes, 
respectively.  Concentrations of total α-amino acids (all measured amino acids 
except for β-alanine and taurine) were a mathematical sum of the individual α-
amino acids.  Data were subjected to least-squares analyses of variance, using 
the PROC GLM, PROC REG, and PROC CORR procedures of Statistical 
Analysis System (SAS, Cary, NC).  Differences between means were 
determined by the Student-Newman-Keuls multiple-comparison test (SAS, Cary, 
NC).  Statistical significance was set at a probability value of 0.05 or less. 
 
Results 
Fetal growth and fluid volume 
Data regarding fetal weights as well as allantoic and amniotic fluid 
volumes are summarized in Table 3.1.  Fetal weights increased with gestational 
age (P < 0.01, quadratic).  The absolute growth rate of the fetal lamb was low 
(2.0 g/day) from Day 30 to Day 60 of gestation but increased rapidly (50.8 g/day) 
from Day 60 to Day 140.  Weight gain from Day 120 to Day 140 of gestation was 
similar to that during the first 4 mo of gestation, indicating increased 
requirements for amino acids for protein deposition during late gestation.  The 
volume of amniotic fluid increased progressively from Day 30 to Day 100 of 
gestation and then declined (P < 0.01, quadratic).  The volume of allantoic fluid 
increased (P < 0.01) progressively from Day 40 to Day 120 of gestation and did  
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TABLE 3.1.  Ovine fetal weight and volumes of allantoic and amniotic fluids 
Day of gestation Fetal weight Allantoic fluid Amniotic fluid 
  (g)  (ml)  (ml) 
30 0.88 ± 0.15 g   31 ± 4.0 d     2.2 ± 0.20 e 
40 4.97 ± 0.30 f    11 ± 3.4 e      23.8 ± 2.5 d  
60   61 ± 3.3 e   31 ± 3.8 d       190 ± 14 c 
80      312 ± 14 d        46 ± 3.9 c 543 ± 26 a 
100    1005 ± 65 c      199 ± 25 b 595 ± 43 a 
120    2322 ± 80 b      491 ± 77 a 383 ± 58 b 
140    4125 ± 418 a      366 ± 73 a 449 ± 71 b 
 
a-gData are means ± SEM for 4 ewes per gestational age.  Means with different 
superscript letters within a column are different (P < 0.01). 
 
not differ (P > 0.05) between Days 120 and 140 of gestation.  Interestingly, the 
increase in allantoic fluid volume was closely correlated with the increase in fetal 
weight between Days 40 and 120 of gestation (r = 0.89, P < 0.01). 
 
Amino acids in maternal uterine arterial and fetal umbilical venous plasma  
Changes (P < 0.01) were observed in concentrations of all amino acids, 
except for proline and tyrosine, in maternal plasma during gestation (Table 3.2).  
Glycine was the most abundant amino acid in maternal plasma at all gestational 
ages (P < 0.01), accounting for approximately 25% of total α-amino acids.  
Alanine, glutamine, glycine, and serine were the most abundant amino acids in 
fetal umbilical venous plasma, which together contributed about 50% of total α-
amino acids (Table 3.3).  Marked changes (P < 0.01) were observed in 
concentrations of all amino acids, except for alanine, aspartate, isoleucine, 
leucine, phenylalanine, tryptophan, and valine, in fetal umbilical venous plasma 
between Days 40 and 140 of gestation.  Fetal:maternal plasma ratios for amino  
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TABLE 3.2.  Concentrations of amino acids (AA) in ovine uterine arterial plasma 
 Day of gestation 
Amino acid 30 40 60 80 100 120 140 SEM 
 µmol/L 
Ala 270 a 241 ab 216 b 273 a 307 a  201 b 205 b     20 
β-Ala   19 c 27 a    22 bc   13 d   21 bc     25 ab    21 bc     1.6 
Arg 191 a   104 c  118 bc  125 bc 134 b 189 a    131 b     7.5 
Asn   38 a  22 c   27 b   28 b   36 a   27 b      37 a     2.1 
Asp   17 a       9.8 c       6.8d       7.5d   13 b   12 b       8.1cd     1.4 
Cit  181 bc 158 cd 210 a 205 a 125 e  157 cd   141 de     10 
Cys 188 b 209 ab 173 b 235 a 191 b 181 b 144 c     11 
Gln  248 bc   177 d 215 c 264 b 370 a 203 c 350 a     15 
Glu 137 a  88 b   48 c   91 b 109 b   90 b   61 c     9.3 
Gly 566 c 587 c 484 d 748 a   676 ab  631bc 655 b     35 
His   70 a  56 b   53 b   56 b    55 b    41 c   44 c     2.6 
Ile   66 c  58 c   61 c   65 c      71 bc    80 ab   85 a     5.0 
Leu  111 a  99 a   76 b 101 a    97 a 108 a 104 a     8.7 
Lys  119 a  90 b    72 c   92 b    83 bc 111 a 114 a     8.9 
Met     22 bc  19 c   24 b   23 b    31 a   31 a   29 a     1.5 
Orn    98 a   81 b   79 b   56 c    55 c   44 d   33 e     6.0 
Phe      33 bc   31 c   24 d 125 a    36 b   39 b    33 bc     2.1 
Pro 115    127    127    113     108    120    114     6.6 
Ser     80 b 118 a  62 c   81 b     87 b    61 c    53 c     6.1 
Taurine      54 bc   43 c  22 d   44 c     64 b    47 c  122 a     8.7 
Thr     98 a   60 b  62 b   73 b     66 b    73 b    46 c     6.3 
Trp     30 a   34 a  23 b   25 b     25 b    21 b    15 c     2.2 
Tyr   43 52     39 45   48 45  41     3.2 
Val   171 a   154 ab 148 b   122 bc    129 bc  128 bc   118 c     9.5 
Total α-AA  2892 a  2573 b  2347 b  2954 a   2851 a 2593 b   2561 b      65 
 
a-eData are means with pooled SEM values for 4 ewes per gestational age. 
Means with different superscript letters within a row are different (P < 0.01).  
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TABLE 3.3.  Concentrations of amino acids (AA) in ovine fetal umbilical venous 
plasma 
 Day of gestation 
Amino acid 40 60 80 100 120 140 SEM
 µmol/L 
Ala 383  296  382  416  417  423  32 
β-Ala     40 e    132 c     78 d   201 b    284 a   266 a 21 
Arg   187 d    364 b    231 c   661 a    360 b   244 c 29 
Asn    51 d      83 b     84 b   117 a      77 c     89 b      7.3
Asp  15      14     12   15       14      11         1.2
Cit  168 d     347 ab   216 c   226 c    302 b   393 a 29 
Cys   190 ab   127 c   214 a   202 a    129 c   173 b       9.2
Gln   351 d   409 d   399 d   879 a     542 c   661 b 59 
Glu   141 a     48 b     35 c     32 c        37 c     35 c      4.5
Gly   424 d    518 cd    612 bc   684 b     985 a 1041a   83 
His     91 a     84 a     54 b     82 a       62 b     65 b      6.2
Ile      104    89     85  112   110  117  15 
Leu      190  168  171  200   187  163  23 
Lys    213 ab    272 a   199 b    204 b     181 b   133 c 21 
Met     35 d      75 b     75 b    101 a      70 b     56 c      7.8
Orn   137 b     214 a    139 b      87 c     114 bc   122 b 17 
Phe  97  110 123 117  107 109      8.3
Pro  209 b     206 b     208 b    203 b     303 a    319 a 19 
Ser  290 e     379 d     441 d    670 b     903 a     554 c 47 
Taurine    99 b     118 b     117 b    166 a     110 b     171 a 18 
Thr   164 c     343 a     314 a     351 a      308 ab     266 b 27 
Trp  37     56     48    52     46    40      3.6
Tyr  118 b      208 a     132 b    132 b     122 b    139 b 16 
Val      378     271    235    307    276    311  31 
Total α-AA    3973 b     4680 b   4410 b   5849 a     5651 a    5466 a    277 
 
a-eData are means with pooled SEM values for 4 ewes per gestational age.  
Means with different superscript letters within a row are different (P < 0.01).  
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TABLE 3.4.  Ovine fetal:maternal ratios of plasma amino acids 
 Day of gestation 
Amino acid 40 60 80 100 120 140 SEM 
        
Ala 1.6 b 1.4 b 1.4 b 1.5 b    2.2 a   2.1 a 0.15 
Β-Ala 1.5 d 6.1 c 5.9 c 9.8 b   12 a   13 a 0.76 
Arg 1.8 c 3.1 b 1.9 c 5.0 a   1.9 c   1.9 c 0.24 
Asn     2.6     3.1     3.2    3.3     2.8 2.5 0.29 
Asp 1.6 b  2.1 a 1.5 b 1.2 b   1.3 b   1.4 b 0.25 
Cit 1.1 c  1.7 b 1.1 c 1.8 b   2.1 b   2.8 a 0.23 
Cys    0.90 b    0.73 c    0.91 b 1.1 a    0.72c   1.2 a 0.05 
Gln   2.1 bc   1.9 c   1.5 d   2.4 ab   2.6 a   1.9 c  0.16 
Glu  1.6 a  1.0 b    0.40 d   0.30 d    0.40d     0.58c 0.07 
Gly    0.73 c  1.1 b    0.81 c 1.0 b   1.6 a   1.6 a 0.06 
His  1.6 a  1.6 a  1.0 b 1.5 a   1.6 a   1.5 a 0.13 
Ile     1.7     1.5     1.3    1.6     1.4 1.4 0.16 
Leu     1.9     2.2     1.7    2.1     1.7 1.6 0.21 
Lys  2.4 b 3.8 a  2.2 b 2.5 b   1.6 c    1.2 c 0.24 
Met  2.1 b 3.2 a  3.3 a 3.3 a    2.2 b    2.0 b 0.31 
Orn  1.7 c 2.7 b  2.5 b 1.6 c    2.6 b    3.7 a 0.24 
Phe  3.1 b 4.6 a  1.0 c 3.3 b    2.8 b    3.3 b 0.27 
Pro  1.7 b 1.7 b  1.9 b 2.0 b    2.7 a    2.9 a 0.16 
Ser  2.5 e 6.1 d  5.6 d 7.8 c   15 a   11 b 0.89 
Taurine  2.3 b 5.4 a  2.6 b 2.6 b    2.3 b    1.5 c 0.35 
Thr  2.8 c 5.6 a  4.3 b 5.3 a    4.4 b    5.8 a 0.47 
Trp  1.1 c 2.5 a  1.9 b  2.2 ab     2.2 ab    2.6 a 0.27 
Tyr  2.3 c 5.4 a  3.0 b  2.7 bc     2.7 bc    3.3 b 0.35 
Val     2.4    1.9     2.0    2.5     2.3  2.6 0.24 
 
a-eData are means with pooled SEM values for 4 ewes per gestational age.  
Means with different superscript letters within a row are different (P < 0.01). 
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acids varied greatly, being the lowest for glutamate (e.g., 0.3 on Day 100 of 
gestation), between 1.5 and 3 for most amino acids throughout gestation, and 
greatest for serine (e.g., 15 on Day 120 of gestation) (Table 3.4).  Interestingly, 
fetal:maternal plasma ratios for asparagine, isoleucine, leucine, and valine did 
not differ (P > 0.05) during gestation.  In contrast, changes (P < 0.01) were 
observed in fetal:maternal plasma ratios for all other amino acids measured 
between Days 40 and 140 of gestation (Table 3.4).  
 
Amino acids in amniotic fluid 
Concentrations of amino acids in amniotic fluid are summarized in Table 
3.5.  As in fetal plasma, alanine, glutamine, glycine, and serine were the most 
abundant α-amino acids at all gestational ages, and contributed about 50% of 
total α-amino acids.  Marked changes were observed in concentrations of all 
amino acids in amniotic fluid during pregnancy.  Between Days 30 and 60 of 
gestation, concentrations of the following amino acids decreased (P < 0.01): 
glutamine, glycine, histidine, lysine, methionine, serine, and threonine.  In 
contrast, concentrations of the following amino acids increased (P < 0.01) from 
Day 30 to Day 60 of gestation: arginine, aspartate, citrulline, cysteine, glutamate, 
leucine, ornithine, proline, taurine, tryptophan, and tyrosine.  Except for β-
alanine, aspartate, citrulline, cysteine, ornithine, serine, and taurine, the lowest 
concentrations of all amino acids were on Days 80-100 of gestation.  Between 
Days 120 and 140 of gestation, concentrations of proline and threonine 
decreased (P < 0.01), whereas concentrations of the following amino acids 
increased (P < 0.01): β-alanine, arginine, citrulline, glutamine, glutamate, 
glycine, histidine, isoleucine, lysine, ornithine, and tryptophan. 
Marked changes were observed in the total content of individual amino 
acids in amniotic fluid during gestation (Table 3.6).  Between Days 30 and 60 of 
gestation, the total content of α-amino acids increased (P < 0.01) by 
approximately 80-fold. 
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TABLE 3.5.  Concentrations of amino acids (AA) in ovine amniotic fluid 
 Day of gestation 
Amino acid 30 40 60 80 100 120 140 SEM
 µmol/L 
Ala   498 b   668 a  573 b 28 e 62 d  201 c  277 c 31 
β-Ala  22 d  20 d    43 c 22 d  34 cd  256 b  396 a 10 
Arg   120 c    105 c  177 b 17 d 15 d  155 b  212 a 14 
Asn  74 a   65 a   82 a 12 c 16 c    36 b    41 b      4.6
Asp      6.8 b       2.8c   10 a      5.1 b 13 a    14 a   12 a      1.7
Cit  42 d   61 c   207 ab 22 e  43 d  164 b  260 a 21 
Cys  43 e    183 a 102 c 33 e 68 d  138 b 130 b      6.3
Gln 501 a 328 c 410 b 41 f 88 e  251 d   388 bc 25 
Glu   27 c    41 b   67 a      8.7 e 18 d    28 c    41 b      3.7
Gly 426 b 230 c  281 c 48 e 94 d   436 b  579 a 38 
His   82 a   48 b   56 b      4.4 d 17 c    23 c    43 b      4.1
Ile   31 a   39 a   37 a      3.4 d      6.1 c    24 b    36 a       3.8
Leu   75 b   97 a 109 a 24 c      7.1 d     87 ab    65 b       9.2
Lys 264 a    135 c 186 b 47 e 24 f    45 e    72 d       7.8
Met   58 a   44 b   43 b     1.6 e      8.3 d    21 c    27 c       2.5
Orn   63 b   38 c 122 a  85 ab 18 d    24 d    43 c       5.9
Phe   30 a   35 a   33 a 21 b      8.2 c    31 a    37 a       2.6
Pro   89 c    145 b 172 a 32 d 25 d  133 b    94 c       8.8
Ser    320 b  214 cd 186 d 84 e 275 bc   897 a   812 a  43 
Taurine   31 c   44 c   89 b 84 b     299 a  105 b     93 b       9.4
Thr  231 a   82 d   103 cd 15 f  47 e  147 b   119 c  19 
Trp   13 b  12 b    19 a      3.1 e      7.4 d        9.4 c      12 b       1.0
Tyr   33 c  49 b    45 b      3.2 e 10 d     52 ab      62 a       5.4
Val    150 a 148 a   138 ab 12 d 28 c  112 b     124 ab  15 
Total α-AA  3177 a 2768 b 3158 a 550 d 898 c 3028 a 3487 a   153 
 
a-f Data are means with pooled SEM values for 4 ewes per gestational age.  
Means with different superscript letters within a row are different (P < 0.01). 
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TABLE 3.6.  Total content of amino acids (AA) in ovine amniotic fluid 
 Day of gestation 
Amino acid 30 40 60 80 100 120 140 SEM
 µmol 
Ala 1.05 e   16 d  112 a 15 d 37 c  76 b   125 a 8.4 
β-Ala 0.05 f    0.48e     8.2 d 12 d 20 c 102 b   176 a 7.7 
Arg 0.28 f   2.6 e 34 c      9.1 d      9.0 d   60 b  94 a 7.3 
Asn 0.17 f   1.6 e 16 ab      6.6 d      9.5 c   14 b  19 a 1.2 
Asp 0.02 f    0.07e     1.9 d      2.8 c      7.6 a      5.2b      5.3b 0.1 
Cit 0.09 g  1.5 f     39 c 12 e  26 d   63 b 116 a  11 
Cys 0.09 e   4.4 d     19 c 17 c  42 b    51 ab   59 a 5.7 
Gln 1.13 f   8.0 e     79 b 22 d  52 c   97 b 176 a 8.4 
Glu 0.06 e   1.0 d 13 b      4.8 c  11 b   12 b   18 a 2.0 
Gly 0.95 f    5.7 e 54 c 26 d  56 c 168 b  261 a  11 
His 0.19 e   1.2 d 11 b      2.4c  10 b      8.9b   20 a 1.5 
Ile 0.07 g    0.94f      6.9 c      1.8e      3.7d      9.2b   17 a 1.3 
Leu    0.17 f   2.4 e 21 b  13 c      4.2d  34 a   29 a 3.7 
Lys 0.60 e   3.3 d 35 a  25 b  14 c  17 c   32 a 2.4 
Met 0.13 e   1.1 d      8.3 b     0.9d      4.9c      8.1b   12 a 1.6 
Orn 0.14 e    0.91d 23 b  46 a  11 c      9.3c   20 b 3.4 
Phe 0.07 e    0.90d      6.4 c  11 b      4.8c  12 b   17 a 1.1 
Pro 0.20 e   3.5 d 33 b  18 c  15 c   52 a   43 a 3.9 
Ser 0.71 e   5.2 d 36 c  47 c    163 b 344 a 366 a  24 
Taurine 0.07 e   1.1 d 17 c  46 b 180 a   41 b   42 b  10 
Thr 0.52 e   2.0 d 20 b      8.2c   28 b   57 a   54 a 5.7 
Trp 0.03 f    0.30e      3.7 c      1.7d      4.6b     3.7c      5.5a 0.1 
Tyr 0.07 f   1.2 e      8.7 c      1.8e      5.9d 20 b  29 a 0.9 
Val 0.34 f   3.7 e 26 c      6.4e  17 d 43 b  57 a 3.3 
Total α-AA    7.1 f   68 e   607 b    299 d    537 c 1165 b  1576 a 121 
 
a-g Data are means with pooled SEM values for 4 ewes per gestational age.  
Means with different superscript letters within a row are different (P < 0.01). 
 
 33
Between Days 60 and 80 of gestation, the total content of β-alanine, cysteine 
and serine did not differ (P > 0.05); the total content of aspartate, ornithine, 
phenylalanine, and taurine increased (P < 0.01); and the total content of other 
amino acids decreased (P < 0.01).  Except for ornithine and taurine, the total 
content of all amino acids in amniotic fluid increased (P < 0.01) from Day 80 to 
Day 140 of gestation.  The marked decrease in concentrations of total α-amino 
acids on Day 80 of gestation was inversely related to the increase in amniotic 
fluid volume (Table 3.1).  However, the increases in concentrations of total α-
amino acids in amniotic fluid during late gestation could not be accounted for by 
changes in amniotic fluid volume (Table 3.1).   
 
Amino acids in allantoic fluid 
Concentrations of amino acids in allantoic fluid are summarized in Table 
3.7.  Remarkable changes (P < 0.01) were observed in the concentrations of all 
amino acids in allantoic fluid during gestation.  Concentrations of alanine, 
citrulline, and glutamine in allantoic fluid increased (P < 0.01) by 20-, 34-, and 
18-fold, respectively, from Day 30 to Day 60 of gestation (Fig 3.1), and were 
approximately 80-, 30-, and 60-fold, respectively, those in ovine fetal plasma on 
Day 60 of gestation.  Alanine, citrulline plus glutamine accounted for 
approximately 80% of total α-amino acid nitrogen in allantoic fluid during early 
pregnancy (Fig 3.2).  Serine was the most abundant amino acid in allantoic fluid 
on Days 100 and 140 of gestation (P < 0.01), contributing 45% - 62% of total α-
amino acid nitrogen (Fig 3.2).  Concentrations of serine in allantoic fluid during 
late gestation were about 30-fold those in ovine fetal plasma (Table 3.3).  The 
increase in concentrations of allantoic fluid serine was closely correlated with the 
increase in fetal weight (r = 0.69, P < 0.01). 
Arginine was not among the most abundant amino acids in ovine allantoic 
fluid during early gestation (Table 3.7).  However, arginine and citrulline were the 
second and third most abundant α-amino acids, respectively, in allantoic fluid on 
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TABLE 3.7.  Concentrations of amino acids (AA) in ovine allantoic fluid 
 Day of gestation 
Amino acid 30 40 60 80 100 120 140 SEM
 µmol/L 
Ala 1199 d 16925 b 24714 a  3809 c 4277 c    927 d    791 d 542 
β-Ala     94 f     462 e    2295 b    861 d 4190 a  1467 c 2717 b 158 
Arg   336 e     639 d      821 c    887 c 2081 a 1220 b 1396 b   75 
Asn   187 e     877 b    1904 a    304 d   610 c    154 e   217 e   58 
Asp     47 c     220 a      206 a    115 b   194 a    128 b   180 a   19 
Cit   277 e   2853 b    9682 a    1930 c 2178 c  1127 d 1216 d 206 
Cys   145 d     167 d      402 a     427 a    340 bc    305 c   367 b   15 
Gln   1217 e 12301 b  23502 a   3141 d  5001 c    814 e 1090 e 720 
Glu   242 c   1175 a     712 b     112 d   230 c   118 d   313 c   66 
Gly   1272 c   2449 b   3130 b   2527 b 5464 a 2220 b 1132 c 197 
His   408 d      725 b   1501 a     238 e   537 c   249 e   310 e   46 
Ile   112 c     190 b    183 b     108 c   316 a     69 d       88 cd   21 
Leu   218 d     385bc    454 b     573 a     94 e   236 d    345 c   23 
Lys   544 b    1081 a  1014 a   1135 a    391 c   178 d    601 b    61 
Met     70 d       69 d    118 c       62 d   386 a      95 c    233 b    17 
Orn   117 d     471 a    495 a     360bc    422 ab    103 d    343 c    34 
Phe   107 c      64 d    121 c     652 a   269 b      93 c    107 c    22 
Pro   211 c    522 b     573 ab     684 a   549 b    541 b     587ab    32 
Ser   510 g  1636 f  5039 d   3802 e 19072 a 11533 c 16468 b  480 
Taurine     86 d  1110 c  2694 b   1239 c    4381 a   3015 b   2474 b  210 
Thr   520 d    740 c  1067 b     716 c   1597 a     640 c     451 d   68 
Trp     66 c      57 c    121 b     107 b     156 a       66 c    123 b       5.2
Tyr   176 b   168 b    258 a       56 c      303 a     138 b     148 b   21 
Val    493 b   960 a    533 b     386 c    1021 a     258 d     311cd   42 
Total α-AA  8474 d 44675 b 76548 a 22130 c 45487 b 21213 c 26818 c 1103
 
a-f Data are means with pooled SEM values for 4 ewes per gestational age.  
Means with different superscript letters within a row are different (P < 0.01). 
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Fig 3.1  Concentrations of alanine, citrulline, glutamine, and serine in ovine 
allantoic fluid.  Pooled SEM values for alanine, citrulline, gltamine, and serine 
were 0.5, 0.2, 0.7, and 0.5 mM, respectively. 
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Fig 3.2  Percentage (%) total free α-amino acid nitrogen represented by alanine, 
citrulline, glycine, glutamine, and serine in ovine allantoic fluid.  Total free α-
amino acid N was calculated on the basis of nitrogen atoms of α- amino acids.  
Pooled SEM values for alanine, citrulline, glycine, glutamine, and serine were 
3.2, 1.7, 3.5, 4.4, and 9.3 %, respectively.  
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Day 140 of gestation (P < 0.01), and contributed approximately 10% of total α-
amino acids (Table 3.7).  Between Days 100 and 140 of gestation, allantoic fluid 
was particularly rich in two β-amino acids: β-alanine (1.5-4.2 mM) and taurine 
(2.5-4.4 mM) (Table 3.7).   
 Except for arginine, cysteine, isoleucine, leucine, lysine, methionine, 
ornithine, phenylalanine, proline, tryptophan, tyrosine, and valine on Day 60 of 
gestation and for cysteine, methionine and phenylalanine on Day 40 of 
gestation, the total content of amino acids was much greater (P < 0.01) in 
allantoic fluid than in amniotic fluid at all gestational ages.  As in amniotic fluid, 
marked changes were observed in the total content of individual amino acids in 
allantoic fluid during gestation (Table 3.8).  Between Days 30 and 60 of 
gestation, the total content of amino acids, except for phenylalanine, tyrosine 
and valine, increased markedly (P < 0.01).  Between Days 60 and 80 of 
gestation, the total content of arginine, cysteine, leucine, lysine, phenylalanine, 
and proline increased (P < 0.01), whereas the total content of alanine, β-alanine, 
asparagine, citrulline, glutamine, glutamate, histidine, taurine, and tyrosine 
decreased (P < 0.01).  Except for leucine, the total content of all amino acids in 
allantoic fluid increased (P < 0.01) between Days 80 and 100 of gestation.  
Indeed, highest values were observed for alanine, glutamine, glycine, histidine, 
isoleucine, methionine, phenylalanine, threonine, tyrosine, and valine on Day 
100 of gestation.  Interestingly, total α-amino acid content in ovine allantoic fluid 
was fairly constant between Days 100 and 140 of gestation.  
 However, concentrations of protein in allantoic fluid were 1.3±0.5, 3.6± 
0.9, 9.8±1.3, 6.6±1.5, 2.7±0.7, 2.4±0.8, and 3.6±0.9 mg/ml, respectively, on 
Days 30, 40, 60, 80, 100, 120, and 140 of gestation.  Concentrations of protein 
in amniotic fluid were 0.4±0.1, 0.2±0.1, 0.3±0.1, 0.4±0.1, 0.5±0.1, 1.3±0.5, and 
1.3±0.4 mg/ml, respectively, on the same days. 
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TABLE 3.8.  Total content of amino acids (AA) in ovine allantoic fluid 
 Day of gestation 
Amino acid 30 40 60 80    100 120 140 SEM 
 µmol 
Ala 38 e   186d    768 a    176 d 857 a 456 b  292 c 64 
β-Ala      3.0 g      5.2 f   72 d   40 e 840 b 722 c  997 a 73 
Arg 11 e       7.1 e   25 d   41 c 419 b 598 a  513 a 44 
Asn      5.9 f       9.6 e   59 c   15 d 122 a   76 b    80 b       7.1
Asp      1.5 d       2.4 d        6.4 c        5.3 c   39 b   62 a    66 a       5.0
Cit      8.6 f  31 e 304 c  89 d 437 b 556 a  447 b 34 
Cys      4.6 e      1.8 f   13 d  20 c   69 b 151 a  133 a       7.8
Gln 38 e   139 d 731 b   145 d  1004 a 399 c  402 c 88 
Glu      7.6 f 13 e   23 d      5.2 g   46 c   58 b  116 a 10 
Gly 40 d 27 d   98 c   115 c   1094a  1093 a  416 b 71 
His 13 c      8.0 d   46 b  11 d  108 a  123 a  113 a 11 
Ile      3.5 d      2.2 d        5.8c       5.0 c    64 a    34 b    32 b       4.2
Leu      6.7 d      4.3 d   15 c 26 b   19 c  117 a  128 a 11 
Lys 17 e 12 e   32 d 52 c   79 b    87 b  221 a 19 
Met      2.1 d      0.75e       3.7c      2.8 c   77 a    48 b    85 a       6.8
Orn      3.6 e      5.2 e   16 d 17 d   84 b    51 c  126 a 15 
Phe      3.4 d      0.71e        3.8d 30 c   54 a    45 b    40 b       3.7
Pro      6.6 e     5.7 e    18 d 32 c  112 b  267 a   215 a 18 
Ser 16 d     18 d  159 c   176 c 3816 b   5665 a 6029 a     423 
Taurine       2.7 g     12 f    85 d  57 e   877 c   1491 a   907 b 95 
Thr 17 d      8.1 e    34 c  33 c   320 a  316 a   166 b 16 
Trp       2.1 d     0.63e        3.8c       4.9 c     32 b    33 b     45 a       4.5
Tyr       5.8 c     1.9 d        8.0c       2.5 d      61 ab    68 a     55 b       3.9
Val 16 c 11 d   17 c  18 c   204 a  127 b   115 b 11 
Total α-AA   268 e 496 d 2392 b 1020 c 9116 a 10432 a 9836 a  1237 
 
a-g Data are means with pooled SEM values for 4 ewes per gestational age.  
Means with different superscript letters within a row are different (P < 0.01). 
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Discussion 
The sheep is a widely used animal model for studying human fetal-
placental development (Lemons et al., 1976; Meier et al., 1981; Rice et al., 
1987; Marconi et al., 1989; Moores et al., 1994; Stewart et al., 2000; Battaglia 
and Regnault, 2001; Osgerby et al., 2002).  However, little is known about the 
dynamics of change in concentrations of amino acids in ovine amniotic and 
allantoic fluids.  To our knowledge, this is the first report of developmental 
changes in concentrations of amino acids in ovine maternal arterial plasma, fetal 
umbilical venous plasma, and fetal fluids.  Three unique, major findings emerged 
from this study: 1) ovine fetal:maternal plasma ratios for amino acids changed 
greatly during gestation, 2) the marked changes in concentrations of amino 
acids in ovine allantoic and amniotic fluids were associated with conceptus 
development, and 3) alanine, citrulline, and serine were unusually abundant in 
ovine allantoic fluid compared with any other biological fluid in animals (for 
example, see Lemons et al., 1976; Marconi et al., 1989; Snell and Fell, 1990; 
Curthoys and Watford, 1995; Wu et al., 1996a; Wu and Morris, 1998; Stipanuk 
and Watford, 2000). 
To our knowledge, this is also the first report of ovine fetal:maternal 
plasma ratios for amino acids throughout the entirety of gestation.  
Fetal:maternal plasma ratios for glutamate and serine were remarkably low and 
high, respectively, during late gestation (Table 3.4).  In vivo studies have 
demonstrated that there is little uterine uptake of glutamate from maternal 
plasma, but that there is placental uptake of glutamate (derived largely from 
glutamine hydrolysis in fetal liver) occurs in the ovine fetus (Marconi et al., 
1989).  Thus, extensive placental catabolism of glutamate (Battaglia and 
Regnault, 2001) and a high rate of fetal utilization of glutamate (a major amino 
acid in tissue protein) (Meier et al., 1981) likely are the major factors responsible 
for its low concentrations in fetal plasma compared with maternal plasma.  In 
contrast, uterine uptake of serine from maternal plasma occurs, but little 
transplacental transport of serine to the ovine fetus takes place because of its 
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catabolism by uteroplacental tissues (Moores et al., 1994; Battaglia and 
Regnault, 2001).  Thus, large amounts of serine are synthesized from glycine 
and N5,N10-methylenetetrahydrofolate via serine hydroxymethyltransferase and 
from 3-phosphoglycerate (an intermediate of glycolysis) and glutamate via 
phosphoglycerate dehydrogenase and phosphoserine aminotransferase 
(Marconi et al., 1989; Moores et al., 1994).  All these enzymes are present in 
fetal ovine liver and kidney, with the liver being the major organ for serine 
synthesis in fetal sheep (Narkewicz et al., 1999, 2002). 
 Amniotic fluid is composed of water and electrolytes from both the fetus 
(kidneys, lungs, epidermis, and fetal blood vessels in the placenta and umbilical 
cord) and the mother (decidual blood vessels via amniotic membranes) (Schmidt, 
1992).  This fluid is removed by both the fetus and the mother through the same 
channels, along with the participation of the fetal intestine after swallowing 
(Schmidt, 1992).  Thus, with the development of intestinal amino acid transport 
systems during gestation (Sagawa et al., 1979), the drinking of amniotic fluid 
provides a source of amino acids for fetal utilization.  The nutritional significance 
of amniotic fluid is graphically illustrated by the finding that esophageal ligation, 
which prevents entry of this fluid into the small intestine, results in intrauterine 
growth retardation in fetal sheep (Trahair and Harding, 1995).  Glutamine, a 
major fuel for enterocytes (Stipanuk and Watford, 2000) and an abundant amino 
acid in amniotic fluid (Table 3.5), may be an important nutrient in this fluid that 
stimulates intestinal growth and development.   
 Allantoic fluid is derived from fetal and maternal secretions but primarily 
from placental transport mechanisms (Bazer, 1989).  Although early anatomical 
studies suggested that the allantoic sac served as a reservoir for fetal wastes, it 
is now clear that allantoic fluid nutrients may be absorbed by the allantoic 
epithelium into the fetal-placental circulation and utilized by fetal-placental 
tissues (Bazer, 1989).  The increases in concentrations of total amino acids in 
allantoic fluids during early pregnancy could not be accounted for by changes in 
allantoic fluid volume (Table 3.1) or by changes in concentrations of amino acids 
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in maternal and fetal plasma (Tables 3.2 and 3.3).  Interestingly, between Days 
30 and 60 of gestation, Na+ and Cl- concentrations in ovine allantoic fluid 
decrease by 40 and 39 mEq/L, respectively, with a combined decrease of 79 
mEq/L (Bazer, 1989).  Such a decrease in electrolyte concentrations is closely 
matched by an increase of 73 mmol/L amino acids in allantoic fluid (Table 3.7), 
suggesting an important role for amino acids as regulators of osmolality in 
allantoic fluid. 
Ovine allantoic fluid was particularly rich in four of the traditionally 
classified nonessential amino acids: alanine, citrulline, glutamine, and serine 
(Table 3.7).  In contrast to alanine, glutamine and serine, citrulline (a nonprotein 
amino acid) is not a building block for tissue protein synthesis and is virtually 
absent from the diet.  Citrulline was the third most abundant amino acid in ovine 
allantoic fluid on Day 60 of gestation (Table 3.7). Although glutamine 
concentrations may be as high as 20 mM in human skeletal muscle (Curthoys 
and Watford, 1995), the unusual abundance of alanine and citrulline in ovine 
allantoic fluid on Day 60 of gestation and of serine during late gestation has not 
been reported for any other biological fluid in animals (e.g., Lemons et al., 1976; 
Marconi et al., 1989; Snell and Fell, 1990; Curthoys and Watford, 1995; Wu et 
al., 1996; Wu and Morris, 1998; Stipanuk and Watford, 2000).  For comparison, 
concentrations of alanine, glutamine, citrulline, and serine in porcine allantoic 
fluid were 0.28, 3.4, 0.07, and 0.90 mM, respectively, on Day 40 of gestation 
(Wu et al., 1996), and 0.67, 0.70, 0.03, and 1.2 mM, respectively, on Day 110 of 
gestation (Wu et al., 1995).   
Our results raise important questions regarding the origin and function of 
alanine, glutamine, citrulline, and serine in ovine fetal-placental nutrition and 
metabolism.  Both glutamine and alanine may be synthesized from branched-
chain amino acids in fetal ovine skeletal muscle (Goodwin et al., 1987).  On the 
basis of maternal arterial-fetal umbilical venous differences in amino acid 
concentrations (Tables 3.2 and 3.3), we suggest that the ovine placenta 
synthesizes citrulline.  Indeed, our in vitro studies demonstrated the formation of 
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citrulline from glutamine in incubated ovine placenta (data not shown) as 
previously reported for the porcine small intestine (Wu et al., 1994a).  As noted 
above, serine is synthesized from glycine and from 3-phosphoglycerate (an 
intermediate of glycolysis) and glutamate (a metabolite of glutamine) in the liver 
and kidneys of fetal sheep (Narkewicz et al., 1999, 2002).  Alanine, glutamine, 
and serine are major glucogenic precursors in humans (Stipanuk and Watford, 
2000) and ewes (Clark et al., 1976).  Serine also plays an important role in one-
carbon unit metabolism essential for 2’-deoxythymidylate synthesis and 
methylation (Snell and Fell, 1990).  Glutamine is a major fuel for the fetus (Bell 
et al., 1989) and is essential for the synthesis of nucleotides, NAD(P)+, and  
aminosugars (glucosamine-6-phosphate, UDP-N-acetylgalactosamine, and 
UDP-N-acetylglucosamine, a precursor for the formation of all macromolecules 
containing amino sugars) (Stipanuk and Watford, 2000; Flynn et al., 2002).  In 
addition, serine participates in the synthesis of phosphatidylserine and ceramide 
(signaling molecules) (Stipanuk and Watford, 2000).  All of these events are 
critical for DNA synthesis and, thus, cell proliferation.   
 In contrast to high concentrations of arginine (4-6 mM) (Fig 3.3) in porcine 
allantoic fluid during early gestation (Wu et al., 1995a, 1996a, 1998a), arginine 
was not a major amino acid in ovine allantoic fluid during early gestation (Table 
3.7).  Concentrations of arginine in ovine allantoic fluid on Days 60, 100, and 
140 of gestation were only 16%, 11%, and 8.5%, respectively, of those of serine 
(Table 3.7).  Thus, our findings do not support the hypothesis that arginine is the 
most abundant amino acid in ovine allantoic fluid.  Why is citrulline, but not 
arginine, particularly abundant in ovine allantoic fluid during early gestation?  
Several answers to this intriguing question are possible.  First, arginase activity 
is present in ovine allantoic fluid on Days 30 and 60 of gestation but is not 
detectable in porcine allantoic fluid on Days 30 to 60 of gestation (unpublished 
data).  The presence of arginase in ovine allantoic fluid would hydrolyse arginine 
and reduce its availability to the fetus.  Because citrulline is an effective 
precursor 
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Fig 3.3  Concentrations of arginine and citrulline in porcine and ovine allantoic 
fluids during early gestation. 
 
 
precursor for arginine synthesis in all animals because of the widespread 
presence of argininosuccinate synthase and lyase in animal tissues (Wu and 
Morris, 1998), high concentrations of citrulline in ovine allantoic fluid would serve 
as an efficient reservoir of precursor for arginine in the fetus.  Second, citrulline 
is a neutral amino acid.  Thus, unlike arginine (a basic amino acid), citrulline 
does not disturb the acid-base balance in ovine allantoic fluid, even at high 
concentrations.  Third, citrulline is an efficient antioxidant, protecting DNA, lipids 
and proteins from hydroxyl radical-induced oxidative damage (Akashi et al., 
2001).  This effect of citrulline may contribute to a protective environment for 
fetal growth and development in sheep. 
 Collectively, our findings indicate that different strategies are used by 
different animal species to conserve arginine, the most abundant nitrogen carrier 
in tissue proteins (Meier et al., 1981; Wu et al., 1999a).  Whatever the 
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differences among species, the unusual abundance of either citrulline (an 
effective precursor of arginine) in ovine allantoic fluid (Table 3.7) or arginine in 
porcine allantoic fluid (Wu et al., 1995a, 1996a, 1998a) during early gestation 
raises intriguing and important questions regarding the physiological significance 
of arginine-dependent pathways in fetal-placental nutrition and development.  In 
this regard, it is noteworthy that maternal undernutrition decreases arginine 
concentrations in porcine fetal plasma and allantoic fluid (Wu et al., 1998a) and 
impairs fetal growth (Wu et al., 1998a; Osgerby et al., 2002), and may also 
program permanent structural, metabolic and functional alterations (Barker and 
Clark, 1997; Symonds et al., 2001).  We recently determined that maternal 
under-nutrition in sheep (50% of NRC nutrient requirements) from Day 28 to Day 
78 of gestation decreased concentrations of citrulline, serine, glutamine, and 
alanine in fetal plasma and allantoic fluid by 35 - 45% and retarded fetal growth 
by 32% on Day 78 of gestation (unpublished data).  Because recent 
epidemiological studies in humans suggest links between intrauterine growth 
retardation and development of chronic disease (e.g., diabetes, hypertension, 
and coronary heart disease) later in life (Barker and Clark, 1997; Symonds et al., 
2001), our novel results may have important implications for both intrauterine 
growth retardation and fetal origins of diseases in adults. 
 In conclusion, remarkable changes occur in concentrations of amino 
acids in ovine fetal allantoic fluid between Days 30 and 140 of gestation.  In this 
fluid, alanine, citrulline, plus glutamine contributed approximately 80% of total α-
amino acids during early gestation, and serine accounted for approximately 60% 
of total α-amino acids during late gestation.  These novel findings raise 
important questions regarding placental and fetal metabolism of the traditionally 
classified nonessential amino acids, and provide a new database for further 
studies to define their roles in ovine conceptus development.  
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CHAPTER IV 
        DEVELOPMENTAL CHANGES IN POLYAMINE LEVELS  
                     AND SYNTHESIS IN OVINE CONCEPTUS 
 
Introduction 
The placentae of all mammalian species undergo rapid formation of new 
blood vessels (angiogenesis) and marked growth during pregnancy (Ford, 1995; 
Reynolds and Redmer, 2001).  Placental angiogenesis is necessary to increase 
placental-fetal blood flow and the supply of nutrients for transfer from maternal to 
fetal blood.  Therefore, placental growth is a critical factor for controlling the 
survival, growth, and development of the fetus, and a better understanding of 
factors that regulate placental growth is essential to improve the reproductive 
efficiency of domestic animals and humans.  The sheep has a 
synepitheliochorial placenta, whose growth is maximal between Days 20 and 60 
of gestation (term is 147 days) (Alexander, 1964; Reynolds and Redmer, 1995).  
The ovine placenta has 60 to 100 individual cotyledons formed by the 
attachment of fetal trophoblast cells at predetermined sites (caruncles) in the 
uterine endometrium, as well as the intercotyledonary chorioallantoic placenta 
(Alexander, 1964).  
 Polyamines (putrescine, spermidine, and spermine) are key regulators of 
angiogenesis, early mammalian embryogenesis, placental trophoblast growth, 
and embryonic development in the uterus (Fozard et al., 1980; Henningsson et 
al., 1982).  Through binding intracellular RNA, DNA, nucleotide triphosphates, 
proteins, and other negatively charged molecules, polyamines (polycationic 
molecules) regulate gene expression, signal transduction, ion channel function, 
as well as DNA and protein synthesis (Igarashi and Kashiwagi, 2000).   
_______________ 
*Reprinted with permission from “Developmental Changes in Polyamine Levels and 
Synthesis in Ovine Conceptus” by Hyukjung Kwon, Guoyao Wu, Fuller W. Bazer, and 
Thomas E. Spencer. 2003. Biol Reprod 69(5): 1626-1634. Copyright by the Society for 
the Study of Reproduction. 
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Polyamines are also endogenous scavengers of reactive oxygen species, 
thereby protecting DNA, proteins, and lipids from oxidative damage 
(Chattopadhray et al., 2003).  Thus, polyamines are essential for cell 
proliferation, differentiation, and function.   
 Ornithine decarboxylase (ODC) is a rate-controlling enzyme of the 
polyamine-synthetic pathway in mammalian cells (Tabor and Tabor, 1984).  It 
converts ornithine (a product of arginine hydrolysis by arginase) into putrescine, 
which is subsequently converted into spermidine and spermine by spermidine 
and spermine synthases, respectively.   Despite previous studies of the role of 
polyamines in placental and fetal development (Fozard et al., 1980; 
Henningsson et al., 1982), little is known about changes in placental polyamine 
synthesis associated with conceptus development in any species.   Although 
placental ODC activity has been reported for some mammals, including rats, 
mice and pigs (Forzard et al., 1980; Henningsson et al., 1982; Wu et al., 1998b), 
it is necessary to determine rates of polyamine synthesis in intact tissues or 
cells.  This is because a change in enzyme (e.g., ODC) activity measured under 
in vitro assay conditions does not necessarily indicate a change in metabolic flux 
or product formation (Fell, 1997; Wu et al., 2000c).  Information about polyamine 
synthesis is crucial for understanding the molecular regulation of placental and 
fetal growth, and for elucidating mechanisms responsible for intrauterine growth 
retardation and fetal origin of adult-onset diseases.   
We recently reported marked increases in concentrations of both 
ornithine and arginine (substrates for polyamine synthesis) in ovine allantoic 
fluids (a reservoir for nutrients in the fetus) between Days 30 and 60 of gestation 
(Kwon et al., 2003a).  Such changes coincide with the period of most rapid 
growth of the ovine placenta (Alexander, 1964; Reynolds and Redmer, 1995).  
On the basis of this observation, we hypothesized that placental ODC and 
arginase activities and polyamine synthesis were maximal during the first half of 
pregnancy.  This hypothesis was tested using ewes between Day 30 and Day 
140 of gestation.  Endometrium was analyzed in the same manner, because it is 
 47
closely associated with placental development and function (Wimsatt, 1950; 
Stewart et al., 2000; Gray et al., 2001).  Because amniotic and allantoic 
compartments are integral parts of the ovine conceptus essential for fetal growth 
(Bazer, 1989), we also determined changes in concentrations of polyamines in 
amniotic and allantoic fluids during pregnancy. 
 
Materials and Methods 
Chemicals 
Putrescine, spermidine, spermine, and amino acids were purchased from 
Sigma Chemicals (St. Louis, MO).  L-[U-14C]ornithine and L-[U-14C]arginine were 
obtained from American Radiolabeled Chemicals (St. Louis, MO).  High-
performance liquid chromatography (HPLC)-grade water and methanol were 
purchased from Fisher Scientific (Fair Lawn, NJ). 
 
Experimental animals 
Columbia cross-bred ewes were mated to Suffolk rams when detected in 
estrus (Day 0) and at 12 and 24 h later.  Ewes were then assigned randomly to 
be hysterectomized (n = 4 per day) on Day 30, 40, 60, 80, 100, 120, or 140 of 
gestation to allow collection of placental and endometrial tissues as well as 
amniotic and allantoic fluids.  Because there were marked changes in 
physiological parameters in the ovine conceptus during pregnancy (e.g., Gray et 
al., 2001; Kwon et al., 2003a) and because coefficients of variations for all 
measured parameters were relatively small (< 3-7%), we used 4 ewes per day of 
gestation on the basis of statistical power calculation.  In preliminary studies, we 
determined that concentrations of polyamines in placental and endometrial 
tissues, amniotic fluid, or allantoic fluid were not affected by the number of 
fetuses (data not shown).  Thus, samples were obtained from one randomly 
selected fetus per ewe for polyamine analysis when there were twin fetal lambs.  
None of the ewes in the study had more than twin fetuses.  Throughout 
gestation, ewes had free access to water and were fed individually 1.4 kg/day of 
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an alfalfa-based diet containing 90.9% dry matter, 58.7% total digestible 
nutrients, 15.8% crude protein, 3.7% fat, 27.0% acid detergent fiber, 35.0% 
neutral detergent fiber, 0.065% vitamin mixture, and 0.15% salt mixture that met 
NRC (National Research Council, 1985) requirements (Kwon et al., 2003a).  
Ewes consumed all of the feed provided daily.  This study was approved by the 
Texas A&M University Institutional Agricultural Animal Care and Use Committee. 
 
Hysterectomy and sample collection 
Hysterectomies were performed between 8:00 and 9:00 A.M., 24 h after 
the last feeding (Kwon et al., 2003a).  All ewes were administered isofluorane 
(5%) via an inhalation mask to induce anesthesia which was maintained with 
isofluorane (1-5%).  A mid-ventral laparotomy was performed to expose the 
reproductive tract.  Amniotic and allantoic fluids were collected through 
amniochorion and chorio-allantoic membranes, respectively.  Placentomes, 
intercotyledonary placenta and intercaruncular endometrium were obtained on 
all days of gestation.  A portion of these tissues was used immediately for ODC 
assays and metabolic studies, and the remaining tissues were stored at –80 oC 
for determination of polyamines, amino acids and arginase activity within 1 
week.  In this study, we did not separate the placentomes into maternal and fetal 
components, because such a procedure would require a prolonged period of 
time to complete, which might compromise the biochemical viability of the 
tissues for metabolic studies.   
 
Determination of ODC activity 
ODC activity in placental and endometrial tissues was measured using L-
[1-14C]ornithine as we described for porcine tissues (Wu et al., 1998b).  Briefly, 
tissues (~200 mg) were homogenized, using a glass homogenizer, in 0.5 ml of 
50 mM sodium phosphate buffer (pH 7.2) containing 0.2 mM pyridoxal-5-
phosphate, 1 mM EDTA, 2.5 mM dithiothreitol, 150 mM sucrose, and protease 
inhibitors (5 µg/ml phenylmethylsulfonyl fluoride, 5 µg/ml aprotinin, 5 µg /ml 
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chymostatin, and 5 µg /ml pepstatin A).  The homogenizer was rinsed with 0.5 
ml of the buffer, and the combined homogenates were centrifuged at 13,000 g 
for 15 min at 4oC.  The supernatants (free of mitochondria) were used for ODC 
assays to prevent the potential production of 14CO2 from [1-14C]ornithine via 
mitochondrial ornithine aminotransferase and Krebs cycle enzymes (Wu et al., 
1996b, 2000c).  Pyrroline-5-carboxylate reductase activity was measured as a 
marker for cytosolic enzymes as previously described (Wu et al., 1996b).  The 
assay mixture (0.5 ml) for ODC consisted of 0.2 mM L-[1-14C]ornithine (5500 
dpm/nmol), 0.2 mM pyridoxal-5-phosphate, 0.2 mM EDTA, 0.5 mM dithiothreitol, 
enzyme preparations (equivalent to ~20 mg tissue), and 50 mM sodium 
phosphate buffer (pH 7.2).  On Days 40 and 140 of gestation, ODC activity was 
also measured in the presence of 2 mM ornithine.  Radioactivity blanks 
containing [1-14C]ornithine but no enzyme preparations were run.  After 
incubation at 37oC for 1 h, 14CO2 was collected in 0.2 ml NCS (a trademark 
name; Amersham, Arlington Heights, IL), and its radioactivity was measured in a 
liquid scintillation counter (Packard, Meriden, CT).  Recovery of 14CO2 from the 
incubation medium was 96%, as determined using a known amount of 
[14C]NaHCO3.  Rates of ornithine decarboxylation by ODC were calculated by 
dividing the radioactivity of collected 14CO2 (dpm) by the specific activity of [1-
14C]ornithine (dpm/nmol) in the assay solution.  Enzyme activity was expressed 
on the basis of the amount of tissue in the assay mixture.  Coefficients of 
variation for intra- and inter-assays of ODC were < 4% and 7%, respectively. 
 
Determination of arginase activity 
Arginase activity in placental and endometrial tissues was measured by 
quantifying ornithine production from arginine as we described previously for 
porcine tissues (Wu et al., 1996b).  Briefly, placental or endometrial tissues 
(~200 mg) were homogenized, using a glass homogenizer, in 1 ml of 
homogenization buffer (pH 7.4) containing 300 mM sucrose, 1 mM EDTA, 3 mM 
dithiothreitol, 5 mM HEPES, protease inhibitors (5 µg/ml phenylmethylsulfonyl 
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fluoride, 5 µg/ml aprotinin, 5 µg /ml chymostatin, and 5 µg /ml pepstatin A), and 
0.5% Triton X-100.  The homogenizer was rinsed with 1 ml of the above buffer, 
and the combined homogenates were used for arginase assays.  The assay 
mixture (1 ml), which consisted of 50 mM potassium phosphate buffer (pH 7.5), 
10 mM arginine, 10 mM MnCl2 and tissue homogenates (equivalent to ~ 10 mg 
tissue), was incubated at 37oC for 0 or 15 min.  On Days 40 and 140 of 
gestation, arginase activity was also measured in the presence of 2 mM 
arginine.  The reaction was terminated by addition of 0.2 ml of 1.5 M HClO4, and 
ornithine produced was analyzed by HPLC (Wu et al., 1998b).  Rates of arginine 
hydrolysis by arginase were calculated on the basis of ornithine production 
during a 15 min assay period.  Enzyme activity was expressed on the basis of 
the amount of tissue in the assay mixture.  Coefficients of variation for intra- and 
inter-assays of arginase were < 3% and 5%, respectively. 
 Fetal fluid samples were centrifuged at 3000 × g at 4°C for 10 min.  
Supernatant fractions were assayed for arginase activity and arginine 
concentrations (1mM and 10mM) by monitoring the conversion of L-[guanido-
14C]arginine to [14C]urea during 20 min incubation.  For example, the assay 
mixture (1 ml), which consisted of 150 mM potassium phosphate buffer (pH 7.5), 
10 mM arginine, 10 mM MnCl2 and fluid samples, was incubated at 37oC for 20 
min.  The reaction was terminated by addition of 0.2 ml of 1.5 M HClO4. 
 
Determination of polyamines and amino acids 
Placental and endometrial tissues (~200 mg) were homogenized at 4°C in 
1 ml of 1.5 mM HClO4 using a glass homogenizer, and the homogenizer was 
rinsed with 1 ml of 1.5 mM HClO4.  The combined homogenates were 
transferred to 12 × 75 mm polypropylene tubes and neutralized with 1 ml of 2 
mM K2CO3. The homogenates were centrifuged at 3000 × g and 4°C for 15 min 
to obtain the supernatant fluid for polyamine analysis. Fetal fluid samples were 
centrifuged at 3000 x g at 4oC for 10 min.  An aliquot of the supernatant (0.5 ml) 
was deproteinized with 0.5 ml of 1.5 M HClO4, followed by neutralization with 
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0.25 ml of 2 M K2CO3.  Recovery of putrescine, spermidine, spermine, ornithine, 
and arginine from placental and endometrial samples as well as fetal fluids was 
determined by adding known amounts of polyamine and amino acid standards 
(Wu et al., 2000c), and was found to be > 93% for polyamines and > 96% for 
amino acids. 
 Polyamines were analyzed by an ion-pairing HPLC method involving 
precolumn-derivatization with o-phthaldialdehyde (Wu et al., 2000c).  Briefly, 100 
µl of sample was mixed with 100 µl of 1.2% benzoic acid (in 40 mM sodium 
borate, pH 9.5) and 1.4 ml HPLC-grade H2O.  An aliquot (100 µl) of the assay 
mixture was derivatized, in an autosampler (Model 712 WISP, Waters Inc., 
Milford, MA), with 100 µl of 30 mM o-phthaldialdehyde (in 3.1% Brij-35, 50 mM 
2-mercaptoethanol and 40 mM sodium borate, pH 9.5).  An aliquot of the 
derivatized mixture (25 µl) was injected into a Supelco 3-µm reversed-phase C18 
column (150 x 4.6 mm I.D.; Sigma Chemicals, St. Louis, MO) guarded by a 
Supelco 40-µm reversed-phase C18 column (50 x 4.6 mm I.D.).  Polyamines 
were separated using a solvent gradient consisting of solution A (0.1 M sodium 
acetate, 2 mM sodium dodecyl sulfate, 0.5% tetrahydrofuran and 9% methanol, 
pH 7.2) and solution B (100% methanol and 2 mM sodium dodecyl sulfate).  
Putrescine, spermidine and spermine in samples were quantified on the basis of 
authentic standards, using Millenium-32 Software (Waters, Milford, MA). 
 Amino acids were analyzed using the HLPC system as described above, 
except that the mobile phase solutions did not contain the ion-pairing agent 
sodium dodecyl sulfate (Wu et al., 1996b).  Amino acids in samples were 
quantified on the basis of authentic standards, using Millenium-32 Software 
(Waters, Milford, MA) (Wu et al., 2000c). 
 
Determination of polyamine synthesis 
Polyamine synthesis was determined in placental and endometrial tissues 
using L-[U-14C]arginine and L-[U-14C]ornithine, as we described for porcine 
tissues (Wu et al., 2000c).  Briefly, placental or endometrial tissues (~500 mg) 
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were rinsed twice with oxygenated (95% O2/5% CO2) Basal Medium Eagle 
(BME) (GIBCOBRL, Grand Island, N.Y.), and then incubated at 37 oC for 3 h in 2 
ml of oxygenated (95% O2/5% CO2) BME containing 5 mM glucose, 0.5 mM L-
methionine, and either 1 mM L-arginine plus 2 µCi L-[U-14C]arginine (1 
µCi/µmol) or 1 mM L-ornithine plus 2 µCi L-[U-14C]ornithine (1 µCi/µmol).  
Incubations, in which medium contained all of the above components but no 
tissues, were run as blanks.  The 14C-labeled substrates were used to improve 
the sensitivity of detecting polyamine synthesis in placental and endometrial 
tissues.  Incubations were terminated by addition of 0.2 ml of 1.5 M HClO4.  The 
acidified tissues plus medium were homogenized using a glass homogenizer, 
and the homogenates were neutralized with 0.1 ml of 2 M K2CO3.  The 
neutralized extracts were dried in a Model RC10.10 centrifugal evaporator 
(Jouan Inc., Winchester, VA), and suspended in 0.3 ml of H2O for separation of 
[14C]putrescine, [14C]spermidine and [14C]spermine by HPLC.  The fractions 
containing [14C]putrescine, [14C]spermidine and [14C]spermine were collected 
from the HPLC column for measuring radioactivities in a Packard liquid 
scintillation counter.  Recovery of [14C]putrescine, [14C]spermidine and 
[14C]spermine from the HPLC column was determined using known amounts of 
[14C]polyamine standards, and was found to be greater than 91%.  Blank 
radioactivities were subtracted from sample values.  Rates of production of 
putrescine, spermidine and spermine were calculated on the basis of 
intracellular specific activities of [14C]ornithine, which were measured as 
described by Wu (1997). 
 
Calculations and statistical analysis 
Concentrations of polyamines and amino acids in placental and 
endometrial tissues as well as fetal fluids were calculated on the basis of the 
recovery rates of putrescine, spermidine, spermine, ornithine and arginine from 
the ovine placental and uterine tissues and fetal fluids.  For each gestational 
age, total content of polyamines in amniotic and allantoic fluids was calculated 
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by multiplying polyamine concentrations by amniotic and allantoic fluid volumes, 
respectively.  Concentrations of total polyamines were a mathematical sum of 
putrescine, spermidine and spermine.  For each gestational age, total activity of 
arginase in amniotic and allantoic fluids was calculated by multiplying arginase 
activity by amniotic and allantoic fluid volumes, respectively.  Data obtained 
between Days 30 and 140 of gestation were subjected to least squares analyses 
of variance and one-way analysis of variance (Steel et al., 1997), using the 
PROC GLM, PROC REG, and PROC CORR procedures of Statistical Analysis 
System (SAS, Cary, NC).  Differences between means were determined by the 
Student-Newman-Keuls multiple comparison test following one-way analysis of 
variance (Steel et al., 1997).  Differences between ODC and arginase activities 
in the same tissue on Day 40 or 140 of gestation were determined by paired t-
test.  Statistical significance was set at a probability value of ≤ 0.05. 
 
Results 
ODC activity in placental and endometrial tissues 
As summarized in Table 4.1, marked changes (P < 0.01) in ODC activity 
occurred in ovine placental and endometrial tissues during conceptus 
development.  In intercotyledonary placenta, ODC activity was the highest on 
Days 30 to 40 of gestation and then decreased (P < 0.01) on Day 60 of 
gestation.  No change in intercotyledonary placental ODC activity was observed 
between Days 60 and 140 of gestation.  In intercaruncular endometrium, ODC 
activity increased (P < 0.01) by 35% between Days 30 and 40 of gestation, 
declined (P < 0.01) progressively between Days 40 and 100, and remained at 
low values on Days 100 to 140.  Placentomes exhibited the greatest ODC 
activity among the placental and endometrial tissues examined between Days 
30 and 140 of gestation (P < 0.01).  Placentomal ODC activity increased (P < 
0.01) approximately 2-fold between Days 30 and 40 of gestation, and then 
decreased (P < 0.01) progressively between Days 40 and 100 of gestation.  
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Placentomal ODC activity did not differ (P > 0.05) between Days 100 and 140 of 
gestation.  
 
Arginase activity in placental and endometrial tissues 
Relatively high arginase activity was present in ovine placentomes, 
intercotyledonary placenta and intercaruncular endometrium (Table 4.2).  
Placentomal arginase activity was the highest (P < 0.01) among the tissues 
examined between Days 30 and 140 of gestation.  In intercotyledonary placenta, 
arginase activity increased (P < 0.01) between Days 30 and 80 of gestation and 
declined (P < 0.01) thereafter.  In intercaruncular endometrium, arginase activity 
increased (P < 0.01) between Days 30 and 60 of gestation and then declined (P 
< 0.01).  In placentomes, arginase activity peaked (P < 0.01) on Day 40 of 
gestation, and declined (P < 0.01) thereafter.  In each of these tissues, arginase 
activity was the lowest (P < 0.01) on Days 120 to 140 of gestation. 
 
 
 
TABLE 4.1. Ornithine decarboxylase activity (nmol/g tissue/h) in ovine placenta 
and endometrium 
                               Day of gestation 
 30 40 60 80 100 120 140 SEM
  
Intercotyledonary placenta 0.58a 0.57a 0.35b 0.32b 0.34b 0.32b 0.35b   0.04
Placentome 1.79b 3.54a 1.50bc 1.44c 0.56d 0.49d 0.47d   0.13
Intercaruncular endometrium 0.60b 0.82a 0.56b 0.54b 0.34c 0.32c 0.35c  51 
 
a-d Data are the mean with pooled SEM values for four ewes per gestational age.  
Means sharing different superscript letters within a row are different (P < 0.01).  
Enzyme activity was measured in the presence of 0.2 mM ornithine. 
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TABLE 4.2. Arginase activity (nmol/g tissue/h) in ovine placenta and 
endometrium 
  Day of gestation 
 30 40 60 80 100 120 140 SEM
  
Intercotyledonary placenta 172b 225a 232a 238a 166b 122c 114c   7 
Placentome 425e 953a 760b 687c 515d 441e 420e 17 
Intercaruncular endometrium 257b 441a 435a 246b 239b 177c 158c   7 
 
a-e Data are the mean with pooled SEM values for four ewes per gestational age.  
Means sharing different superscript letters within a row are different (P < 0.01).  
Enzyme activity was measured in the presence of 10 mM arginine. 
 
Arginase activity in allantoic and amniotic fluids 
 As summarized in Table 4.3, marked changes in arginase activity 
occurred in allantoic and amniotic fluids during gestation.  In allantoic fluid, 
arginase activity in presence of 1mM of arginine was similar between Days 30 
and 80, declined on Day 100, and increased again on Day 120, and decreased 
progressively with the lowest values on Day 140 of gestation, whereas arginase 
activity in presence of 10mM of arginine peaked on Day 30, the lowest value on 
Day 80, and increased again between Days 80 and 120 of gestation.  Total 
arginase activities in the presence of 1mM and 10mM of arginine peaked on Day 
120 of gestation in allantoic fluid.  In amniotic fluid, arginase activity in presence 
of 1mM of arginine was the lowest values on Days 40 and 60, increased on Day 
80, decreased on Days 100, and increased again on Day 120 and 140 of 
gestation, whereas arginase activity in presence of 10mM of arginine increased 
between Days 30 and 80, declined on Day 100, and increased again between 
Days 100 and 140 of gestation.  Total arginase activities in presence of 1mM 
and 10mM of arginine were the highest values on Days 80 and 140 of gestation 
in amniotic fluid.  
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TABLE 4.3.  Arginase activity in allantoic and amniotic fluids 
Day Allantoic Fluid  Amniotic fluid 
 nmol/ml/min nmol/min nmol/ml/min nmol/min 
 1 mM 10 mM 1 mM 10 mM 1 mM 10 mM 1 mM 10 mM
30 0.14 1.31 3.69   40 0.21 0.33     0.42       0.73
40 0.12 0.43 1.58     4.09 0.08 0.46     1.78      11 
60 0.11 0.50 3.09   15.49 0.09 0.43   18      80 
80 0.13 0.20 5.92     9.60 0.50 1.91  284  1055 
100 0.07 0.42   14   89.16 0.18 1.06  103    586 
120 0.19 0.89   93  441 0.49 1.44    60    299 
140 0.04 0.39   17  158 0.68 3.05   261  1219 
SEM 0.03 0.12 9.87    50 0.08 0.40     24    133 
 
Data are means ± SEM for 4 ewes per gestational age.  For each gestational 
age, total activity of arginase in amniotic and allantoic fluids was calculated by 
multiplying arginase activity by amniotic and allantoic fluid volumes, respectively.   
 
 
Polyamine synthesis in placental and endometrial tissues 
Data regarding polyamine synthesis from [14C]ornithine and [14C]arginine 
are summarized in Tables 4.4 and 4.5, respectively. Rates of polyamine 
synthesis from [14C]ornithine or [14C]arginine were greatest in placentomes 
compared with other sites on all Days of gestation (P < 0.01).  Polyamine 
synthesis from ornithine peaked (P < 0.01) on Day 40 of gestation in 
placentomes, intercaruncular endometrium, and intercotyledonary placenta.  In 
each of these tissues, polyamine synthesis from arginine peaked (P < 0.01) on 
Day 40 of gestation and declined (P < 0.01) thereafter, with the lowest values on 
Days 120 to 140.  Rates of putrescine, spermidine and spermine synthesized 
from ornithine or arginine varied greatly with placental and endometrial tissues 
as well as gestational ages.  In placentomes, spermidine and spermine were the 
major polyamines synthesized from ornithine between Days 30 and 40 and 
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TABLE 4.4.  Polyamine synthesis (pmol/g tissue/3 h) from ornithine in ovine 
placenta and endometrium 
Day of gestation 
  30 40 60 80 100 120 140 SEM 
Intercotyledonary placenta 
Putrescine  170a   190a 121b 127b   82c   87c   75c   5 
Spermidine  223a   206a 135b 113b 129b 120b 124b   7 
Spermine  130b   204a 103c 106c 126b 142b 128b   6 
Total  523a   598a 359b 345b 337b 349b 327b 16 
Placentome 
Putrescine    363bc   694a  424b  343c 133d 117d 124d 15 
Spermidine    624b 1044a  508c  441d 248e 255e  221e 12  
Spermine   648b 1171a  487c  449c 227d 214d 202d 29 
Total 1635b 2909a 1419bc 1233c 608d 586d 546d 56 
Intercaruncular endometrium 
Putrescine  150b   202a 146b 135b   87c   89c   77c   7 
Spermidine   226b   369a   218bc 197c 152d 101d 113d   8 
Spermine   221b   281a 241b 236b 146c 152c 162c   8 
Total   598b   853a 603b 567b 385c 341c 352c 20 
 
a-e Data are the mean with pooled SEM values for four ewes per gestational age.  
Means sharing different superscript letters within a row are different (P < 0.01).   
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TABLE 4.5. Polyamine synthesis (pmol/g tissue/3 h) from arginine in ovine 
placenta and endometrium 
Day of gestation 
  30 40 60 80 100 120 140 SEM 
Intercotyledonary placenta 
Putrescine 21b 27a 20bc 18bc 17c  12d 12d 1  
Spermidine 26b  36a  23b 25b 20c 16d 15d 1  
Spermine 15c 32a 24b  22b  16c 14c  13c 1 
Total 62b  95a 67b  65c  53d  42e  40e  3  
 Placentome  
Putrescine 113b 224a 108b 107b 56c 42d 38d 3 
Spermidine 132c 326a 176b 129c  89d 63e 60e 6 
Spermine 120c  365a 192b 171b  93d  66e  68e 6  
Total 365c 915a 477b 407c 237d 182e 166e 11  
 Intercaruncular endometrium  
Putrescine 23c   41a  32b 21c 15d 14d 13d 1 
Spermidine 31c    69a   44b   26d  21e  17f  16f  1  
Spermine 25e   57a  45b 39c 30d 24e 23e 1  
Total 78c  167a 121b 86c 65d  54e 52e 2  
 
a-e Data are the mean with pooled SEM values for four ewes per gestational age.  
Means sharing different superscript letters within a row are different (P < 0.01).  
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between Days 80 and 140 of gestation, whereas rates of putrescine, spermidine, 
and spermine synthesis were similar on Day 60 of gestation. In intercaruncular 
endometrium, spermidine and spermine were the major polyamines synthesized 
from ornithine and arginine between Days 30 and 100 of gestation, whereas 
rates of spermine synthesis were highest on Days 120 to 140.  In 
intercotyledonary placenta, rates of putrescine, spermidine and spermine 
synthesized were similar between Days 40 and 80 of gestation, whereas 
spermidine and spermine were the major polyamines synthesized between Days 
100 and 140 of gestation.  
 
Polyamine concentrations in placental and endometrial tissues 
Data are summarized in Table 4.6.  There were biphasic changes in total 
polyamine concentrations in intercotyledonary placenta during pregnancy, as 
values were similar (P > 0.05) between Days 30 and 40 of gestation, increased 
(P < 0.01) approximately 2-fold on Days 60 to 80, declined (P < 0.01) on Day 
100, and increased again (P < 0.01) on Days 120 to 140 to values similar to 
those on Days 60 to 80 of gestation.  Concentrations of total polyamines in 
intercaruncular endometrium were 41-45% higher (P < 0.01) on Days 40 to 60 
compared with Day 30 of gestation, and they progressively declined (P < 0.01) 
between Days 60 and 100 of gestation.  Placentomes exhibited the highest (P < 
0.01) concentrations of polyamines among the ovine placental and endometrial 
tissues examined between Days 30 and 120 of gestation.  Placentomal 
concentrations of total polyamines increased (P < 0.01) by 113% between Days 
30 and 40 of gestation and decreased (P < 0.01) markedly between Days 40 
and 80 of gestation.  There were no changes  (P > 0.05) in placentomal 
concentrations of total polyamines between Days 80 and 120 of gestation.  
Concentrations of polyamines were similar (P > 0.05) among intercotyledonary 
placenta, intercaruncular endometrium, and placentomes on Day 140 of 
gestation. 
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TABLE 4.6. Concentration (nmol/g tissue) of polyamines in ovine placenta and 
endometrium 
Day of gestation 
  30 40 60 80 100 120 140 SEM 
Intercotyledonary placenta 
Putrescine   91b   85b 154a 170a   81b   93b   95b   8 
Spermidine   90c   93c 192a 182a   92c 145b 185a   9 
Spermine   73c   82c 135b 171a   84c 170a 196a   8 
Total 254c 260c  481a 523a 257c 408b  476a 23 
 Placentome  
Putrescine   314b   665a   387b 152c 169c 144c 115d 25 
Spermidine      477c    1039a   682b 274d 349d 288d 231d 32 
Spermine   506c 1064a   710b 353d 387d 367d 191e 51 
Total 1298c 2767a 1779b 778d 904d 799d 537e 96 
 Intercaruncular endometrium  
Putrescine  226c   298b   356a 180d 116e 124e 127e   7 
Spermidine  355c   554a   447b 314c 244d 229d 244d 16 
Spermine  329c   505a   512a 442b 260d 258d 239d 20 
Total  910b 1357a 1316a 936b 620c 611c 594c 47 
 
a-d Data are the mean with pooled SEM values for four ewes per gestational age.  
Means sharing different superscript letters within a row are different (P < 0.01).  
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TABLE 4.7.  Concentrations (nmol/g tissue) of ornithine and arginine in ovine 
placenta and endometrium 
Day of gestation 
  30 40 60 80 100 120 140 SEM 
Intercotyledonary placenta 
Ornithine   316c   537b   852a   906a   328c   322c   340c  34 
Arginine 1003e 1217d 1618b 1773b 1994a 1407c 1025e  72 
 Placentome  
Ornithine 183e 1719a   964b   613c   336d   324d   378d  78  
Arginine 564e 3027a 1797c 1848c 2357b 1325d 1244d 104 
 Intercaruncular endometrium  
Ornithine 422c   897a 577b 395c  296d  288d 301d  36 
Arginine 813c 1055b 807c  886bc 1569a 1051b 799c  59 
 
a-d Data are the mean with pooled SEM values for four ewes per gestational age.  
Means sharing different superscript letters within a row are different (P < 0.01). 
 
Ornithine and arginine concentrations in placental and endometrial tissues 
Concentrations of arginine were higher (P < 0.01) than those of ornithine 
in all placental and endometrial tissues examined between Days 30 and 140 of 
gestation (Table 4.7).  Placentomal arginine and ornithine concentrations 
increased (P < 0.01) by 437% and 840% between Days 30 and 40 of gestation, 
respectively, and declined (P < 0.01) thereafter.  In intercotyledonary placenta, 
concentrations of ornithine increased (P < 0.01) progressively between Days 30 
and 60-80 of gestation and declined (P < 0.01) thereafter, whereas 
concentrations of arginine increased progressively between Days 30 and 100 of 
gestation and then decreased (P < 0.01) progressively between Days 100 and 
140 of gestation.  In intercaruncular endometrium, concentrations of ornithine 
increased (P < 0.01) between Days 30 and 40 of gestation and declined (P < 
0.01) thereafter, whereas concentrations of arginine increased (P < 0.01) 
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between Days 30 and 100 of gestation and decreased (P < 0.01) progressively 
during late gestation. Interestingly, arginine concentrations peaked (P < 0.01) on 
Day 100 of gestation in both intercotyledonary placenta and intercaruncular 
endometrium.  Also, placentomal arginine concentrations were higher (P < 0.01) 
on Day 100 of gestation, compared with earlier (Days 30 and 60-80) and later 
(Days 120-140) stages of gestation.  
 
Polyamine concentrations in allantoic and amniotic fluids 
Data are summarized in Table 4.8.  Concentrations of total polyamines in 
ovine allantoic fluid were higher than (P < 0.01), similar to (P > 0.05), and lower 
than (P < 0.01), those in amniotic fluid on Days 30 to 80, 100, and 120 to 140, 
respectively.  Concentrations of total polyamines in allantoic fluid increased (P < 
0.01) progressively between Days 30 and 60 of gestation, and declined (P < 
0.01) during the remainder of pregnancy, with the lowest values being observed 
on Days 120 to 140 of gestation.  Concentrations of total polyamines in amniotic 
fluid increased (P < 0.01) progressively between Days 30 and 100 of gestation, 
and then declined (P < 0.01) during late gestation (Days 120 to 140).  In 
allantoic or amniotic fluids, concentrations of polyamines did not differ (P > 0.05) 
between Days 120 and 140 of gestation.  Concentrations of putrescine, 
spermidine and spermine in allantoic and amniotic fluids varied greatly with day 
of gestation.  For example, concentrations of putrescine in allantoic fluid were 
greater than (P < 0.01), similar to (P > 0.05), and lower than (P < 0.01), those of 
spermidine and spermine on Days 30 to 40, 60 to 80, and 100 to 140 of 
gestation, respectively.  In addition, concentrations of putrescine in amniotic fluid 
were greater than (P < 0.01) those of spermine, similar to (P > 0.05) and lower 
than (P < 0.01) those of spermidine and spermine on Days 30, 40-60, and 100 
of gestation, respectively.   
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TABLE 4.8. Concentrations (nmol/L) of polyamines in ovine allantoic and 
amniotic fluids 
  Day of gestation 
   30 40 60 80 100 120 140 SEM 
  
Allantoic fluid Putrescine 2088b 3090a 3468a 1348c   545d   433d   423d 203 
 Spermidine 1055d 1898b 3063a 1445c 2748a   795e   618e 167 
 Spermine   923d 2155b 3260a 1643c 1195d   758e   865de 106 
 Total 4065c 7143b 9790a 4435c 4488c 1985d 1905d 285 
          
Amniotic fluid Putrescine   480e    813bc   995a   773cd   698d   905ab    278f   50 
 Spermidine    853bc 1060b    823bc 1745a 1978a  740c    545d 103 
 Spermine   335e 1000d 1153d 1035d 1800c 2297b  2993a 132 
  Total 1668d 2873c 2970c 3553b 4475a 3942b 3815ab 161 
 
a-f Data are the mean with pooled SEM values for four ewes per gestational age.  
Means sharing different superscript letters within a row are different (P < 0.01).   
 
 
Data regarding allantoic and amniotic fluid volumes as well as fetal weights of 
the same sheep as used for the present study have been published previously 
(Kwon et al., 2003a).  The volumes of ovine allantoic fluid averaged 31, 11, 31, 
46, 199, 491, and 366 ml, respectively, on Days 30, 40, 60, 80, 100, 120, and 
140 of gestation.  On the same days, the volumes of ovine amniotic fluid 
averaged 2.2, 23.8, 190, 543, 595, 383, and 449 ml, respectively.  These data, 
along with concentrations of polyamines in allantoic and amniotic fluids (Table 
4.8), were used to calculate the total content of polyamines in these two fetal 
fluid compartments (Table 4.9).  Total content of polyamines in allantoic fluid 
was greater than (P < 0.01), similar to (P > 0.05), and lower than (P < 0.01), that 
in amniotic fluid on Days 30, 40, and 60 to 140 of gestation, respectively. Total 
content of polyamines in allantoic and amniotic fluids peaked (P < 0.01) on Day  
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TABLE 4.9. Total content (nmol) of polyamines in ovine allantoic and amniotic 
fluids 
  Day of gestation 
   30 40 60 80 100 120 140 SEM 
  
Allantoic fluid Putrescine    64d 34e 108c    62d   109c   214a   155b   11 
 Spermidine   31f 23f   96d    67e   548a   393b   227c   18 
 Spermine   30e 26e 102d    76d   240c   371a   316b   15 
 Total 125e 83f 306c  205d   895a   978a   670b   66 
          
Amniotic fluid Putrescine 1f 19e 189c  420a   416a   345b   126d   24 
 Spermidine 2g 25f 157e  949b 1178a   283c   245d   76 
 Spermine 1f 24e 218d  563c 1072b   882b 1344a 129 
  Total 4f 68e 564d 1931b 2667a 1510c  1715bc 195 
 
a-g Data are the mean with pooled SEM values for four ewes per gestational age.  
Means sharing different superscript letters within a row are different (P < 0.01).  
 
100 of gestation.  Total content of spermine in amniotic fluid increased (P < 
0.01) progressively with advancing gestation.  On the basis of ovine fetal 
weights, which averaged 0.88, 5.0, 61, 312, 1005, 2322, 4125 g on Days 30, 40, 
60, 80, 100, 120, and 140 of gestation, respectively (Kwon et al., 2003a), total 
content of spermine in amniotic fluid was positively correlated with ovine fetal 
weights between Days 30 and 140 of gestation (r = 0.88, P < 0.01).   
 
Placental and endometrial ODC and arginase activities measured with the 
same substrate concentration (2 mM) 
Intercotyledonary placenta, placentomes, and intercaruncular 
endometrium obtained on Days 40 and 140 of gestation were analyzed for ODC  
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and arginase activities in the presence of the same substrate concentration (2 
mM) (Table 4.10).  Placental and endometrial ODC activities measured in the 
presence of 2 mM ornithine were about 1.4 times greater than those obtained in 
the presence of 0.2 mM ornithine (Table 4.1), whereas arginase activities 
measured in the presence of 2 mM arginine were approximately 30% of the 
values obtained in the presence of 10 mM arginine (Table 4.2).  At the same 
substrate concentration, arginase activity was 60- to 180-fold higher than ODC 
activity in ovine placental and endometrial tissues (P < 0.01).  
 
 
 
TABLE 4.10.  Ornithine decarboxylase (ODC) and arginase activities (nmol/g 
tissue/h) in ovine placenta and endometrium 
  Day 40 of gestation  Day 140 of gestation 
   ODC   Arginase    ODC   Arginase  
  
Intercotyledonary placenta   0.82 ± 0.06     64 ±  3 *   0.48 ± 0.03     33 ± 2 * 
Placentome   4.97 ± 0.35   304 ± 12 *   0.67 ± 0.04   120 ± 6 * 
Intercaruncular endometrium   1.16 ± 0.09   136 ±  7 *   0.49 ± 0.03     51 ± 3 * 
 
Data are means ± SEM, n = 4.  *  P < 0.01 vs ODC activity.  ODC and arginase 
activities were measured in the presence of 2 mM ornithine and 2 mM arginine, 
respectively. 
 
Correlations between ODC activity and polyamine synthesis or polyamine 
concentrations in placental and endometrial tissues 
These data are summarized in Table 4.11.  In placentomes and 
intercaruncular endometrium, ODC activities were positively correlated (P < 
0.01) with both rates of polyamine synthesis and concentrations of polyamines.   
In both tissues, concentrations of polyamines were positively correlated with 
rates of polyamine synthesis.  Likewise, in intercotyledonary placenta, ODC 
activities were positively correlated (P < 0.01) with rates of putrescine, 
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spermidine and total polyamine synthesis.  Interestingly, ODC activities were 
negatively correlated (P < 0.05) with concentrations of spermine, while rates of 
spermidine, spermine and total polyamine synthesis were also negatively 
correlated (P < 0.05) with their concentrations in intercotyledonary placenta.         
  
TABLE 4.11.  Correlations between ornithine decarboxylase activity (ODC) and 
polyamine synthesis (PAS) or polyamine concentrations ([PA]) in ovine placenta 
and endometrium 
  
ODC  
vs PAS  
 
ODC  
vs [PA] 
 
[PA] 
vs PAS 
 
Intercotyledonary placenta Putrescine  0.480 *  0.204 NS  0.005 NS 
 Spermidine  0.527 *  0.325 NS -0.608 * 
 Spermine  0.335 NS -0.406 † -0.390 † 
 Total  0.523 *  0.357 NS -0.599 * 
     
Placentome Putrescine  0.937 *  0.904 *  0.903 * 
 Spermidine  0.947 *  0.823 *  0.859 * 
 Spermine  0.940 *   0.769 *  0.819 * 
 Total  0.953 *  0.834 *  0.882 * 
     
Intercaruncular endometrium Putrescine  0.669 *  0.556 *  0.754 * 
 Spermidine  0.697 *  0.718 *  0.890 * 
 Spermine  0.696 *  0.423 †   0.809 * 
  Total  0.708 *  0.594 *  0.854 * 
 
Values are Pearson correlation coefficients, n = 28.  †  P < 0.05;  * P < 0.01.  NS, 
not significant.   
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Discussion 
To our knowledge, this is the first report of changes in polyamine 
synthesis and concentrations in ovine placental and endometrial tissues during 
pregnancy.  The present study has four major findings: 1) maximal activities of 
ODC and arginase as well as the highest concentrations of polyamines were 
expressed in ovine placentomes, intercotyledonary placenta, and intercaruncular 
endometrium in the first half of pregnancy; 2) the highest concentrations of 
polyamines in ovine allantoic and amniotic fluids occurred in early and late 
gestation, respectively; 3) concentrations of putrescine, spermidine and 
spermine varied greatly among ovine placental and endometrial tissues, fetal 
fluids, and day of gestation; and 4) arginine was an important precursor for 
polyamine synthesis in the ovine placenta and endometrium.   
Despite the previous reports of changes in rat placental ODC activity 
during pregnancy (Guha and Janne, 1976; Hoshiai et al., 1981), little is known 
about polyamine synthesis or concentrations of its physiological substrates in 
placenta or endometrium of any species.  Results of the present study 
demonstrate clearly that ODC activity, polyamine synthesis from ornithine or 
arginine, and polyamine concentrations were maximal in ovine placentomes on 
Day 40 of gestation (Tables 4.1-4.2 and 4.4-4.6) when placental growth and 
placentomal development are most rapid (Alexander, 1964; Reynolds and 
Redmer, 1995).  ODC activity and polyamine synthesis in intercotyledonary 
placenta and intercaruncular endometrium, as well as endometrial 
concentrations of polyamines, also peaked on Day 40 of gestation, when these 
tissues undergo marked morphological and functional changes (Wimsatt 1950; 
Stewart et al., 2000; Gray et al., 2001).  On the basis of water content of the 
ovine placentome (approximately 81%), intercotyledonary placenta 
(approximately 87%) and intercaruncular endometrium (approximately 74%) (our 
unpublished data), concentrations of polyamines in these tissues were estimated 
to be 0.66-3.5 mM, 0.29-0.61 mM, and 0.82-1.8 mM, respectively.  These values 
are substantially higher than concentrations of polyamines in maternal or fetal 
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plasma (2-5 µM) (our unpublished data), indicating the abundance of 
polyamines in ovine placental and endometrial tissues.  Our results suggest an 
important role for polyamines in placental and endometrial growth and therefore 
fetal growth.  In support of this view, an inhibition of ODC activity during 
pregnancy markedly reduced placental size and birth weights of rats (Ishida et 
al., 2002).   
A novel finding of this study is the relatively high arginase activity in ovine 
placental and endometrial tissues (Table 4.2).  In addition to ODC, the arginine-
derived ornithine can be catabolized by ornithine aminotransferase to yield 
pyrroline-5-carboxylate (P5C), a substrate for the synthesis of glutamate and 
proline by mitochondrial P5C dehydrogenase and cytosolic P5C reductase, 
respectively (Wu and Morris, 1998).  Thus, through the formation of ornithine, 
arginase would be expected to play a regulatory role in polyamine synthesis 
from arginine in the ovine placenta and endometrium, as recently reported for 
endothelial cells, vascular smooth muscle cells, and activated macrophages (Wu 
and Morris, 1998; Li et al., 2001; Wei et al., 2001).  Indeed, our results 
demonstrate that arginine was actively converted into polyamines in ovine 
placental and endometrial tissues (Table 4.5) and those rates of polyamine 
synthesis were closely correlated with arginase activity in these tissues (Table 
4.2).  Ovine allantoic fluid is rich in ornithine and arginine (Kwon et al., 2003a), 
and is likely a major source of these two amino acids for placenta and 
endometrium.  This view is supported by our findings that the highest 
concentrations of arginine in ovine allantoic fluid on Day 100 of gestation (Kwon 
et al., 2003a) were associated with the highest concentrations of arginine in 
intercotyledonary placenta and intercaruncular endometrium (Table 4.7) and 
with elevated concentrations of arginine in placentomes (Table 4.7), because 
probably arginase activity in allantoic fluid was low value on Day 100 of 
gestation (Table 4.3).  On the basis of water content of ovine placentomes, 
intercotyledonary placenta and intercaruncular endometrium, concentrations of 
ornithine in these tissues were estimated to be 0.23-2.1 mM, 0.36-1.0 mM, and 
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0.39-1.2 mM, respectively, and concentrations of arginine in these tissues were 
estimated to be 0.70-3.7 mM, 1.2-2.3 mM, and 1.1-2.1 mM, respectively.  These 
values are substantially higher than concentrations of ornithine and arginine in 
ovine maternal plasma (0.04-0.2 mM) and fetal plasma (0.1-0.6 mM) (Kwon et 
al., 2003a).  Interestingly, between Days 30 and 80 of gestation, increases in 
substrate concentrations and polyamine synthesis in ovine placental and 
endometrial tissues (Tables 4.4-4.6) are associated with increases in ornithine 
and arginine concentrations in ovine allantoic fluid (Kwon et al., 2003a) because 
arginase activity in allantoic fluid was higher between Days 30 and 80 of 
gestation than on Days 100 and 140 of gestation (Table 4.3), further supporting 
the earlier suggestion that this fetal fluid is an important nutrient reservoir during 
gestation (Bazer, 1989).  Collectively, our results indicate that arginine is a major 
source of the ornithine used for polyamine synthesis in ovine placental and 
endometrial tissues.   
The ODC and arginase assay conditions, which involved 0.2 mM 
ornithine (about 2 times the Km value of the mammalian ODC for ornithine) 
(Tabor and Tabor, 1984) and 10 mM arginine (about 2 times the Km value of the 
mammalian arginase for arginine) (Wu and Morris, 1998), respectively, were 
commonly found in the literature (e.g., Guha and Janne, 1976; Hoshiai et al., 
1981; Wu et al., 1998b; Wei et al., 2001).  The higher arginase activity (Table 
4.2) compared to ODC activity (Table 4.1) in ovine placental and endometrial 
tissues was not caused by the inclusion of higher substrate (arginine) 
concentrations in assay solutions.  For example, when ODC and arginase 
activities were determined using the same substrate concentrations (2 mM), 
which were similar to ornithine and arginine concentrations in the placentomes 
on Day 40 of gestation (Table 4.7), we found that arginase activity was also 
much higher than ODC activity in ovine placental and endometrial tissues (Table 
4.10).  Importantly, results of this study indicate that changes in ODC and 
arginase activities in ovine placental and endometrial tissues during pregnancy 
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are consistent with changes in rates of polyamine synthesis from ornithine and 
arginine, respectively.   
Tissue concentrations of polyamines depend on the balance between 
rates of their synthesis and catabolism (Wu and Morris, 1998).  Polyamine 
synthesis is regulated by ODC and arginase activities as well as the availability 
of ornithine and arginine (Wu and Morris, 1998; Li et al., 2001; Wei et al., 2001).  
Thus, ODC activity was positively correlated with polyamine concentrations in 
placentomes and endometrium (Table 4.11).  In addition, concentrations of both 
ornithine and polyamines peaked between Days 60 and 80 of gestation in 
intercotyledonary placenta (Tables 4.5 and 4.6).  These data further support an 
important role for polyamine synthesis in regulating polyamine concentrations.  
In mammalian cells, ODC degradation is catalyzed by the 26S proteasome via 
an ubiquitin-independent pathway and is greatly accelerated by its association 
with the polyamine-induced regulatory protein antizyme (Hoyt et al., 2003).  
Spermidine/spermine N1-acetyltransferase converts spermine and spermidine to 
acetyl-spermine and N1-acetyl-spermidine, respectively.  Acetyl-spermine and 
N1-acetyl-spermidine are catalysed by polyamine oxidase to form spermidine 
and putrescine, respectively.  The latter is oxidized by diamine oxidase to form 
succinate plus ammonia.  At present, little is known about developmental 
changes of the ODC antizyme or polyamine-degrading enzymes in ovine tissues.  
Future studies are necessary to obtain such information to fully explain the 
developmental changes in polyamine concentrations in ovine tissues (including 
intercotyledonary placenta) during pregnancy. 
 Amniotic and allantoic fluid derive, in part, from secretions and transport 
of water across the placenta and endometrium.  Thus, increases in polyamine 
concentrations in allantoic fluid between Days 30 and 60 of gestation (Table 4.8) 
were closely correlated with increases in polyamine synthesis in ovine 
placentomes and endometrium (Tables 4.4 and 4.5).  With the development of 
intestinal polyamine transport systems during gestation, the intake of amniotic 
fluid by the fetus provides a source of polyamines for supporting proliferation 
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and differentiation of intestinal epithelial cells.  This is consistent with the 
increasing content of total polyamines in amniotic fluid with advancing gestation 
(Table 4.9) and increasing with total activities of arginase in amniotic fluid with 
advancing gestation (Table 4.3).  The nutritional significance of amniotic fluid is 
graphically illustrated by the finding that esophageal ligation, which prevents the 
entry of this fluid into the small intestine, results in intrauterine growth retardation 
in fetal sheep (Trahair and Harding, 1995).  Although early anatomical studies 
suggested that the allantoic sac served as a reservoir for fetal wastes, it is now 
clear that allantoic fluid nutrients may be absorbed by the allantoic epithelium 
into the fetal-placental circulation and utilized by fetal tissues (Bazer, 1989).  The 
increases in concentrations of polyamines (Table 4.8) and substrates (ornithine 
and arginine) for polyamine synthesis (Kwon et al., 2003a) in allantoic fluid 
during early gestation may play an important role in fetal growth and 
development. 
 Our findings indicate that patterns of polyamine synthesis and substrate 
availability vary greatly with ovine placental and endometrial tissues.  Whatever 
the differences, the highest concentrations of polyamines in these tissues 
(Tables 4.1-4.2 and 4.4-4.6) occur when their growth is the most rapid during 
gestation (Alexander, 1964; Bazer, 1979; Atkinson et al., 1984; Reynolds and 
Redmer, 1995; Taylor et al., 2000).  Importantly, our results reveal metabolic 
coordination among the several integrated pathways that support high rates of 
polyamine synthesis in placental and endometrial tissues.  For example, 
placentomal arginase activity and arginine concentrations peaked on Day 40 of 
gestation (Table 4.2), thus maximizing the hydrolysis of arginine to ornithine and 
markedly increasing intracellular concentrations of ornithine (Table 4.7).  The 
latter was coupled with the highest ODC activity for polyamine synthesis (Table 
4.1), thereby maximizing polyamine concentrations (Table 4.6) in ovine 
placentomes during early gestation.  Similarly, arginase and ODC activities, 
intracellular ornithine concentrations, and polyamine synthesis from both 
ornithine or arginine were maximal in intercaruncular endometrium on Day 40 of 
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gestation, resulting in highest concentrations of polyamines (Table 4.6).  
Furthermore, concentrations of glutamine, a major substrate for ornithine and 
arginine synthesis (Wu and Morris, 1998) and a stimulator of ODC activity (Wu 
et al., 2000c), were highest in ovine allantoic fluid between Days 40 and 60 of 
gestation (Kwon et al., 2003a).  
 The present findings raise important questions regarding the physiologic 
significance of polyamine synthesis in fetal-placental nutrition and development.  
In this regard, it is noteworthy that maternal undernutrition decreases ornithine 
concentrations in porcine fetal plasma and allantoic fluid and impairs fetal growth 
(Wu et al., 1998a; Osgerby et al., 2002), and may also program permanent 
structural, metabolic and functional alterations (Barker and Clark, 1997; 
Symonds et al., 2001).  Maternal undernutrition in sheep (50% of NRC nutrient 
requirements) from Day 28 to Day 78 of gestation decreased concentrations of 
putrescine, spermidine and spermine in amniotic and allantoic fluids by 38-43% 
(our unpublished data), and reduced fetal growth by 32% on Day 78 of gestation 
(Vonnahme et al., 2003).  Because recent epidemiological studies in humans 
suggest that the existence between intrauterine growth retardation and 
development of chronic disease (e.g., diabetes, hypertension, and coronary 
heart disease) later in life (Barker and Clark, 1997; Symonds et al., 2001), 
placental synthesis of polyamines may have important implications for both 
intrauterine growth retardation and fetal origins of diseases in adults. 
 As noted previously, physiological concentrations of polyamines 
(putrescine, spermidine and spermine) are key regulators of angiogenesis, early 
embryogenesis, placental trophoblast growth, and embryonic development in the 
uterus (Forzard et al., 1980; Henningsson et al., 1982).  Results of the present 
study indicate that polyamine synthesis and concentrations were the highest in 
ovine placentomes and endometrium on Day 40 of gestation when their growth 
and morphological changes were most rapid.  Relatively high levels of 
polyamine concentrations were present in ovine placental and endometrial 
tissues in the second half of pregnancy when there is continued development of 
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the placental vascular bed and increases in total uterine blood flow to support 
fetal growth (Ford, 1995; Reynolds and Redmer, 1995).  Importantly, there is 
metabolic coordination among the several integrated pathways that support high 
rates of polyamine synthesis in the placenta and endometrium.  Our findings 
provide a new base of information for future studies to define the roles of 
polyamines in fetal-placental growth and development.    
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CHAPTER V 
              DEVELOPMENTAL CHANGES IN NITRIC OXIDE SYNTHESIS  
                                IN THE OVINE PLACENTA 
 
Introduction 
 The placentae of all mammalian species undergo rapid formation of new 
blood vessels (angiogenesis) and marked growth during pregnancy (Ford, 1995; 
Reynolds and Redmer, 2001).  Placental angiogenesis is necessary to increase 
placental-fetal blood flow and the transfer of nutrients from maternal to fetal 
blood.  Therefore, placental growth is crucial for controlling the survival, growth, 
and development of the fetus, and a better understanding of factors that regulate 
placental growth is essential to improving reproductive efficiency of domestic 
animals and humans.  The sheep has a synepitheliochorial placenta, whose 
growth is maximal between Days 20 and 60 of gestation (term is 147 days) 
(Alexander, 1964; Reynolds and Redmer, 1995).  The ovine placenta has 60 to 
100 individual cotyledons formed by the attachment of fetal trophoblast cells at 
predetermined sites (caruncles) in the uterine endometrium, as well as the 
intercotyledonary chorioallantoic placenta (Alexander, 1964). 
 Nitric oxide (NO), which is synthesized from L-arginine by NO synthases 
(NOS), is a key regulator of angiogenesis, early mammalian embryogenesis, 
placental trophoblast growth, and conceptus development in the uterus (Maul et 
al., 2003).  There are three isoforms of the NOS: neuronal NOS (nNOS or type I), 
inducible NOS (iNOS or type II), and endothelial NOS (eNOS or type III), all of 
which require tetrahydrobiopterin (BH4) and NADPH as essential cofactors 
(Alderton et al., 2001).  In most tissues, nNOS and eNOS are constitutively 
expre 
_______________ 
*Reprinted with permission from “Developmental Changes in Nitric Oxide Synthesis in 
Ovine Placenta” by Hyukjung Kwon, Guoyao Wu, Cynthia J. Meininger, Fuller W. Bazer, 
and Thomas E. Spencer. 2004. Biol Reprod. Copyright by the Society for the Study of 
Reproduction. 
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expressed, and are termed constitutive NOS (cNOS), whereas iNOS is induced 
by inflammatory cytokines and hormones.  cNOS, but not iNOS, requires Ca2+ 
for enzymatic activity.  Both cNOS and iNOS are expressed in placentae of 
mammals, including humans, pigs, and sheep (Weiner et al.,1994; Magness et 
al., 1997; Farina et al., 2001; Galan et al., 2001).  In ovine placenta, cNOS is 
composed primarily of eNOS but little nNOS (Magness et al., 1997).  Although 
there are reports of NOS expression and NO synthesis in ovine placenta during 
late gestation (Days 110-142) (Zheng et al., 2000), little is known about changes 
in NO synthesis, NOS activity or its cofactors in ovine utero-placental tissues 
associated with conceptus development.   
We recently reported marked increases in concentrations of both arginine 
and its precursor citrulline in ovine allantoic fluids (a reservoir of nutrients for the 
fetal-placental tissues) between Days 30 and 60 of gestation (Kwon et al., 
2003a).  Interestingly, these temporal changes coincide with the period of most 
rapid growth of the ovine placenta (Alexander, 1964; Reynolds and Redmer, 
1995).  On the basis of this observation, we hypothesized that placental NO 
synthesis was maximal during the first half of pregnancy.  This hypothesis was 
tested in ewes between Day 30 and Day 140 of gestation by analyzing both 
placental and endometrial tissues, because uterine functions are closely 
associated with placental development and function (Gray et al., 2001). 
 
Materials and Methods 
Chemicals. 
Tetrahydrobiopterin (BH4), HEPES, NG-monomethyl-L-arginine, biopterin, 
NADPH, GTP, arginine, dithiothreitol (DTT), EGTA, EDTA, aprotinin, 
chymostatin, phenylmethylsulfonylfluoride, pepstatin, FAD, FMN, and calmodulin 
were purchased from Sigma Chemicals (St. Louis, MO).  L-[U-14C]arginine was 
obtained from American Radiolabeled Chemicals (St. Louis, MO).  High-
performance liquid chromatography (HPLC)-grade water and methanol were 
purchased from Fisher Scientific (Fair Lawn, NJ).  Nitrate reductase and alkaline 
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phosphatase were procured from Roche (Indianapolis, IN).  Dowex 50W-X8 
resin (H+ form, 200-400mesh) was purchased from Bio-Rad (Richmond, CA) and 
was converted to the Na+ from before use as recommended by the manufacturer. 
 
Experimental animals 
Columbia cross-bred ewes were mated to Suffolk rams when detected in 
estrus (Day 0) and 12 and 24 h later.  Ewes were then assigned randomly to be 
hysterectomized (n = 4 per day) on Day 30, 40, 60, 80, 100, 120, or 140 of 
gestation to allow collection of placental and endometrial tissues.  Because there 
were marked changes in physiological parameters in the ovine conceptus during 
pregnancy (e.g. Kwon et al., 2003a, 2003b) and because coefficients of 
variations for all measured parameters were relatively small (< 5-8%), we used 4 
ewes per day of gestation on the basis of statistical power calculation.  In 
preliminary studies, we determined that rates of NO synthesis in placental and 
endometrial tissues were not affected by the number of fetuses (data not 
shown).  Thus, samples were obtained from one randomly selected fetus per 
ewe for this study when there were twin fetal lambs.  None of the ewes in the 
study had more than twin fetuses.  Throughout gestation, ewes had free access 
to water and were fed individually 1.4 kg/day of an alfalfa-based diet containing 
90.9% dry matter, 58.7% total digestible nutrients, 15.8% crude protein, 3.7% 
fat, 27.0% acid detergent fiber, 35.0% neutral detergent fiber, 0.065% vitamin 
mixture, and 0.15% salt mixture that met National Research Council (NRC) 
requirements (Kwon et al., 2003a).  Ewes consumed all of the feed provided 
daily.  This study was approved by the Texas A&M University Institutional 
Agricultural Animal Care and Use Committee. 
 
Hysterectomy and sample collection 
Hysterectomies were performed between 8:00 and 9:00 A.M., 24 h after 
the last feeding (Kwon et al., 2003a).  All ewes were administered isofluorane 
(5%) via an inhalation mask to induce anesthesia which was maintained with 
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isofluorane (1-5%).  A mid-ventral laparotomy was performed to expose the 
reproductive tract.  Placentomes, intercotyledonary placenta and intercaruncular 
endometrium were obtained on all indicated days of gestation.  A portion of 
these tissues was used immediately for metabolic studies and BH4 analysis, and 
the remaining tissues were stored at -80oC for enzyme assays and NADPH 
analysis within 1 week.  In this study, we did not separate the placentomes into 
maternal and fetal components, because such a procedure would require a 
prolonged period of time to complete, which might compromise the biochemical 
viability of the tissues for metabolic studies.   
 
Determination of NO synthesis 
Placental and endometrial tissues (~200 mg) were rinsed three times with 
1 mL of oxygenated (95% O2/5% CO2; v/v) basal medium Eagle (BME) 
containing 0.4 mM L-arginine, 0.5 mM L-glutamine, 5 mM D-glucose, 100 
units/ml penicillin, 100 µg/ml streptomycin and 0.25 µg/ml amphotericin B, 
preincubated at 37°C for 0.5 h in 4 ml of oxygenated BME, and then incubated 
at 37°C for 6 h in 0.5 ml fresh oxygenated BME.  Concentrations of other amino 
acids in the BME were as follows (mM): alanine, 0.4; asparagine, 0.05; 
aspartate, 0.05; glutamate, 0.1; cystine, 0.05; glycine, 0.3; histidine, 0.05; 
isoleucine, 0.2; leucine, 0.2; lysine, 0.2; methionine, 0.1; phenylalanine, 0.1; 
proline, 0.2; serine, 0.2; threonine, 0.2; tryptophan, 0.1; tyrosine, 0.1; and valine, 
0.2.  At the end of a 6-h incubation period, media were analyzed for nitrite plus 
nitrate (stable oxidation products of NO).  In all experiments, medium incubated 
without cells was run as the blank.  
Nitrite and nitrate in culture medium were analyzed by HPLC as 
previously described (Li et al., 2000).  Briefly, 100 µl medium (diluted 1:2) was 
incubated for 10 min at room temperature with 10 µl of 316 µM 2,3-
diaminonapthalene, followed by addition of 5 µl of 2.8 M NaOH.  The derivative 
was separated on a C8 column (150 X 4.6 mm I.D.) using 15 mM sodium 
phosphate buffer (pH 7.5; 50% methanol; flow rate, 1.3 ml/min) and detected 
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with excitation at 375 nm and emission at 415 nm.  Nitrate in culture medium 
was measured using this HPLC method after its conversion to nitrite by nitrate 
reductase (Li et al., 2000).  Nitrite and nitrate were quantified using NaNO2 and 
NaNO3 standards, respectively. 
 
Determination of NOS activity 
The activities of total NOS, cNOS and iNOS in placental and endometrial 
tissues were measured using [14C] arginine (Meininger and Wu, 2002).  Briefly, 
tissues (~300 mg) were homogenized in 1 ml of 50 mM buffer containing 1 mM 
DTT, 1 mM EDTA, and protease inhibitors (5 µg/ml phenylmethylsulfonyl-
fluoride, 5 µg/ml aprotinin, 5 µg/ml chymostatin and 5 µg/ml pepstatin).  The 
homogenates were centrifuged at 600 g for 15 min, and the supernatants were 
used for NOS assays.  Total NOS activity was determined by mixing 100 µl of 
tissue extract with 50 µl of 8 mM CaCl2, and 50 µl of reagent mixture (1 mM 
DTT, 1 mM MgCl2, 0.1 mM [U-14C] arginine (5x103 dpm/nmol), 0.1 mM citrulline, 
10 mM valine (an inhibitor of arginase), 0.1 mM NADPH, 0.1 mM BH4, 0.1 mM 
FAD, 0.1 mM FMN, 10 µg calmodulin, and 0.1 M HEPES, pH 7.4).  iNOS activity 
was measured by mixing 100 µl of tissue extract with 50 µl of the reagent 
mixture, 25 µl of 16 mM EGTA, and 25 µl H2O.  A blank was prepared by mixing 
100 µl of tissue extract with 50 µl of the reagent mixture, 25 µl of 16 mM EGTA, 
and 25 µl of 16 mM NG-monomethyl-L-arginine (an inhibitor of NOS).  All assay 
tubes were incubated at 37oC for 30 min.  Reactions were terminated by addition 
of 50 µl of 1.5 M HClO4.  Neutralized solution (0.5 ml) was loaded into an AG 
50W-X8 resin (Na+ form) column (0.55 x 6 cm), and the column eluted with 4 ml 
H2O.  The eluate containing [14C]citrulline was measured for radioactivity. NOS 
activity was calculated on the basis of [14C]citrulline production and medium 
specific activity (SA) of [14C]arginine.  Total NOS activity =  (14C dpm in the total 
NOS tube – 14C dpm in the blank tube)/[14C]arginine SA).  iNOS activity =  (14C 
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dpm in the iNOS tube – 14C dpm in the blank tube)/[14C]arginine SA).  cNOS 
activity = total NOS activity – iNOS activity. 
 
Determination of GTP-CH activity 
GTP-CH activity in placental and endometrial tissues was determined 
using HPLC (Meininger and Wu, 2002).  Briefly, placental tissues (~300 mg) 
were homogenized in 1 ml of 100 µM phenylmethylsulfonyl fluoride and 0.1 M 
Tris buffer (pH 7.8, 0.3 M KCl, 2.5 mM EDTA, 10% glycerol). The tissue 
homogenate was centrifuged at 600 g for 15 min.  The supernatant fluid was 
loaded on a Sephadex G-25 column (5 x 60 mm), followed by washing with 0.45 
ml of 0.1 M Tris buffer.  An additional 0.5 ml of 0.1 M Tris buffer was added to 
the column, and the eluate collected for enzyme assays.  The desalting of tissue 
extracts removed small molecules (e.g., amino acids and biopterin) that 
potentially interfere with GTP-CH analysis.  An aliquot (200 µl) of the desalted 
enzyme preparation was mixed with 100 µl of 6 mM GTP in a brown 
microcentrifuge tube, and the solution was incubated at 37oC in the dark. After 
90 min, 25 µl of 1% I2/2% KI (in 1 M HCl) was added to the tube.  A separate 
blank consisted of 200 µl of the desalted enzyme preparation and 25 µl of 1% 
I2/2% KI (in 1 M HCl); after 5 min, 100 µl of 6 mM GTP was added to the blank 
tube.  All tubes were then centrifuged at 10,000 g for 1 min.  The supernatant 
fluid was mixed with 25 µl of 114 mM ascorbic acid, followed by neutralization 
with 25 µl of 1 M NaOH.  Alkaline phosphatase was added to each tube (10 
U/tube).  After a 60-min incubation at 37oC in the dark, 50 µl of the solution was 
analyzed for neopterin on a Phenosphere 5 ODS-1 column (4.6 mm x 25 cm, 5 
um) using isocratic elution (flow rate of 1 ml/min) and fluorescence detection 
(excitation 350 nm and emission 440 nm).  The mobile phase solvent was 5% 
HPLC-grade methanol, 95% HPLC-grade water, 7.5 mM sodium phosphate (pH 
6.35).  
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Determination of BH4 
BH4 was analyzed by HPLC as described by Meininger and Wu (2002).  
Briefly, tissues (~50 mg) were homogenized in 0.5 ml of 0.1 M phosphoric acid 
containing 5 mM dithioerythritol and 60 µl of 2 M trichloacetic acid (TCA).  BH4 
standard (50 pmol/ml) or cell extract (100 µl) was mixed with 15 µl of 0.2 M TCA 
and 15 µl of acidic oxidizer (1% I2/2% KI in 0.2 M TCA) (acidic oxidation) or with 
15 µl of 1 M NaOH and 15 µl of alkaline oxidizer (1% I2/2% KI in 3 M NaOH) 
(alkaline oxidation).  After 1-h incubation at 25oC in the dark, excess iodine was 
removed by adding 25 µl of 114 mM ascorbic acid.  After neutralization, 50 µl of 
the solution was analyzed for biopterin as described above for neopterin.  The 
amount of BH4 in tissue extracts was determined by subtracting the amount of 
biopterin measured after alkaline oxidation from the amount of biopterin 
measured after acidic oxidation. 
 
Determination of NADPH 
NADPH in placental and endometrial tissues was determined using HPLC 
as described previously (Wu et al., 2001).  Briefly, 100 mg tissue was 
homogenized in 1 ml of 1 mM bathophenanthrolinedisulfonic acid/250 mM KOH.  
Ice-cold 1 M KH2PO4 (250 µl) and 1 ml of 1 mM bathophenanthrolinedisulfonic 
acid were added sequentially to the homogenates, followed by centrifugation 
(3000 g, 15 min).  An aliquot of the supernatant (25 µl) was analyzed on a 
Phenosphere 5 ODS-1 column (4.6 x 25 cm, 5 µm) using isocratic elution (1 
ml/min) and fluorescence detection (excitation 340 nm, emission 460 nm).  The 
mobile phase solution was 150 mM potassium phosphate/5 mM 
tetrabutylammonium hydrogen sulfate/23% methanol; pH 7.5).   NADPH in 
samples was quantified on the basis of NADPH standard. 
 
Calculations and Statistical Analysis 
NOS and GTP-CH activities as well as BH4 and NADPH concentrations 
in placentae and endometria were calculated on the basis of tissue weight.  Data 
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were subjected to least squares analyses of variance, one-way analysis of 
variance, and correlation analysis (Steel et al., 1997), using the PROC GLM and 
PROC CORR procedures of Statistical Analysis System (SAS, Cary, NC).  
Differences between means were determined by the Student-Newman-Keuls 
multiple comparison test following one-way analysis of variance (Steel et al., 
1997).  Statistical significance was set at a probability value of ≤ 0.05. 
 
Results 
NOS activity in placental and endometrial tissues 
Marked changes in NOS activities occurred (P < 0.01) in ovine placental 
and endometrial tissues during conceptus development (Table 5.1).  In 
intercotyledonary placenta, iNOS activity increased (P < 0.01) approximately 
7.5-fold between Days 30 and 60 of gestation, declined (P < 0.01) on Day 80 of 
gestation, and increased again on Day 100 of gestation.  cNOS activity in this 
tissue increased (P < 0.01) 10-fold between Days 30 and 40 of gestation, further 
increased (P < 0.01) to Day 80 of gestation, and declined thereafter.  
Intercotyledonary placental cNOS activities were similar to (P > 0.05), greater 
than (P < 0.01), and lower than (P < 0.01) iNOS activities on Days 40, 120 and 
140, Day 80, and Days 30, 60 and 100 of gestation, respectively.  In 
intercaruncular endometrium, iNOS activity increased (P < 0.01) approximately 
8-fold between Days 30 and 60 of gestation, declined (P < 0.01) by Days 80-100 
of gestation, and increased again on Days 120-140 compared with Day 100 of 
gestation.  Endometrial cNOS activity increased (P < 0.01) 17-fold between 
Days 30 and 40 of gestation, declined (P < 0.01) progressively between Days 40 
and 80 of gestation, and increased again on Days 120-140 compared with Day 
100 of gestation.  In intercaruncular endometrium, cNOS activity was similar to 
(P > 0.05) and greater than (P < 0.01) iNOS activity on Days 30, 80, 100 and 
140 and Days 40, 60, and 120 of gestation, respectively.  Placentomes exhibited 
the highest (P < 0.01) NOS activity among the placental and endometrial tissues 
during early (Day 30) and late (Days 80-140) gestation.  Placentomal iNOS and 
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cNOS activities increased (P < 0.01) progressively between Days 30 and 60 of 
gestation, and then declined (P < 0.01) by Day 80 of gestation.  In placentomes, 
iNOS activities increased (P < 0.01), but cNOS activities decreased (P < 0.01), 
between Days 80 and 120 of gestation, while total NOS activity remained 
constant.  Placentomal cNOS activities were similar to (P > 0.05), greater than 
(P < 0.01), and lower than (P < 0.01) iNOS activities during early (Days 30-40), 
 
TABLE 5.1.  Nitric oxide synthase activities (nmol•g tissue-1•h-1) in ovine 
placenta and endometrium  
  Day of gestation   
    30  40   60   80  100  120  140 SEM 
 Intercotyledonary placenta 
Inducible NOS 0.18d 0.51c 1.52a 0.54c 1.09b 0.56c 0.42c 0.08 
Constitutive NOS 0.04d 0.44bc 0.49bc 1.03a 0.36c 0.43bc 0.58b 0.08 
Total NOS 0.22d 0.95c 2.01a 1.57b 1.46b 0.97c 1.00c 0.1 
 Placentome 
Inducible NOS 1.44e 2.01d 3.13c 2.24d 6.02b 8.45a 5.68b 0.24 
Constitutive NOS 1.26d 2.59c 5.33a 3.82b 2.91c 1.02d 2.55c 0.22 
Total NOS 2.71d 4.60c 8.46a 6.05b 8.93a 9.47a 8.24a 0.31 
 Intercaruncular endometrium 
Inducible NOS 0.37f 0.69e 3.26a 1.80cd 1.47d 2.37b 2.12bc 0.2 
Constitutive NOS 0.42f 7.60a 5.69b 1.91e 1.80e 3.44c 2.41d 0.39 
Total NOS 0.79e 8.28a 8.95a 3.70d 3.26d 5.81b 4.53c 0.37 
 
a-f Data are the mean with pooled SEM values for four ewes per gestational age.  
Means with different superscript letters within a row are different (P < 0.01).  
NOS, nitric oxide synthase. 
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mid (Days 60-80), and late (Days 100-140) gestation, respectively.  Total NOS 
activity peaked (P < 0.01) on Days 40-60 of gestation in intercaruncular 
endometrium and on Day 60 of gestation in both intercotyledonary placenta and 
placentomes. 
 
NO synthesis in placental and endometrial tissues 
These data are summarized in Table 5.2.  In intercotyledonary placenta, 
NO production increased (P < 0.01) 160% between Days 30 and 60 of gestation 
and declined (P < 0.01) thereafter.  In intercaruncular endometrium, NO 
synthesis increased (P < 0.01) 150-170% on Days 40-60 compared with Day 30 
of gestation, and declined (P < 0.01) on Days 80-100 of gestation.  Endometrial 
NO synthesis increased on Days 120-140 compared with Days 80-100 of 
gestation.  Placentomes exhibited the highest (P < 0.01) rate of NO synthesis 
among the placental and endometrial tissues between Days 30 and 140 of 
gestation.  Placentomal NO production increased (P < 0.01) 10-fold between 
Days 30 and 60 of gestation, declined (P < 0.01) on Day 80 of gestation, and 
increased (P < 0.01) again during late gestation (Days 100-140) compared with 
con 
 
TABLE 5.2.  Nitric oxide synthesis (nmol•g tissue-1•h-1) in ovine placenta and 
endometrium 
      Day of gestation       
  30 40 60 80 100 120 140 SEM
Intercotyledonary placenta 0.25d 0.47b 0.64a 0.49b 0.47b 0.38c 0.36c 0.02
Placentome  0.29d 0.89c 3.15a 0.86c 1.79b 1.73b 1.66b 0.1 
Intercaruncular endometrium 0.26d 0.66a 0.70a 0.35c 0.33c 0.47b 0.45b 0.03
 
a-d Data are the mean with pooled SEM values for four ewes per gestational age.  
Means with different superscript letters within a row are different (P < 0.01).   
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Day 80 of gestation.  In all placental and endometrial tissues, NO synthesis did 
not differ (P > 0.05) between Days 120 and140 of gestation.  Rates of NO 
generation peaked (P < 0.01) on Days 40-60 of gestation in intercaruncular 
endometrium and on Day 60 of gestation in both intercotyledonary placenta and 
placentomes.   
 
GTP-CH activity in placental and endometrial tissues 
GTP-CH activity was the highest (P < 0.01) in placentomes among the 
ovine placental and endometrial tissues studied between Days 30 and 140 of 
gestation (Table 5.3).  Throughout pregnancy, marked changes in GTP-CH 
activity occurred (P < 0.01) in placentomes and, to a lesser extent, in 
intercotyledonary placenta and intercaruncular endometrium.  In 
intercotyledonary placenta, GTP-CH activity increased (P < 0.01) 225% between 
Days 30 and 60 of gestation and declined (P < 0.01) thereafter.  In 
intercaruncular endometrium, GTP-CH activity increased (P < 0.01) 245-260% 
on Days 40-60 compared with Day 30 of gestation, and then declined (P < 0.01) 
 
 
TABLE 5.3.  GTP cyclohydrolase I activity (nmol•g tissue-1•h-1) in ovine placenta 
and endometrium 
      Day of gestation       
  30 40 60 80 100 120 140 SEM
Intercotyledonary placenta 0.84d 1.96b   2.73a 2.01b    1.93b   1.44c    1.36c 0.11 
Placentome  1.90d 5.38c  15.3a 5.17c  10.8b  10.4b  10.2b 0.53 
Intercaruncular endometrium 0.89d 3.07a   3.22a 1.63c    1.75c    2.37b    2.34b 0.14 
 
a-d Data are the mean with pooled SEM values for four ewes per gestational age.  
Means with different superscript letters within a row are different (P < 0.01).   
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on Days 80-100 of gestation.  Endometrial GTP activity increased (P < 0.01) 
approximately 35% on Days 120-140 compared with Days 80-100 of gestation.  
Strikingly, placentomal GTP activity increased (P < 0.01) 7-fold between Days 
30 and 60 of gestation, declined (P < 0.01) markedly on Day 80 of gestation, 
and increased by approximately 100% (P < 0.01) on Days 100-140 compared 
with Day 80 of gestation.  In all placental and endometrial tissues, GTP activity 
did not differ (P > 0.05) between Days 120 and 140 of gestation.  GTP activity 
peaked (P < 0.01) on Days 40-60 of gestation in intercaruncular endometrium 
and on Day 60 of gestation for both intercotyledonary placenta and placentomes. 
 
BH4 and NADPH concentrations in placental and endometrial tissues 
These data are summarized in Table 5.4.  Placentomes exhibited the 
highest levels of BH4 and the most dramatic changes (P < 0.01) during 
pregnancy.  Interestingly, BH4 levels were similar (P > 0.05) between 
intercotyledonary placenta and intercaruncular endometrium throughout 
gestation. In intercotyledonary placenta, BH4 levels increased (P < 0.01) by 
180% between Days 30 and 60 of gestation and declined (P < 0.01) thereafter.  
In intercaruncular endometrium, BH4 levels doubled (P < 0.01) between Day 30 
and Days 40-60 of gestation, and then declined (P < 0.01) approximately 37% 
by Days 80-100 of gestation.  Endometrial BH4 levels increased (P < 0.01) by 
approximately 30% on Days 120-140 compared with Days 80-100 of gestation.  
Remarkably, placentomal BH4 concentrations increased (P < 0.01) 8.4-fold 
between Days 30 and 60 of gestation, declined (P < 0.01) to Day 80 of gestation, 
and increased 2-fold (P < 0.01) on Days 100-140 compared with Day 80 of 
gestation.  In all placental and endometrial tissues, BH4 levels did not differ (P > 
0.05) between Days 120 and 140 of gestation.   
 The patterns of change in NADPH levels during pregnancy were similar 
among intercotyledonary placenta, placentome, and intercaruncular 
endometrium (Table 5.4).  In all of these tissues, NADPH levels increased (P < 
0.01) progressively between Days 30 and 60 of gestation, declined (P < 0.01) by 
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 TABLE 5.4.  Tetrahydrobiopterin and NADPH concentrations (nmol•g tissue-1) 
in ovine placenta and endometrium 
  Day of gestation  
  30 40 60 80 100 120 140 SEM 
   Intercotyledonary placenta   
Tetrahydrobiopterin 0.24d 0.52b 0.68a 0.55b 0.53b 0.40c 0.38c 0.02 
NADPH 3.19c 5.63b 8.10a 6.24b 5.97b 6.02b 5.74b 0.23 
   Placentome     
Tetrahydrobiopterin 0.43d 1.26c 4.04a 1.12c 2.26b 2.43b 2.11b 0.09 
NADPH 4.20c 9.11b  12.3a 9.06b 8.43b 8.61b 8.32b 0.42 
   Intercaruncular endometrium   
Tetrahydrobiopterin 0.26d 0.75a 0.77a 0.47b 0.49b 0.61c 0.63c 0.02 
NADPH 3.45c 5.98b 8.72a 6.51b 6.23b 6.01b 6.14b 0.18 
 
a-d Data are the mean with pooled SEM values for four ewes per gestational age.  
Means with different superscript letters within a row are different (P < 0.01).   
 
Day 80 of gestation, and did not differ (P > 0.05) between Days 80 and 140 of 
gestation.  Placentomes exhibited the highest (P < 0.01) levels of NADPH 
among the placental and endometrial tissues examined between Days 30 and 
140 of pregnancy. 
 
Correlations between NO synthesis and NOS activity, GTP-CH activity, and 
NOS cofactors 
Rates of NO synthesis were positively correlated (P < 0.01) with NOS 
activity, GTP-CH activity, BH4 levels and NADPH levels in intercotyledonary 
placenta, placentomes, and intercaruncular endometrium (Table 5.5).  
Correlation coefficients between GTP-CH activity and BH4 levels were 0.89, 
0.91, and 0.85 (n = 28; P < 0.01) in the same tissues, respectively. 
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TABLE 5.5.  Correlations between NO synthesis and NOS activity, GTP-CH 
activity, BH4 level, and NADPH level in ovine placenta and endometrium 
  Total NOS GTP-CH BH4 NADPH 
  activity activity level level 
          
Intercotyledonary placenta  0.79 *  0.85 *  0.87 *  0.84 * 
     
Placentome  0.75 *  0.94 *  0.95 *  0.72 * 
     
Intercaruncular endometrium  0.87 *  0.92 *  0.83 *  0.67 * 
 
Values are Pearson correlation coefficients, n = 28.  * P < 0.01.   BH4, 
tetrahydrobiopterin; GTP-CH, GTP cyclohydrolase I; NO, nitric oxide; NOS, nitric 
oxide synthase. 
 
Discussion 
Since the 1988 discovery of NO synthesis by macrophages and 
endothelial cells, there have been extensive studies of the role of NO in 
placental and fetal development (Sladek et al., 1997; Bird et al., 2003; Maul et 
al., 2003).  The available evidence suggests that uterine synthesis of NO 
increases during pregnancy and decreases at the onset of parturition (Maul et la., 
2003).  In addition, recent studies with the ovine model demonstrated that NO is 
a major mediator of placental-fetal blood flow during pregnancy (Rosenfeld et al., 
1996).  Despite the report of NOS expression and NO synthesis in ovine 
placenta during late gestation (Days 110-142) (Zheng et al., 2000), little is 
known about changes in NO production by ovine utero-placental tissues 
associated with conceptus development.  Such information is crucial for 
understanding the molecular regulation of placental and fetal growth, and for 
elucidating mechanisms responsible for intrauterine growth retardation and fetal 
origin of adult-onset diseases (Barker and Clark, 1997) that are related to 
disturbed NO metabolism (Ozaki et al., 2000; Edwards and McMilen, 2001).  
Because changes in NOS activity may not necessarily indicate changes in NO 
production by intact cells (Wu and Morris, 1998; Alderton et al., 2001), it is 
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important that rates of NO synthesis be determined in placental and endometrial 
tissues to better understand the role of this pathway in conceptus development. 
To our knowledge, this is the first report of NO synthesis, NOS and GTP-
CH activities, as well as concentrations of BH4 and NADPH in placental and 
endometrial tissues of any species during early, mid, and late pregnancy.  There 
are four major findings from this study: (1) maximal activities of NOS and GTP-
CH, the greatest availability of BH4 and NADPH, and the highest rate of NO 
synthesis occurred in ovine placenta and endometrium in the first half of 
pregnancy; (2) all of these measured parameters, except for NADPH, exhibited 
a second peak during late gestation when there is a continued increase in fetal-
placental blood flows; (3) cNOS and iNOS activities varied greatly among ovine 
tissues and with gestational age; and (4) metabolic coordination occurred among 
the several integrated pathways that support high rates of NO synthesis in the 
placenta and endometrium.   
 The NOS (a dimer in its active form) is a flavoheme enzyme that contains 
binding sites for NADPH, FAD and FMN in its reductase domain as well as 
arginine, BH4 and iron protoporphyrin IX (heme) in its oxygenase domain 
(Alderton et al., 2001).  The C-terminal reductase domain is linked to the N-
terminal oxygenase domain by a calmodulin-recognition site, which regulates 
electron transfer.  In iNOS, Ca2+ is tighly bound to calmodulin, and thus 
exogenous Ca2+ is not required for its enzymatic activity.  Although the precise 
role of BH4 in the NOS reaction is not fully understood, suggested functional 
roles include: a) promotion of dimer formation, arginine binding, and NADPH 
oxidation, b) prevention of enzyme autoinactivation, and c) redox function 
(Alderton et al., 2001).  Recent evidence shows that BH4 primarily plays a redox 
role in NOS catalysis, in which BH4 donotes an electron to the heme of the 
oxygenase domain to form a BH4 radical (BH4•+), which then returns to the 
reduced state (BH4) by accepting an electron from a flavin in the reductase 
domain (Wei et al., 2003).   In the presence of O2, NADPH, FAD, FMN and BH4, 
all isoforms of the NOS catalyze oxidation of L-arginine to NO and L-citrulline, 
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with Nω-hydroxyl-L-arginine as an enzyme-bound intermediate.   L-Citrulline can 
be recyled into L-arginine via argininosuccinate synthase and argininosuccinate 
lyase in virtually all animal cells (Wu and Morris, 1998).  For example, in ovine 
placentomes, argininosuccinate synthase and lyase activities were 0.85 ± 0.07 
and 0.94 ± 0.11 nmol/mg protein/min (means ± SEM, n = 4), respectively, at Day 
40 of gestation, and increased (P < 0.01) to 1.73 ± 0.16 and 2.46 ± 0.21 
nmol/mg protein/min (means ± SEM, n = 4), at Day 60 of gestation (Wu G, 
unpublished data).   The increase in enzyme activities is associated with 
increased arginine concentration in ovine allantoic fluid between Days 40 and 60 
of gestation (Kwon et al., 2003a).             
Because of the intracellular compartmentalization of NO synthesis and its 
functional consequence (Wu and Morris, 1998), much attention has been 
directed towards determining NOS isoforms in the female reproductive organs 
(e.g., Weiner et al., 1994; Magness et al., 1997; Farina et al., 2001; Galan et al., 
2001; Maul et al., 2003).  Both cNOS and iNOS are present in the gravid rat and 
ovine uterine tissues and may vary with species and gestational age (Natuzzi et 
al., 1993; Figueroa and Massmann, 1995; Buhimschi et al., 1996; Ali et al., 
1997; Massmann et al., 1999).  For example, nNOS and eNOS were more 
predominant than iNOS in the ovine uterus during the last third of gestation 
(Massmann et al., 1999), whereas the opposite was reported for the rat uterus 
throughout pregnancy (Ali et al., 1997).  In contrast, cNOS and iNOS activities 
were similar in both porcine placenta and endometrium during early and mid 
gestation (Wu et al., 1998b).  Despite these reports, little is known about 
developmental changes in cNOS and iNOS activities in both placental and 
endometrial tissues throughout pregnancy.  An interesting finding of this study 
was that cNOS and iNOS activities vary greatly with ovine placental and 
endometrial tissues and gestational age.  For example, in placentomes, cNOS 
and iNOS activities predominated during mid (Days 60-80) and late (Days 120-
140) gestation, respectively.  In intercaruncular endometrium, cNOS activity was 
10-fold greater than, and similar to, iNOS activity on Days 40 and 140 of 
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gestation, respectively.  In contrast, in intercotylednonary placenta, cNOS 
activity was less and greater than iNOS activity on Days 30 and 80 of gestation, 
respectively.  The changes in placental and endometrial NOS expression during 
gestation may be brought about by changes in many factors, including 
hormones (Weiner et al., 1994; Bird et al., 2003), cytokines (Alderton et al., 
2001), uterine secretions (Maul et al., 2003), as well as nutrients and their 
metabolites (Wu and Meininger, 2002). 
Placental synthesis of NO, like that of polyamines (other products of 
arginine catabolism) essential for placental angiogenesis and growth) (Kwon et 
al., 2003b), increased markedly between Days 30 and 60 of gestation (Table 
5.2) when placental growth and placentomal development are most rapid 
(Alexander, 1964; Reynolds and Redmer, 1995).  Likewise, NO synthesis in 
intercaruncular endometrium peaked on Days 40-60 of gestation, when this 
tissue undergoes marked morphological and functional changes (Gray et al., 
2001).  Results of the present study support our hypothesis that NO and 
polyamines are crucial for placental and endometrial growth during early 
pregnancy (Kwon et al., 2003b; Maul et al., 2003) and, therefore, for fetal growth 
and development.  In support of this view, inhibition of NOS or ornithine 
decarboxylase (a key enzyme in polyamine synthesis) activity during early 
pregnancy markedly reduced placental size and caused intrauterine growth 
retardation in rats (Diket et al., 1994; Buhimschi et al., 1995; Greenberg et al., 
1997; Ishida et al., 2002).  It is noteworthy that there was a second peak in 
placentomal NO synthesis on Day 100 of gestation, when placental-fetal blood 
flow continues to increase in pregnant ewes (Ford, 1995; Reynolds and Redmer, 
1995).  The increase in NO synthesis during late gestation may play an 
important role in enhancing the transfer of nutrients and oxygen from maternal to 
fetal blood to support the most rapid absolute growth of the fetus.  For example, 
fetal weight gain between Days 120 and 140 of gestation is similar to that during 
the first 4 mo of gestation in sheep (Kwon et al., 2003a).  This necessitates an 
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increased provision of nutrients (e.g., amino acids) for metabolic utilization (e.g., 
tissue protein synthesis and gluconeogenesis). 
In the present study, it was not possible to discern whether the 
placentomal changes in NO synthesis were of placental or maternal origin, 
because placentomes were not separated into cotyledonary and caruncular 
components.  In ewes, vascular density of the cotyledonary bed remains relative 
constant between Days 40 and 80 of gestation, and then increases exponentially 
thereafter (Stegeman, 1974; Teasdale, 1976).  In contrast, vascular density of 
caruncular tissues increases substantially until mid-gestation and then more 
slowly thereafter (Teasdale, 1976).   These data are consistent with the finding 
that umbilical blood flow increases more rapidly than uterine blood flow during 
the last half of gestation in ewes (Rudolph and Heymann, 1970; Reynolds and 
Ferrell, 1987).   On the basis of these observations, we surmise that the 
placentomal increase in NO synthesis between Days 30 and 60 and between 80 
and 140 of gestation occurred primarily in caruncular tissues and the 
cotyledonary bed, respectively.   Future studies are necessary to evaluate NO 
synthesis patterns in the fetal and maternal placentomal tissues in order to 
dtermine if the changes are related to the known differences in caruncular and 
cotyledonary angiogenesis and vascular development.  
Although NADPH and BH4 are known to be essential cofactors for NO 
synthesis in cells and tissues (Alderton et al., 2001), including human placenta 
(Kukor et al., 2000), little is known about their concentrations in placenta and 
endometrium of any species during pregnancy.  In animal cells, NADPH is 
produced primarily from glucose metabolism via the pentose cycle (Wu et al., 
1994), whereas GTP-CH catalyzes the first and rate-controlling step in the de 
novo synthesis of BH4 from GTP (Thöny et al., 2000).  Consistent with this view, 
changes in GTP-CH activity were positively correlated with changes in BH4 
levels in ovine intercotyledonary placenta, placentome, and intercaruncular 
endometrium between Days 30 and 140 of gestation.  Intriguingly, in ovine 
placenta and endometrium, both NADPH and BH4 levels increased markedly 
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between Days 40 and 60 of gestation (Table 5.4), as did allantoic fluid 
concentrations of citrulline (the precursor of arginine) and arginine (Kwon et al., 
2003a).  Between Days 80 and 100 of gestation, BH4 concentrations also 
increased in placentome and endometrium (Table 5.4), as did concentrations of 
arginine in allantoic fluid (Kwon et al., 2003a).   This amino acid, which is a 
potential regulator of the pentose cycle activity (Wu et al., 1994) and a stimulator 
of endothelial GTP-CH expression (Wu et al., 2003), may play an important role 
in regulating the synthesis of NADPH and BH4 and, therefore, NO production in 
placenta and endometrium.  In support of this view, rates of NO synthesis in 
ovine placenta and endometrium were positively correlated with NADPH and 
BH4 levels during pregnancy (Table 5.5).    
On the basis of water content of the ovine placentome (approximately 
81%), intercotyledonary placenta (approximately 87%) and intercaruncular 
endometrium (approximately 74%) (Kwon et al., 2003b), mean concentrations of 
NADPH in these tissues were estimated to be 3.7-9.3 µM, 5.2-15.2 µM, and 4.7-
11.2 µM, respectively.  Mean concentrations of BH4 in the same tissues were 
estimated to be 0.28-0.78 µM, 0.53-5.0 µM, and 0.35-1.04 µM, respectively.  
Although these values were higher than the Km of purified eNOS and iNOS for 
NADPH (~ 1 µM) and BH4 (~ 0.1 µM) (Alderton et al., 2001), changes in tissue 
NADPH and BH4 levels can modulate both constitutive and inducible NO 
production (Meininger et al., 2000; Wu et al., 2001; Medina et al., 2003; Zheng 
et al., 2003).  For example, increasing NADPH levels from 230 to 330 µM in 
endothelial cells through the metabolic stimulation of the pentose cycle 
increased NO synthesis by 62% (Wu et al., 2001).  Furthermore, increasing BH4 
levels 140% through GTP-CH gene transfer increased NO production by 260% 
in carotid arteries of hypertensive rats (Zheng et al., 2003).  Similarly, 
intracellular concentrations of arginine (~1-2 mM) are much higher than the Km 
of purified eNOS and iNOS for arginine (~ 3 to 20 µM) (Alderton et al., 2001), but 
increasing tissue arginine above 2 mM stimulates NO production by both 
endothelial cells and activated macrophages (Wu and Meininger, 2002).  This 
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so-called “paradox of NO synthesis” may be explained by the 
compartmentalization of BH4, NADPH, and arginine (Wu and Morris, 1998), 
multiple competitive pathways for their utilization (Medina et al., 2003), and 
protein-protein interaction in intact cells (Alderton et al., 2001). 
  Our findings indicate that patterns of NO synthesis as well as the 
availability of cofactors of NOS vary greatly among ovine placental and 
endometrial tissues. Whatever the differences, the highest rates of NO synthesis 
in these tissues occur when their growth is the most rapid during gestation 
(Alexander, 1964; Bazer, 1979; Atkinson et al., 1984; Reynolds and Redmer, 
1995; Gray et al., 2001).  Additionally, our results suggest metabolic 
coordination among the several integrated pathways that support high rates of 
NO in placental and endometrial tissues (Figure 5.1).  For example, 
concentrations of citrulline (the effective precursor of arginine) in ovine allantoic 
fluid increase 34-fold between Days 30 and 60 of gestation (Kwon et al., 2003a), 
thus increasing the availability of arginine for metabolism in placental and 
endometrium (Kwon et al., 2003b).  In addition, placentomal GTP-CH activity 
peaked on Day 60 of gestation (Table 5.2), thus maximizing the de novo 
synthesis of BH4.  Consequently, placentomal BH4 and NADPH concentrations 
were highest on Day 60 of gestation (Table 5.5).  All of these changes contribute 
to maximal NO production during early pregnancy.  Our findings raise important 
questions regarding the physiological significance of NO synthesis in fetal-
placental nutrition and development.  It is noteworthy that maternal 
undernutrition decreases concentrations of arginine in fetal plasma and allantoic 
fluid and impairs fetal growth (Wu et al., 1998; Osgerby et al., 2002), and may 
also program permanent structural, metabolic and functional alterations (Barker 
and Clark, 1997; Symonds et al., 2001).  Maternal undernutrition in sheep (50% 
of NRC nutrient requirements) from Day 28 to Day 78 of gestation decreased 
concentrations of arginine and biopterin (an indicator of BH4 availability) in fetal 
pl 
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Fig 5.1.  Role of arginine, tetrahydrobiopterin and NADPH in nitric oxide 
synthesis.  AS, argininosuccinate; ASL, argininosuccinate lyase; ASS, 
aegininosuccinate synthase; NO, nitric oxide.  Tetrahydrobiopterin (BH4) 
primarily plays a redox role in NOS catalysis, in which BH4 donotes an electron 
to the heme to form a BH4 radical (BH4•+), which then returns to the reduced 
state (BH4) by accepting an electron from a flavin. 
 
plasma and allantoic fluids by 20-38% (Kwon H, Wu G, Bazer FW, Spencer TE, 
Ford SP, unpublished data), and reduced fetal growth by 32% on Day 78 of 
gestation (Vonnahme et al., 2003).   Because recent epidemiological studies in 
humans suggest that there are links between intrauterine growth retardation and 
development of chronic disease (e.g., diabetes, hypertension, and coronary 
heart disease) later in life (Barker and Clark, 1997; Symonds et al., 2001), 
placental synthesis of NO may have important implications for both intrauterine 
growth retardation and fetal origins of diseases in adults. 
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 In conclusion, results of the present study indicate that NO synthesis was 
highest in both placentomes and endometrium of ewes on Day 60 of gestation 
when their growth and morphological changes are most rapid and when fetal-
placental blood flow increases substantially.  Relatively high rates of NO 
synthesis occurred in the second half of pregnancy in association with further 
increases in the placental vascular bed and uterine blood flow to support rapid 
fetal growth.  Importantly, there is metabolic coordination among the several 
integrated pathways that support high rates of NO synthesis in the ovine 
conceptus.  These results establish a new base of information for future studies 
to define the roles of polyamines in fetal-placental growth and development. 
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CHAPTER VI 
MATERNAL UNDERNUTRITION REDUCES CONCENTRATIONS OF AMINO 
ACIDS AND POLYAMINES IN OVINE FETAL PLASMA AND FLUIDS 
 
Introduction 
 Studies over past decades have established intrauterine growth 
retardation (IUGR) in response to undernutrition in humans, sheep, pigs, and 
rats (Widdowson, 1977; Osgerby et al., 2002; Ramachandran, 2002; Vonnahme 
et al., 2003).  Undernutrition in pregnant women may result from low dietary 
intake of nutrients owing to either a limited supply of foods or severe nausea and 
vomiting known as hyperemesis gravidarum (Snell et al., 1998).  Epidemiological 
studies in humans suggest that alterations in fetal nutrition and endocrine status 
may result in developmental adaptations that permanently change the structure, 
physiology and metabolism of the offspring, thereby predisposing individuals to 
cardiovascular, metabolic and endocrine diseases in adult life (Barker and Clark, 
1997).  In domestic animals, undernutrition during gestation also occurs in the 
U.S. and worldwide.  For example, the nutrient intake of grazing ewes in the 
western United States is often < 50% of the NRC requirement because of 
significant fluctuations in both quantity and quality of forage due to extreme 
variations in precipitation (Thomas and Kott, 1995).  A recent report indicated 
that, in India, sheep reared on rangeland are severely underfed for most part of 
the year because of low biomass (Chaturvedi et al., 2003).  Unsupplemented 
grazing ewes lose a significant amount of body weight from early to mid-
gestation and even after supplementation later in gestation, their health, fetal 
growth and lactation performance are compromised (Thomas and Kott, 1995).  
Thus, studies of the mechanisms for IUGR brought about by maternal 
undernutrition have important implications for both human medicine and animal 
agriculture.   
 Amino acids play a vital role in development of the conceptus 
(embryo/fetus and associated placental membranes).  In addition to serving as 
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building blocks for tissue protein synthesis, amino acids function as antioxidants, 
regulators of hormone secretion, major fuels for fetal growth, and cell signaling 
molecules (Wu and Morris, 1998; Stipanuk and Watford, 2000; Flynn et al., 
2002).  Furthermore, amino acids are essential precursors for the synthesis of 
non-protein substances with enormous versatility and biological importance, 
including nitric oxide, polyamines, neurotransmitters, amino sugars, purine and 
pyrimidine nucleotides, creatine, carnitine, porphyrins, melatonin, melanin, and 
sphingolipids (Stipanuk and Watford, 2000).  For example, nitric oxide, a product 
of arginine catabolism, plays a crucial role in regulating placental angiogenesis 
and fetal-placental blood flows during gestation (Sladek et al., 1997; Reynolds 
and Redmer, 2001; Bird et al., 2003).  Polyamines (polycationic molecules) 
regulate gene expression, signal transduction, ion channel function, DNA and 
protein synthesis, as well as cell proliferation, differentiation, and function (Flynn 
et al., 2002).  Surprisingly, little is known about the effect of maternal 
undernutrition on concentrations of amino acids and polyamines in the 
conceptus of any species.  
 The sheep is a widely used animal model for studying human fetal-
placental development (Lemons et al., 1976; Sladek et al., 1997; Wallace, 2000; 
Bird et al., 2003).  We have recently reported striking changes in concentrations 
of amino acids and polyamines in the ovine conceptus during pregnancy (Kwon 
et al., 2003a, 2003b).  The significance of these changes for normal fetal growth 
and development may be underscored under a pathophysiological condition 
(e.g., maternal undernutrition or overnutrition) that is known to cause IUGR.  We 
hypothesized that maternal undernutrition reduces the availability of both amino 
acids and polyamines in the conceptus.  This hypothesis was tested using our 
established ovine model of maternal undernutrition and IUGR (Vonnahme et al., 
2003). 
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Materials and Methods 
Animals 
 Two series of experiments were conducted with multiparous ewes of 
mixed breeding (Vonnahme et al., 2003). In both Experiment 1 and 2, maternal 
undernutrition (50% of NRC nutrient requirements) of ewes between Days 28 
and 78 was carried out as described previously (Vonnahme et al., 2003).  
Briefly, the diet consisted of a pelleted beet pulp (79.7% total digestible nutrient, 
93.5% dry matter, 10% crude protein) and a mineral-vitamin mixture.  On Day 20 
of gestation, 16 ewes were weighed so that individual diets could be calculated 
on a metabolic body weight basis (weight0.75).  On Day 21 of gestation, all ewes 
were placed in individual pens and provided all nutrients that met NRC 
maintenance requirements for early gestation.  On Day 28 of gestation, ewes 
were assigned randomly to a control group (n = 8) fed 100% of NRC nutrient 
requirements) or a nutrient-restricted group (n = 8; 50% of NRC nutrient 
requirements).  Every 7 days beginning on Day 28 of gestation, ewes were 
weighed and rations adjusted for changes in body weight.  On Day 45 of 
gestation, the number of fetuses carried by each ewe was determined by 
ultrasonography (Ausonics Microimager 1000 sector scanning instrument; 
Ausonics Pty Ltd, Sydney, Australia).  On Day 78 of gestation, each ewe in 
Experimnet 1 was administered an overdose of sodium pentabarbitol (Abbott 
Laboratories, Abbott Park, IL) and exsanguinated.  After the tip of the gravid 
uterine horn was exposed, blood samples were withdrawn from uterine artery 
and umbilical vein into cooled heparinized tubes.  The tubes were immediately 
centrifuged at 4 oC and 3000 g for 10 min to obtain plasma.  All plasma samples 
were stored at –80 oC until analyzed.  On Day 78 in Experiment 2, nutrient-
restricted ewes either continued to be fed 50% of NRC nutrient requirements or 
realimented to 100% of NRC nutrient requirements.  On Day 135 of gestation, 
blood samples were obtained from uterine artery and umbilical vein of all ewes, 
as described for Experiment 1. 
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Fetal weights on Day 78 of gestation were heavier (P<0.05) for the 
control ewes than for the nutrient-restricted ewes, averaging 326.36±19.99 g 
and 221.68±7.90 g, respectively.  On Day 135 of gestation, fetal weights of 
control-fed and nutrient-restricted realimented ewes were similar averaging 
4782.0±165.1 g and 4639.6±236.4 g, respectively, while fetal weights of 
continuously undernourished ewes were reduced (P<0.05) when compared to 
control-fed ewes averaging 4047.0±175.5 g. 
 
Analysis of amino acids 
Plasma and fetal fluids were analyzed for amino acids, as described 
previously (Wu et al., 1997).  Briefly, amino acids, except for proline, were 
determined by fluorometric HPLC methods involving pre-column derivatization 
with o-phthaldialdehyde.  The values for total cysteine in plasma and fluids 
represent free cysteine plus ½ cystine.  Proline was measured using a 
fluorometric HPLC method involving pre-column derivatization with 9-
fluorenylmethyl chloroformate.  Amino acids in samples were quantified on the 
basis of known amounts of standards (Sigma Chemicals, St. Louis, MO) using 
Millenium-32 Software (Waters, Milford, MA). 
 
Analysis of polyamines 
 Fetal fluids were analyzed for polyamines by an ion-pairing HPLC method 
involving precolumn-derivatization with o-phthaldialdehyde (Wu et al., 1998b).  
Putrescine, spermidine and spermine in samples were quantified on the basis of 
known amounts of standards (Sigma Chemicals), using Millenium-32 Software 
(Waters, Milford, MA). 
 
Statistics Analysis 
Statistical comparisons between the two groups of ewes euthanized on 
Day 78 of gestation were performed using the unpaired t-test.  Statistical 
comparisons among the three groups of ewes euthanized on Day 135 of 
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gestation were completed using a one-way analysis of variance.  Post hoc 
analysis was performed with a Tukey’s test for highly significant differences.  All 
statistical analyses were performed using the SAS V8.2 program for Windows® 
(SAS Inst. Inc., Cary, NC), and significance was accepted when P ≤ 0.05.   
 
Results 
Maternal undernutrition between Days 28 and 78 of gestation 
 Table 6.1 summarizes amino acid concentrations in maternal and fetal 
plasma on Day 78 of gestation.  Glycine was the most abundant amino acid in 
both maternal and fetal plasma.  Compared with control-fed ewes, maternal 
undernutrition between Days 28 and 78 of gestation increased (P < 0.01) 
plasma concentration of glycine, but decreased (P < 0.05) plasma 
concentrations of many amino acids (arginine, citrulline, cysteine, glutamine, 
isoleucine, leucine, ornithine, phenylalanine, proline, serine, and valine) in both 
maternal and fetal plasma.  Nutrient restriction also decreased (P < 0.05) 
concentrations of lysine, methionine, threonine, tryptophan, and tyrosine in 
maternal plasma, but had no effect (P > 0.05) on these amino acids in fetal 
plasma.  Underfeeding had no effect (P > 0.05) on concentrations of β-alanine, 
asparagine, aspartate, glutamate, histidine, and taurine in either maternal or 
fetal plasma. Concentrations of total α-amino acids were 8.8% and 8.3% lower 
(P < 0.01), respectively, in maternal and fetal plasma of nutrient-restricted ewes, 
when compared with control-fed ewes.   
 Concentrations of amino acids in allantoic and amniotic fluids on Day 78 
of gestation are summarized in Table 6.2.  Alanine, citrulline, glutamine, glycine, 
and serine represented 73% and 76% of total α-amino acids in allantoic fluid of 
control-fed and nutrient-restricted ewes, respectively.  Compared with control-
fed 
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TABLE 6.1.  Amino acid concentrations (µM) in ovine maternal and fetal plasma 
on Day 78 of gestation  
 Uterine arterial plasma  Fetal umbilical plasma 
Amino acid    Control    Restricted     Control   Restricted 
Ala   229 ± 8   200 ± 7 †    405 ± 16   421 ± 17  
β-Ala     11 ± 0.6     10 ± 0.5       86 ± 5     83 ± 3  
Arg   130 ± 3   100 ± 4 *    223 ± 11   157 ± 5 * 
Asn     21 ± 0.9     19 ± 0.8       79 ± 4     80 ± 7  
Asp     11 ± 0.8     11 ± 0.7       16 ± 0.9     14 ± 0.7  
Cit   175 ± 3   130 ± 7 *    211 ± 9   140 ± 4 * 
Cys   168 ± 3   139 ± 5 *    186 ± 4   170 ± 5 † 
Gln   219 ± 7   156 ± 3 *    437 ± 13   349 ± 10 * 
Glu     69 ± 2     65 ± 2       72 ± 4     73 ± 4  
Gly   454 ± 17   669 ± 20 *    499 ± 15   772 ± 15 * 
His     49 ± 2     46 ± 1.5       55 ± 2     58 ± 3  
Ile     65 ± 1.4     46 ± 1.4 *      77 ± 2     64 ± 2 * 
Leu     97 ± 4     71 ± 3 *    158 ± 5   128 ± 4 * 
Lys   102 ± 3     83 ± 2 *    189 ± 6   175 ± 7  
Met     21 ± 0.6     17 ± 0.3 *      63 ± 2     57 ± 2  
Orn     53 ± 2     37 ± 1.5 *    114 ± 5     95 ± 3 * 
Phe     48 ± 2     37 ± 1.6 *    118 ± 6   100 ± 6 † 
Pro   111 ± 4     78 ± 3 *    194 ± 4   153 ± 4 * 
Ser     75 ± 2     54 ± 2 *    418 ± 16   323 ± 16 * 
Taurine     68 ± 3     63 ± 3     131 ± 8   119 ± 7  
Thr     71 ± 2     57 ± 2 *    333 ± 9   305 ± 10  
Trp     31 ± 2     23 ± 0.7 *      49 ± 1.3     51 ± 1.7  
Tyr     52 ± 2     38 ± 1 *    126 ± 8   118 ± 4  
Val   164 ± 3   125 ± 4 *     195 ± 5   164 ± 4 * 
Total α-AA 2411 ± 21 2200 ± 41 *   4215 ± 49 3865 ± 38 * 
 
Data are means ± SEM. n=8, † P < 0.05; * P<0.01.  Control, fed 100% of NRC 
requirements between Days 28 and 78 of gestation.  †Fed 50% of NRC nutrient 
requirements betweens Days 28 and 78 of gestation.  AA, amino acids.  
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TABLE 6.2.  Amino acid concentrations (µM) in ovine fetal fluids on Day 78 of 
gestation 
  Allantoic fluid Amniotic fluid 
Amino acid      Control      Restricted        Control     Restricted 
Ala   4183 ± 272   3905 ± 256        43 ± 2      37 ± 2.2  
β-Ala   1049 ± 34   1033 ± 65        31 ± 1      28 ± 1.8  
Arg     813 ± 24     653 ± 23 *       30 ± 2      23 ± 0.9 * 
Asn     374 ± 27     338 ± 23        16 ± 0.8      14 ± 1  
Asp     136 ± 9     145 ± 11          6.6 ± 0.4        5.8 ± 0.3  
Cit   2541 ± 126   1534 ± 121 *       36 ± 1.7      23 ± 1.1 * 
Cys     536 ± 15     469 ± 34        42 ± 2      34 ± 2 † 
Gln   4431 ± 264   3218 ± 133 *       76 ± 4      49 ± 2 * 
Glu     150 ± 9     151 ± 6        11 ± 0.6        9.5 ± 0.6  
Gly   3308 ± 145   7129 ± 408 *       79 ± 3    180 ± 8 * 
His     221 ± 20     200 ± 19          4.6 ± 0.3        4.2 ± 0.3  
Ile     150 ± 9     119 ± 4 *         5 ± 0.3        3.7 ± 0.2 * 
Leu     553 ± 31     453 ± 19 †       39 ± 2      29 ± 1 * 
Lys   1076 ± 44   1025 ± 47        54 ± 3      46 ± 2 † 
Met       65 ± 3       70 ± 3          4.4 ± 0.2        4 ± 0.2  
Orn     386 ± 28     293 ± 12 †       82 ± 6      73 ± 3  
Phe     385 ± 21     361 ± 14        27 ± 1.6      24 ± 1.3  
Pro     735 ± 23     591 ± 30 *       43 ± 1.8      35 ± 1.3 * 
Ser   4296 ± 186   3480 ± 176 *       95 ± 3      65 ± 3 * 
Taurine   1383 ± 82   1208 ± 82        92 ± 3      82 ± 3 † 
Thr     795 ± 47     765 ± 26        27 ± 1.8      25 ± 1.9  
Trp     118 ± 3     111 ± 6          4.8 ± 0.4        4.4 ± 0.2 
Tyr     103 ± 5       93 ± 6          5.5 ± 0.4        5 ± 0.3  
Val     414 ± 20     349 ± 14 †       25 ± 1.4      20 ± 0.9 † 
Total α-AA 25768 ± 596 25449 ± 556      753 ± 11    714 ± 11 † 
 
Data are means ± SEM.  n = 8, † P < 0.05 vs control; * P<0.01 vs control.  AA, 
amino acids. 
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TABLE 6.3.  Polaymine concentrations (µM) in ovine fetal fluids on Day 78 of 
gestation  
Polyamine Allantoic fluid  Amniotic fluid 
  Control Restricted Control Restricted 
Putrescine 1469 ± 49 951± 33 *  760± 20 547 ± 37 * 
Spemidine 1544 ± 53 1015± 52 *  1753± 73 1104 ± 65 * 
Spermine 1655 ± 47 994± 62 *  1120± 72 753 ± 20 * 
Total PA 4668 ± 144 2961± 121 *  3633± 133 2404 ± 61 * 
 
Data are means ± SEM.  n = 8, * P < 0.01 vs control.  
 
Compared with control-fed ewes, maternal undernutrition between Days 28 and 
78 of gestation increased (P < 0.01) concentrations of glycine more than 2-fold 
but decreased (P < 0.05) concentrations of many amino acids (arginine, 
citrulline, glutamine, isoleucine, leucine, proline, serine, and valine) (Table 6.2) 
as well as polyamines (Table 6.3) in both allantoic and amniotic fluids.  Nutrient 
restriction had no effect (P > 0.05) on concentrations of cysteine, lysine, and 
taurine in allantoic fluid, but decreased (P < 0.05) concentrations of these amino 
acids in amniotic fluid; the opposite was observed for ornithine.  Concentrations 
of alanine, β-alanine, asparagine, aspartate, glutamate, histidine, methionine, 
phenylalanine, threonine, tryptophan, and tyrosine in allantoic and amniotic 
fluids did not differ (P > 0.05) between control-fed and nutrient-restricted ewes.  
On Day 78 of gestation, maternal undernutrition had no effect (P > 0.05) on 
concentrations of total α-amino acids in allantoic fluid, but slightly decreased (P 
< 0.05) concentrations of total α-amino acids by 5% in amniotic fluid.  
 
Maternal undernutrition between Days 28 and 135 of gestation 
 Concentrations of amino acids in maternal and fetal plasma on Day 135  
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TABLE 6.4.  Amino acid concentrations (µM) in ovine maternal and fetal plasma 
on Day 135 of gestation  
  Maternal plasma  Fetal plasma 
Amino acid Control Restricted† Realimented‡ Control Restricted† Realimented‡
Ala 172 ± 5a 138 ± 6b  194± 14a  485± 19a 374 ± 26b 448 ± 16a 
β-Ala 34 ± 3 31 ± 1 29± 2  205± 17 192 ± 24 198 ± 12 
Arg 184 ± 8  97 ± 2b  113± 6b  309± 18a 224 ± 22b 182 ± 12b 
Asn 39 ± 2 26 ± 2 36± 3  103± 3a 69 ± 5b 88 ± 5b 
Asp 10 ± 1 9 ± 0.3 10± 1   21± 1 18 ± 1 19 ± 1 
Cit 150 ± 8a 83 ± 2b 79± 5b  239± 9a 145 ± 9b 150 ± 7b 
Cys 149 ± 4a 63 ± 3c 93± 4b  186± 8a 100 ± 3c 118 ± 6b 
Gln 329 ± 19a 244 ± 6b 241± 19b  881± 35a 753 ± 25b 726 ± 29b 
Glu 86 ± 3 113 ± 7 89 ± 6  71± 4a 46 ± 4c 63 ± 3b 
Gly 565 ± 22 515 ± 29 497± 25  1052± 49a 635 ± 40c 829 ± 45b 
His 47 ± 2a 28 ± 1b 31± 2b  73± 4a 54 ± 5b 69 ± 4a 
Ile 83 ± 4a 67 ± 2b 70± 2b  147± 3a 106 ± 3b 119 ± 4b 
Leu 112 ± 5a 66 ± 4c 80± 3b  211± 8a 130 ± 13b 161 ± 8b 
Lys 139 ± 6a 85 ± 3c 98± 4b  200± 9a 140 ± 7b 149 ± 8b 
Met 27 ± 1a 17 ± 0.6c 21± 1b  67± 2a 38 ± 6c 52 ± 2b 
Orn 41 ± 3c 31 ± 2b 33± 2b  143± 8a 73 ± 3c 93 ± 5b 
Phe 46 ± 2a 27 ± 2c 36± 2b  153± 9a 112 ± 12b 113 ± 5b 
Pro 135 ± 4a 64 ± 6c 85± 6b  309± 9a 163 ± 5c 212 ± 11b 
Ser 88 ± 4 104 ± 12 97 ± 7  629± 31a 328 ± 30c 406 ± 15b 
Taurine 118 ± 9a 72 ± 2b 108± 8a  221± 11a 79 ± 5b  187 ± 17a 
Thr 87 ± 5a 44 ± 6c 57± 4b  515± 26a 360 ± 33b 358 ± 20b 
Trp 37 ± 2a 19 ± 2c 26± 2b  71± 4a 49 ± 5c 63 ± 2b 
Tyr 57 ± 3a 37 ± 1b 42± 3b  184± 8a 119 ± 10b 163 ± 12a 
Val 132 ± 6a 75 ± 5b 87± 5b  357± 14a 220 ± 9b  254 ± 12b 
Total α-AA 2713 ± 52a 1952 ± 39c 2138± 37b  6407± 140a 4255 ± 72c 4943 ± 101b
 
Data are means ± SEM.  Means with different superscript letters are different (P 
< 0.05).   Control, ewes were fed 100% of NRC requirements between Days 28 
and 135 of gestation (n = 8).  †Fed 50% of NRC nutrient requirements betweens 
Days 28 and 135 of gestation (n = 5).  ‡Fed 50% of NRC nutrient requirements 
betweens Days 28 and 78 of gestation and realimented to 100% of  NRC 
nutrient requirements between Days 78 and 135 of gestation (n = 8).  AA, amino 
acids. 
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of gestation are summarized in Table 6.4.  Maternal undernutrition between Day 
28 and 135 of gestation markedly reduced (P < 0.05) concentrations of most 
amino acids (alanine, arginine, citrulline, cysteine, glutamine, histidine, 
isoleucine, leucine, lysine, methionine, ornithine, phenylalanine, proline, serine, 
taurine, threonine, tryptophan, tyrosine, and valine) in both maternal and fetal 
plasma.  Concentrations of β-alanine, aspartate, glutamate, glycine, and serine 
in maternal plasma, and concentrations of β-alanine and aspartate in fetal 
plasma did not differ (P > 0.05) between control-fed and nutrient-restricted ewes.  
Realimentation of underfed ewes beginning on Day 78 of gestation increased (P 
< 0.05) concentrations of alanine, cysteine, methionine, proline, taurine, and 
tryptophan in both maternal and fetal plasma by Day 135 of gestation, compared 
with ewes fed 50% of NRC nutrient requirements between Days 28 and 135 of 
gestation.  Concentrations of total α-amino acids were 28% and 34% lower (P < 
0.05), respectively, in maternal and fetal plasma of ewes fed 50% of NRC 
nutrient requirements between Days 28 and 135 of gestation, when compared 
with control-fed ewes.   Realimentation of underfed ewes completely restored, to 
values for control-fed ewes, concentrations of alanine in maternal plasma and of 
alanine, histidine, taurine, and tyrosine in fetal plasma.  However, in maternal 
and fetal plasma, concentrations of most amino acids remained lower (P < 0.05) 
in realimented ewes, in comparison with control-fed ewes.  In maternal and fetal 
plasma, concentrations of total α-amino acids in realimented ewes were 10-16% 
higher (P < 0.01) than those in underfed ewes, but were 21-23% lower (P < 
0.01) than those in control-fed ewes.  
 Table 6.5 summarizes concentrations of amino acids in allantoic and 
amniotic fluids on Day 135 of gestation.  Maternal undernutrition between Days 
28 and 135 of gestation markedly reduced (P < 0.05) concentrations of most 
amino acids (arginine, citrulline, cysteine, glutamate, histidine, isoleucine, 
leucine, lysine, methionine, ornithine, phenylalanine, proline, serine, taurine, 
tryptophan, tyrosine, and valine) in both allantoic and amniotic fluids.  The 
decrease in allantoic fluid serine (84%) was the most striking.  Surprisingly, con- 
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TABLE 6.5.  Amino acid concentrations (µM) in ovine fetal fluids on Day 135 of 
gestation 
  Allantoic fluid   Amniotic fluid 
Amino acid     Control   Restricted†  Realimented‡   Control  Restricted† Realimented‡
Ala 1075±  56a 1342± 75a  774± 110b 194± 8a 71 ±  2c 114± 11b 
β-Ala 1044 ± 49 1162± 139 1041± 46  162± 11 149 ±  8 144± 13 
Arg 670 ± 44a 272± 28c 476± 36b  186± 8a 39 ±  4c 95± 13b 
Asn 260 ± 16 274± 12 285± 17  37± 2a 17 ±  2b 32± 3a 
Asp 182 ± 13 143± 11 153± 9  22± 1a 15 ±  2b 17± 1b 
Cit 592 ± 35a 214± 18c 318± 20b  178± 8a 22 ±  3c 43± 5b 
Cys 393 ± 18a 196± 17c 265± 15b  127± 4a 50 ±  4c 87± 5b 
Gln 1036 ± 50b 1469± 117a 798± 74c  368± 14a 86 ±  8c 121± 8b 
Glu 215 ± 16a 155± 10b 202± 12a  69± 4a 47 ±  3b 50± 4b 
Gly 1447 ± 65b 3103± 373a 1299± 22b  326± 14a 184 ±  6c 240± 18b 
His 341 ± 20a 264± 12b 358± 18a  26± 2a 12 ±  1c 18± 1b 
Ile 167 ± 8a 108± 7b 103± 5b  29± 2a 10 ±  1c 14± 1b 
Leu 258 ± 11a 151± 6b 150± 7b  50± 2a 17 ±  1c 31± 2b 
Lys 493 ± 36a 287± 17b 266± 25b  55± 2a 19 ±  2c 28± 2b 
Met 197 ± 12a 106± 4c 129± 5b  22± 2a 16 ±  1b 17± 1b 
Orn 152 ± 11a 99± 2b 89± 5b  25± 1a 13 ±  1b 14± 1b 
Phe 136 ± 11a 105± 4b 100± 6b  27± 2a 9 ±  1c 13± 1b 
Pro 590±  26a 275± 12c 371± 18b  141± 5a 54±  3c 82± 5b 
Ser 19814±  556 3110± 157c 14438± 1591b 771± 43a 205 ±  4c 365± 31b 
Taurine 1010 ± 51 984± 69 958± 78  127± 10 102 ±  8 103± 10 
Thr 494 ± 28b 1087± 85a 486± 83b  201± 13a 64 ±  4c 99± 6b 
Trp 165 ± 7a 86± 3c 112± 6b  15± 1a 9 ±  1b 13± 1a 
Tyr 222 ± 10a 180± 7b 182± 18b  44± 2a 13 ±  1c 20± 1b 
Val 407 ± 16a 229± 15c 304± 9b   78± 4a 28 ±  2c 50± 4b 
Total α-AA  29304 ± 615 13255± 373c 23168± 526b 2988± 86a 998 ±  22c 1620± 70b 
 
Data are means ± SEM.  Means with different superscript letters are different (P 
< 0.05).  Control, ewes were fed 100% of NRC requirements between Days 28 
and 135 of gestation (n = 8).  †Fed 50% of NRC nutrient requirements betweens 
Days 28 and 135 of gestation (n = 5).  ‡Fed 50% of NRC nutrient requirements 
betweens Days 28 and 78 of gestation and realimented to 100% of  NRC 
nutrient requirements between Days 78 and 135 of gestation (n = 8).  AA, amino 
acids. 
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centrations of alanine, glutamine, glycine, and threonine in allantoic fluid 
increased (P < 0.01) in underfed ewes compared with control-fed ewes.  
Concentrations of alanine, β-alanine, asparagine, and taurine in allantoic fluid or 
concentrations of β-alanine and aspartate in amniotic fluid did not differ (P > 
0.05) between control-fed and nutrient-restricted ewes.  Concentrations of total 
α-amino acids were 55% and 67% lower (P < 0.01), respectively, in allantoic and 
amniotic fluids of underfed ewes, when compared with control-fed ewes.  
Realimentation of underfed ewes beginning on Day 78 of gestation increased (P 
< 0.05) concentrations of arginine, citrulline, cysteine, histidine, proline, serine, 
tryptophan, and valine in both allantoic and amniotic fluids, compared with non-
realimented ewes.  However, in these fetal fluids, concentrations of most amino 
acids in allantoic and amniotic fluids remained lower (P < 0.05) in realimented 
ewes, in comparison with control-fed ewes.  Realimentation of underfed ewes 
completely restored, to values for control-fed ewes, concentrations of glutamate  
 
TABLE 6.6. Polyamine concentrations (µM) in ovine fetal fluids on Day 135 of 
gestation 
Polyamine Allantoic fluid  Amniotic fluid 
  Control Restricted† Realimented‡  Control Restricted† Realimented‡
Putrescine 423 ± 17a 152± 16c 267± 17b  396± 18a 131 ± 10c 273 ± 11b 
Spemidine 723 ± 28a 236± 21c 517± 20b  589± 21a 164 ± 12c 383 ± 25b 
Spermine 946 ± 66a 303± 23c 647± 31b  2787± 76a 821 ± 43c 1697 ± 93b 
Total PA 2092 ± 38a 691± 42c 1431± 38b  3773± 84a 1116 ± 52c 2353 ± 78b 
 
Data are means ± SEM.  Means with different superscript letters are different (P 
< 0.05).   Control, ewes were fed 100% of NRC requirements between Days 28 
and 135 of gestation (n = 8).  †Fed 50% of NRC nutrient requirements betweens 
Days 28 and 135 of gestation (n = 5).  ‡Fed 50% of NRC nutrient requirements 
betweens Days 28 and 78 of gestation and realimented to 100% of  NRC 
nutrient requirements between Days 78 and 135 of gestation (n = 8).  PA, 
polyamines. 
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and histidine in allantoic fluid and of asparagine and tryptophan in amniotic fluid.  
In both allantoic and amniotic fluids, concentrations of total α-amino acids (Table 
6.5) and polyamines (Table 6.6) in realimented ewes were higher (P < 0.01) 
than those in underfed ewes, but were lower (P < 0.01) than those in control-fed 
ewes. 
 
Discussion 
There is growing interest in the Barker hypothesis of the “fetal origin of 
adult disease” initially formulated on the basis of human epidemiological studies 
of the offspring exposed to undernutrition in utero (Barker and Clark, 1997).  
Elucidation of the underlying mechanisms will improve strategies to ensure 
optimal fetal growth and development, as well as reduce the risk of chronic 
diseases in adult life.  Despite reports of reduced concentrations of amino acids 
in plasma of fetal rats (Malandro et al., 1996) as well as plasma and fluids of 
fetal pigs (Wu et al., 1998a) in response to maternal protein deficiency, little else 
is known about the effects of undernutrition on the concentrations of amino acids 
and polyamines in the conceptus of any species.  In addition, although changes 
in concentrations of amino acids in maternal and fetal plasma of women with 
IUGR were documented (Cetin et al., 1988, 1990, 1992a, 1996; Economides et 
al., 1989), whether these changes were caused by maternal undernutrition or 
other genetic and environmental factors was not known.   
This is the first report of changes in concentrations of both amino acids 
and polyamines in the ovine conceptus in response to experimentally controlled 
maternal undernutrition.  There are four major findings from this study: 1) 
maternal undernutrition markedly reduced concentrations of arginine-family 
amino acids (arginine, citrulline, glutamine, ornithine and proline) and branched-
chain amino acids in maternal and fetal plasma and in fetal fluids; 2) serine 
exhibited the most striking decrease in allantoic fluid (84%) and amniotic fluid 
(73%) by late gestation; 3) concentrations of polyamines in allantoic and 
amniotic fluids were much lower in underfed ewes than in control-fed ewes; and 
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4) realimentation of underfed ewes increased concentrations of total α-amino 
acids in maternal and fetal plasma and of total α-amino acids (particularly 
serine) and polyamines in fetal fluids, in association with the compensatory 
growth of the fetal lambs. 
An important finding of this study was that concentrations of all essential 
amino acids in maternal plasma (except for histidine on Day 78 of gestation) 
decreased markedly at both mid- and late-gestation in response to nutrient 
restriction (Tables 6.1 and 6.4).  This result is in sharp contrast to the report that 
concentrations of most essential amino acids in maternal plasma were elevated 
in women with IUGR of unknown etiology (Cetin et al., 1996).  Plasma 
concentrations of amino acids in pregnant animals depend on several factors, 
including rate of amino acids entering the portal vein, rates of whole body amino 
acid synthesis and catabolism, rate of amino acid transfer from maternal to fetal 
plasma, and whole body protein turnover (synthesis and degradation).  Because 
of reduced dietary intake of protein, the entry of amino acids to the portal vein 
and the synthesis of nonessential amino acids were lower in nutrient-restricted 
ewes, compared with control-fed ewes.  A decrease in concentration of urea (a 
major nitrogenous product of protein catabolism) in maternal and fetal plasma of 
underfed ewes (Vonnahme et al., 2003) suggests a decrease in amino acid 
degradation by the whole body.  Likewise, owing to reduced placental-fetal blood 
flows (Ford, 1995), transfer of amino acids from maternal to fetal plasma would 
be reduced in nutrient-restricted ewes, compared with control-fed ewes.  Thus, 
the mobilization of maternal protein reserve (mainly from skeletal muscle) did not 
appear to sufficiently compensate for the decrease in dietary protein intake.  Our 
finding that concentrations of total α-amino acids in both maternal and fetal 
plasma were decreased in underfed ewes supports the view that placental 
transport is a major mechanism responsible for amino acid homeostasis in the 
fetus (Bell and Ehrhardt, 2002).  
Each amino acid has its own unique metabolic pathway that is cell- and 
tissue-specific manner (Stipanuk and Watford, 2000).  Consistent with this 
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notion, maternal undernutrition differentially affected concentrations of amino 
acids in maternal and fetal plasma (Tables 6.1 and 6.4).  For example, on Day 
78 of gestation, concentrations of glycine in both maternal and fetal plasma of 
nutrient-restricted ewes increased 47-55%, but concentrations of most amino 
acids (including serine) decreased, when compared with control-fed ewes (Table 
6.1).  In contrast, on Day 135 of gestation, concentrations of glycine and serine 
in maternal plasma were similar between control-fed and nutrient-restricted 
ewes, but their concentrations in fetal plasma decreased by 40-48% in 
comparison with control-fed ewes (Table 6.1).  Our results indicate the 
metabolism of different amino acids varies with maternal undernutrition.  
Although the alterations in amino acid metabolism may be beneficial for fetal 
survival and growth in response to maternal undernutrition, they may have an 
important impact on postnatal life.   
Remarkably, concentrations of arginine-family amino acids (arginine, 
citrulline, and proline) and all branched-chain amino acids (isoleucine, leucine 
and valine) consistently decreased in all measured compartments of underfed 
ewes at mid- and late gestation.  Similarly, IUGR in humans is associated with 
reduced concentrations of arginine (Bajoria et al., 2001) and branched-chain 
amino acids (Cetin et al., 1988, 1990, 1992a, 1996) in fetal plasma.  A decrease 
in arginine availability would reduce endothelial nitric oxide synthesis (Wu and 
Meininger, 2002), and, therefore, placental-fetal blood flows.  Furthermore, a 
reduced availability of branched-chain amino acids in maternal and fetal plasma 
would impair the synthesis of glutamine by placenta and fetal tissues (e.g., 
skeletal muscle), which is a major fuel for the growing fetus, a primary 
transporter of both carbon and nitrogen among fetal organs, and an essential 
substrate for the synthesis of DNA and aminosugars (Flynn et al., 2002).  
Allantoic fluid is derived from fetal and maternal secretions, but primarily 
from placental transport mechanisms (Bazer, 1989).  Although early anatomical 
studies suggested that the allantoic sac served as a reservoir for fetal wastes, it 
is now clear that amino acids and their metabolic products (e.g., polyamines) in 
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allantoic fluids may be absorbed by the allantoic epithelium into the fetal-
placental circulation and utilized by fetal-placental tissues (Bazer, 1989; Kwon et 
al., 2003a, 2003b).  We recently reported an unusual abundance of serine (16–
19 mM) in ovine allantoic fluid during late gestation (Days 100-140) (Kwon et al., 
2003a), suggesting a critical role for this neutral amino acid in fetal growth.  
Strikingly, serine concentration in allantoic fluid decreased 84% by Day 135 of 
gestation in underfed ewes, compared with control-fed ewes (Table 6.4).   
Our finding that serine was the only amino acid that exhibited such a 
marked change in response to maternal undernutrition raised an important 
question regarding serine metabolism and its significance to fetal development.  
The available evidence indicates that there is uterine uptake of serine from 
maternal plasma, but there is little transplacental transport of serine to the ovine 
fetus owing to its extensive catabolism by uteroplacental tissues (Moores et al., 
1994; Bell et al., 1989).  Thus, in fetal lambs, large amounts of serine are 
synthesized from glycine and N5,N10-methylenetetrahydrofolate via serine 
hydroxymethyl-transferase and from 3-phosphoglycerate (an intermediate of 
glycolysis) and glutamate via phosphoglycerate dehydrogenase and 
phosphoserine aminotransferase (Moores et al., 1994; Narkewicz et al., 1999).  
All these enzymes are present in fetal ovine liver and kidney, with the liver being 
the major organ for serine synthesis in fetal sheep (Narkewicz et al., 1999, 
2002).  The reduction in serine seen as a result of maternal undernutrition may 
therefore be an indicator of liver and/or kidney damage, both of which have long 
term metabolic and cardiovascular consequences later in life. Maternal 
undernutrition may also reduce the expression of these enzymes, thereby 
suppressing serine production.  In support of this view, the concentration of 
glycine in allantoic fluid on Day 135 of gestation was markedly elevated in 
nutrient-restricted ewes (Table 6.5).  Serine is a major glucogenic amino acid in 
humans and ewes (Clark et al., 1976).  It also plays an important role in one-
carbon unit metabolism essential for 2’-deoxythymidylate synthesis and 
methylation (Snell and Fell, 1990).  In addition, serine participates in the 
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synthesis of phosphatidylserine and ceramide (signaling molecules) (Stipanuk 
and Watford, 2000). All of these events are critical for DNA synthesis and thus 
cell proliferation.  Therefore, we surmise that a reduced availability of serine in 
the conceptus may impair the synthesis of glucose, DNA and protein, thereby 
contributing to IUGR in underfed ewes. 
 Amniotic fluid is composed of water and electrolytes from both the fetus 
(kidneys, lungs, epidermis, and fetal blood vessels in the placenta and umbilical 
cord) and the mother (decidual blood vessels via amniotic membranes) (Schmidt, 
1992).  This fluid is removed by both the fetus and the mother through the same 
channels, along with the participation of the fetal intestine following swallowing 
(Schmidt, 1992).  Through the kidney, bladder and urachus, and placental 
vasculature, there are nutrient exchanges between amniotic and allantoic fluid 
(Bazer, 1989).  We recently reported that glutamine (a major fuel for enterocytes 
and a regulator of intestinal function) and polyamines (essential for intestinal cell 
proliferation and differentiation) are particularly abundant in amniotic and 
allantoic fluids (Kwon et al., 2003a, 2003b).  Thus, with the development of 
intestinal amino acid and polyamine transport systems during gestation (Sagawa 
et al., 1979), the drinking of amniotic fluid provides a source of both amino acids 
and polyamines for utilization by the fetal intestine and other fetal tissues.  The 
nutritional significance of amniotic fluid is graphically illustrated by the finding 
that esophageal ligation, which prevents the entry of this fluid into the small 
intestine, results in IUGR in fetal sheep (Trahair and Harding, 1995).  
Remarkably, concentrations of both glutamine and polyamines were severely 
depleted in ovine amniotic and allantoic fluids at mid- and late gestation (Tables 
6.3 and 6.6).  The reduced availability of glutamine and polyamines may 
contribute to the retarded growth of the fetal small intestine and other fetal 
tissues in underfed ewes.  
 Realimentation of underfed ewes beginning from mid-gestation increased 
concentrations of total α-amino acids in maternal and fetal plasma as well as α-
amino acids and polyamines allantoic and amniotic fluids, compared with non-
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alimented ewes (Table 6.4).  These results indicate that increasing maternal 
concentrations of amino acids can increase their availability in fetal plasma and 
fluids.  Importantly, realimentation of underfed ewes increased serine 
concentrations in allantoic fluid 4-fold in comparison with underfed ewes (Table 
6.5), suggesting an increase in intra-fetal synthesis of serine.  However, in all of 
the measured compartments, concentrations of total α-amino acids and 
polyamines remained lower in realimented ewes, compared with control-fed 
ewes.  There are several possible explanations for these findings.  First, 
utilization of amino acids for tissue protein synthesis was augmented to meet the 
increased need for compensatory growth of both the mother and the fetus 
between Days 78 and 135 of gestation.  Because the provision of dietary protein 
to realimented ewes was the same for control-fed ewes (per kg metabolic 
weight), an increase in tissue protein synthesis in both dams and fetal lambs 
likely led to decreased availability of free amino acids in maternal and fetal 
plasma and in fetal fluids.  Second, because underfed ewes exhibit 
compensatory growth of placentomes in response to realimentation during late 
gestation (Gardner et al., 2002), increased amounts of amino acids would be 
directed towards placentomal protein synthesis, thereby reducing their transfer 
from maternal and fetal blood.  Third, arginine, ornithine and methionine, as well 
as proline and glutamine (precursors of ornithine) are important substrates for 
the synthesis of putrescine, spermidine and spermine (Wu and Morris, 1998), 
and, therefore, the reduced availability of these amino acids in fetal plasma and 
fluids would contribute to a decrease in polyamine synthesis by placental, 
uterine and fetal tissues.   
 There are multiple genetic and environmental factors that can cause 
IUGR (Marsal, 1995).  Although the fetal genome plays an important role in 
growth potential in utero, increasing evidence suggests that the intrauterine 
environment is a major determinant of fetal growth.  For example, embryo-
transfer studies show that it is the recipient mother rather than the donor mother 
that more strongly influences fetal growth (Brooks et al., 1995).  Among 
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intrauterine environmental factors, nutrition appears to play a critical role in 
influencing placental growth and fetal programming (Godfrey and Robinson, 
1998).  Because amino acids and their metabolic products (e.g., nitric oxide and 
polyamines) are crucial for placental-fetal growth and development (Sladek et al., 
1997; Wu and Morris, 1998; Reynolds and Redmer, 2001; Bird et al., 2003), 
increasing provision of arginine, serine, branched-chain amino acids, and other 
amino acids may help prevent IUGR.  In humans, even a modest increase in 
fetal growth will bring a significant improvement in pregnancy outcomes (Brooks 
et al., 1995; Godfrey and Robinson, 1998; Marsal, 2002; Kramer, 2003).  
Therefore, identifying new means to promote an optimal intrauterine 
environment will be very beneficial to ensure optimal pregnancy outcomes while 
saving billions of healthcare dollars annually both in the U.S. and around the 
world. 
 In conclusion, the availability of total α-amino acids, particularly serine, 
arginine-family amino acids, and branched-chain amino acids, were severely 
reduced in maternal and fetal plasma and in fetal fluids of underfed ewes.  
Maternal undernutrition also markedly decreased polyamine concentrations in 
fetal allantoic and amniotic fluids.  Realimentation of underfed ewes beginning 
from mid-gestation increased concentrations of total α-amino acids in maternal 
and fetal plasma and of polyamines in fetal fluids.  These findings establish a 
foundation for further studies to define the roles of amino acids and polyamines 
in the prevention and treatment of IUGR brought about by maternal 
undernutrition. 
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CHAPTER VII 
                                      SUMMARY AND CONCLUSIONS  
 
This is the first known report of changes in concentrations of amino acids 
in ovine fetal fluids and plasma, and changes in polyamine synthesis and 
concentrations, and NO synthesis in ovine placental and endometrial tissues 
throughout gestation.  Four major findings from these studies were: (1) 
concentrations of amino acids and polyamines in ovine allantoic and amniotic 
fluids, plasma and utero-placental tissues change markedly during gestation; (2) 
the activities of ODC, arginase, and NO synthase are expressed in ovine 
placentomes, intercotyledonary placenta, and intercaruncular endometrium; (3) 
polyamine synthesis and NO production vary greatly among ovine placental and 
endometrial tissues, fetal fluids and with day of gestation; and (4) maternal 
undernutrition markedly reduced concentrations of amino acids and polyamines 
in fetal fluids. 
The experiment described in Chapter III was conducted to test the 
hypothesis that arginine is the most abundant amino acid in ovine allantoic fluid 
during early gestation, because an unusual abundance of arginine (4 to 6 mM) 
was previously reported for porcine allantoic fluid during early gestation (Wu et 
al., 1996).  However, it is not known whether such high concentrations of 
arginine are unique for porcine allantoic fluid or if they represent an important 
physiological phenomenon for mammals.  The measurement of amino acids 
other than arginine is necessary to determine its relative abundance in ovine 
fetal fluids.  In contrast to high concentrations of arginine in porcine allantoic fluid 
during early gestation, arginine was not the major amino acid in ovine allantoic 
fluid during early gestation.  Rather, ovine allantoic fluid was particularly rich in 
four of the traditionally classified nonessential amino acids: alanine, citrulline, 
glutamine, and serine (Table 3.7).  Concentrations of alanine, citrulline, and 
glutamine in allantoic fluid increased by 20-, 34-, and 18-fold, respectively, 
between Days 30 and 60 of gestation, and were 24.7, 9.7, and 23.5 mM, 
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respectively, on Day 60 of gestation (compared with 0.8 mM arginine).  
Remarkably, alanine, citrulline and glutamine accounted for about 80% of total 
α-amino acids in allantoic fluid during early gestation.  Serine (16.5 mM) 
contributed about 60% of total α-amino acids in allantoic fluid on Day 140 of 
gestation.  The unusual abundance of alanine and citrulline on Day 60 of 
gestation and of serine during late gestation has not been reported for any other 
biological fluid in animals (e.g., Lemons et al., 1976; Marconi et al., 1989; Snell 
and Fell, 1990; Curthoys and Watford, 1995; Wu et al., 1996; Wu and Morris, 
1998; Stipanuk and Watford, 2000).  However, the increases in concentrations 
of total amino acids in allantoic fluids during early pregnancy could not be 
accounted for by changes in allantoic fluid volume (Table 3.1) or by changes in 
concentrations of amino acids in maternal and fetal plasma (Tables 3.2 and 3.3). 
On the other hand, alanine, glutamine, glycine and serine in amniotic fluid 
were the most abundant α-amino acids at all gestational ages and contributed 
approximately 50 % of total α-amino acids.  Glycine was the most abundant 
amino acid in maternal uterine arterial plasma, representing about 25% of total 
α-amino acids.  Alanine, glutamine, glycine and serine contributed about 50% of 
total α-amino acids in fetal plasma.  Fetal:maternal plasma ratios for amino acids 
varied greatly, being < 1 for glutamate during late gestation, 1.5 to 3 for most 
amino acids throughout gestation, and > 10 for serine during late gestation.   
 Results of this study raise important questions regarding the origin and 
function of alanine, glutamine, citrulline, and serine in ovine fetal-placental 
nutrition and metabolism.  Both glutamine and alanine may be synthesized from 
branched-chain amino acids in fetal ovine skeletal muscle (Goodwin et al., 
1987).  On the basis of maternal arterial-fetal umbilical venous differences in 
amino acid concentrations (Tables 3.2 and 3.3), it is suggested that the ovine 
placenta synthesizes citrulline.  Arginine is the most abundant nitrogen carrier in 
tissue proteins (Meier et al., 1981; Wu et al., 1999a).  Whatever the differences 
among species, the unusual abundance of either citrulline (an effective 
precursor of arginine) in ovine allantoic fluid (Table 3.7) or arginine in porcine 
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allantoic fluid (Wu et al., 1995a, 1996a, 1998a) during early gestation raises 
intriguing and important questions regarding the physiological significance of 
arginine-dependent pathways in fetal-placental nutrition and development.  It is 
now clear that allantoic fluid nutrients may be absorbed by the allantoic 
epithelium into the fetal-placental circulation and utilized by fetal-placental 
tissues (Bazer, 1989), although early anatomical studies suggested that the 
allantoic sac served only as a reservoir for fetal wastes.  The amino acids that 
accumulate in allantoic fluid during early gestation may play an important role in 
fetal growth and development.  
The experiment described in Chapter IV was designed to determine the 
ODC and arginase activities, arginine, ornithine, and polyamine concentrations, 
and polyamine synthesis during pregnancy, because marked increases in 
concentrations of both ornithine and arginine (substrate for polyamine synthesis) 
in ovine allantoic fluids (a reservoir for nutrients in the fetus) between Days 30 
and 60 of gestation, and amniotic and allantoic derive, in part, from secretions 
and transport of water across the placenta and endometrium.  Ovine allantoic 
fluid is rich in ornithine and arginine (Kwon et al., 2003a), and is likely a major 
source of these two amino acids for placenta and endometrium.  This view is 
supported by the fact that the highest concentrations of arginine in ovine 
allantoic fluid on Day 100 of gestation (Kwon et al., 2003a) were associated with 
the highest concentrations of arginine in intercotyledonary placenta and 
intercaruncular endometrium (Table 4.7) and with elevated concentrations of 
arginine in placentomes (Table 4.7).  In addition, between Days 30 and 80 of 
gestation, increases in substrate concentrations and polyamine synthesis in 
ovine placental and endometrial tissues (Tables 4.4-4.6) are associated with 
increases in ornithine and arginine concentrations in ovine allantoic fluid (Kwon 
et al., 2003a), further supporting the earlier suggestion that this fetal fluid is an 
important nutrient reservoir during gestation (Bazer, 1989).  In ovine allantoic 
and aminotic fluids, polyamines were most abundant during early (Days 40-60) 
and late (Days 100-140) gestation.  Increases in polyamine concentrations in 
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allantoic fluid between Days 30 and 60 of gestation (Table 4.8) were closely 
correlated with increases in polyamine synthesis in ovine placentomes and 
endometrium (Tables 4.4 and 4.5). 
Polyamine synthesis is regulated by ODC and arginase activities as well 
as the availability of ornithine and arginine (Wu and Morris, 1998; Li et al., 2001; 
Wei et al., 2001), because, through the formation of ornithine, arginase would be 
expected to play a regulatory role in polyamine synthesis from arginine and 
arginine was actively converted into polyamines in ovine placental and 
endometrial tissues (Table 4.5).  Thus, rates of polyamine synthesis were 
closely correlated with arginase activity in these tissues (Table 4.2) and ODC 
activity was positively correlated with polyamine concentrations in placentomes 
and endometrium (Table 4.11).  In addition, concentrations of both ornithine and 
polyamines peaked between Days 60 and 80 of gestation in intercotyledonary 
placenta (Tables 4.5 and 4.6).  These results further support an important role 
for polyamine synthesis in regulating polyamine concentrations.   
Collectively, placentomal arginase activity and arginine concentrations 
peaked on Day 40 of gestation (Table 4.2), thus maximizing the hydrolysis of 
arginine to ornithine and markedly increasing intracellular concentrations of 
ornithine (Table 4.7).  The latter was coupled with the highest ODC activity for 
polyamine synthesis (Table 4.1), thereby maximizing polyamine concentrations 
(Table 4.6) in ovine placentomes during early gestation.  Similarly, arginase and 
ODC activities, intracellular ornithine concentrations, and polyamine synthesis 
from both ornithine or arginine were maximal in intercaruncular endometrium on 
Day 40 of gestation, resulting in highest concentrations of polyamines (Table 
4.6).  Furthermore, concentrations of glutamine, a major substrate for ornithine 
and arginine synthesis (Wu and Morris, 1998) and a stimulator of ODC activity 
(Wu et al., 2000c), were highest in ovine allantoic fluid between Days 40 and 60 
of gestation (Kwon et al., 2003a).  
Finally, arginine is an important precursor for polyamine synthesis in the 
ovine placenta and endometrium, metabolic coordination among the several 
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integrated pathways that support high rates of polyamine synthesis in the 
placenta and endometrium during early gestation. 
The experiment described in Chapter V was designed to determine the 
NOS and GTP-CH activities, NO synthesis, tetrahydrobiopterin and NADPH in 
placenta and endometium, because arginase and NOS use arginine as a 
common substrate, and metabolic coordination among the several integrated 
pathways that may support high rates of NO in placenta and endometrial tissues.  
Placental synthesis of NO, like that of polyamines (other products of arginine 
catabolism essential for placental angiogenesis and growth), increased markedly 
between Days 30 and 60 of gestation when placental growth and placentomal 
development are most rapid.  Likewise, NO synthesis in intercaruncular 
endometrium peaked on Days 40-60 of gestation, when this tissue undergoes 
marked morphological and functional changes.  It is noteworthy that there was a 
second peak in placentomal NO synthesis on Day 100 of gestation, when 
placental-fetal blood flow continues to increase in pregnant ewes (Ford, 1995; 
Reynolds and Redmer, 1995).  The increase in NO synthesis during late 
gestation may play an important role in enhancing the transfer of nutrients and 
oxygen from maternal to fetal blood to support the most rapid absolute growth of 
the fetus.  In addition, cNOS and iNOS activities vary greatly with ovine placental 
and endometrial tissues and gestational age.  For example, in placentomes, 
cNOS and iNOS activities predominated during mid (Days 60-80) and late (Days 
120-140) gestation, respectively.  In intercaruncular endometrium, cNOS activity 
was 10-fold greater than, and similar to, iNOS activity on Days 40 and 140 of 
gestation, respectively.  In contrast, in intercotylednonary placenta, cNOS 
activity was less and greater than iNOS activity on Days 30 and 80 of gestation, 
respectively. 
 Placentomal GTP-CH activity peaked on Day 60 of gestation (Table 5.2), 
thus maximizing the de novo synthesis of BH4.  Consequently, placentomal BH4 
and NADPH concentrations were highest on Day 60 of gestation (Table 5.5).  All 
of these changes contribute to maximal NO production during early pregnancy.  
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Thus, maximal activities of NOS and GTP-CH, the greatest availability of BH4 
and NADPH, and the highest rate of NO synthesis occurred in ovine placenta 
and endometrium in the first half of pregnancy.  All of these measured 
parameters, except for NADPH, exhibited a second peak during late gestation 
when there is a continued increase in fetal-placental blood flows.  In addition, 
changes in GTP-CH activity were positively correlated with changes in BH4 
levels in ovine intercotyledonary placenta, placentome, and intercaruncular 
endometrium between Days 30 and 140 of gestation.  Intriguingly, in ovine 
placenta and endometrium, both NADPH and BH4 levels increased markedly 
between Days 40 and 60 of gestation (Table 5.4), as did allantoic fluid 
concentrations of citrulline (the precursor of arginine) and arginine (Kwon et al., 
2003a).  Between Days 80 and 100 of gestation, BH4 concentrations also 
increased in placentome and endometrium (Table 5.4), as did concentrations of 
arginine in allantoic fluid (Kwon et al., 2003a).  In support of this view, rates of 
NO synthesis in ovine placenta and endometrium were positively correlated with 
NADPH and BH4 levels during pregnancy (Table 5.5). 
 Finally, NO synthesis was highest in both placentomes and endometrium 
of ewes on Day 60 of gestation when their growth and morphological changes 
are most rapid and when fetal-placental blood flows increase substantially.  
Relatively high rates of NO synthesis occurred in the second half of pregnancy 
in association with further increases in the placental vascular bed and uterine 
blood flow to support rapid fetal growth.   
 These novel results may have important implications for both intrauterine 
growth retardation and fetal origins of diseases in adults, because recent 
epidemiological studies in humans suggest links between intrauterine growth 
retardation and development of chronic disease (e.g., diabetes, hypertension, 
and coronary heart disease) later in life (Barker and Clark, 1997; Symonds et al., 
2001). 
 The experiment described in Chapter VI was designed to determine the 
concentrations of amino acids and polyamines in fetal fluids in response to 
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maternal undernutrition, because the significance of these changes for normal 
fetal growth and development may be underscored under a pathophysiological 
condition.  Concentrations of all essential amino acids in maternal plasma 
(except for histidine on Day 78 of gestation) decreased markedly at both mid- 
and late-gestation in response to nutrient restriction (Tables 6.1 and 6.4).  In 
addition, concentrations of arginine-family amino acids (arginine, citrulline, and 
proline) and all branched-chain amino acids (isoleucine, leucine and valine) 
consistently decreased in all measured compartments (including maternal and 
fetal plasma as well as allantoic and amniotic fluids) of underfed ewes at mid- 
and late gestation.  Particularly, serine exhibited the most striking decrease in 
allantoic fluid (84%) and amniotic fluid (73%) by late gestation in response to 
maternal undernutrition.  On the other hand, realimentation of underfed ewes 
increased concentrations of total α-amino acids in maternal and fetal plasma, 
and concentrations of polyamines and total α-amino acids (particularly serine in 
allantoic fluid by 4-fold over value for underfed ewes) (Table 6.5) in fetal fluids, 
because of suggesting an increase in intra-fetal synthesis of serine.  However, in 
all of the measured compartments, concentrations of total α-amino acids and 
polyamines remained lower in realimented ewes, compared with control-fed 
ewes.  Concentrations of polyamines in allantoic and amniotic fluids were much 
lower in underfed ewes than in control-fed ewes. 
In conclusion, remarkable changes occur in the concentrations of amino 
acids in ovine fetal allantoic fluid between Days 30 and 140 of gestation.  In this 
fluid, alanine, citrulline, and glutamine contributed approximately 80 % of total α-
amino acids during early gestation, and serine accounted for approximately 
60 % of total α- amino acids during late gestation.  In addition, polyamine 
synthesis and concentrations, and NO synthesis were highest in both 
placentomes and endometrium of ewes on Days 40, and 60 of gestation 
(respectively) when their growth and morphological changes are most rapid and 
when fetal-placental blood flows increase substantially.  However, 
concentrations of amino acids and polyamines in fetal fluids markedly decreased 
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in response to maternal undernutrition.  Therefore, amino acids and their 
metabolic products (e.g., nitric oxide and polyamines) are crucial for placental-
fetal growth and development (Sladek et al., 1997; Wu and Morris, 1998; 
Reynolds and Redmer, 2001; Bird et al., 2003), and, because of increasing 
provision of arginine, serine, branched-chain amino acids, and other amino acids 
they may help prevent IUGR.  These results establish a new base of information 
for future studies to define the roles of amino acids and polyamines in fetal-
placental growth and development.  Future studies are necessary to detect 
mRNAs and proteins for NO synthases, ODC using in situ hybridization and 
immunohistochemical analysis. 
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